Articles and methods for analyte concentration measurement

By contacting the probe with the fluid and detecting signal changes, the problem of insufficient measurement of analyte concentration velocity and accuracy in the prior art is solved, and fast, continuous and high-precision analyte concentration measurement is achieved, which simplifies the operation of the biological treatment system.

CN119013389APending Publication Date: 2024-11-22SARTORIUS BIOANALYTICAL INSTRUMENTS INC
View PDF 0 Cites 2 Cited by

Patent Information

Application Number
CN202380035657.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-09-20
Filing Date
2023-04-24
Publication Date
2024-11-22

AI Technical Summary

Technical Problem

Existing scientific instruments are difficult to measure analyte concentrations in fluids with high specificity, high concentrations, low hysteresis, or high velocity.

Method used

The probe is used to contact the fluid, and the signal changes are detected to determine the analyte concentration, and based on this change, the instructions are sent to the biological processing system, and the measurement is performed using the optical signal and the analyte fixed rate on the probe.

Benefits of technology

The rapid continuous detection of high concentration analytes is achieved, which improves measurement accuracy and speed, simplifies operation and troubleshooting of biological processing systems, and reduces dependence on operators.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119013389A_ABST
    Figure CN119013389A_ABST
Patent Text Reader

Abstract

Instruments and associated methods are generally provided. Advantageously, some instruments described herein may be capable and / or configured to rapidly and continuously detect the concentration of an analyte in a flowing fluid, in a fluid comprising a high concentration of the analyte, and / or in several fluids and / or samples of fluids. Some methods may include detecting the concentration of an analyte, which is advantageous for one or more of the foregoing reasons.
Need to check novelty before this filing date? Find Prior Art

Description

CROSS-REFERENCE TO RELATED APPLICATIONS

[0001] This application claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application No. 63 / 334,452, filed on April 25, 2022, entitled “Articles and Methods for Analyte Concentration Measurements,” and U.S. Provisional Application No. 63 / 408,279, filed on September 20, 2022, entitled “Advanced Control Strategies for Continuous Capture of Monoclonal Antibodies Based on Biolayer Interferometry,” each of which is incorporated herein by reference for all purposes. Technical Field

[0002] Apparatus and associated methods for assessing analyte concentrations are generally described. Background Art

[0003] Scientific instruments can be used to determine the concentration of analytes in various fluids. However, such instruments may have difficulty measuring analytes with high specificity, high concentration, low hysteresis, or high speed.

[0004] Therefore, new instruments and methods are needed. Summary of the invention

[0005] The present disclosure generally describes apparatus and methods. In some cases, the subject matter described herein relates to interrelated products, alternative solutions to a particular problem, and / or multiple different uses of one or more systems and / or articles.

[0006] In some embodiments, a method is provided. The method includes: contacting a probe with a fluid for a first time period; detecting a change in a signal during the first time period; determining a first concentration based on the change in the signal during the first time period; and sending instructions to a bioprocessing system based on the determination of the first concentration. The fluid is flowing through the probe. An analyte is present in the fluid at a first concentration. At least a portion of the analyte becomes immobilized on the probe.

[0007] In some embodiments, a method includes contacting a probe with a fluid during a first time period. The fluid is flowing through the probe. An analyte is present in the fluid at a first concentration. At least a portion of the analyte becomes fixed on the probe. The method also includes detecting a change in an optical signal during the first time period. The method also includes determining a first concentration based on a change in the optical signal during the first time period. The optical signal includes light reflected from an interface inside the probe and light reflected from an end of the probe.

[0008] In some embodiments, a system is provided. The system includes a first instrument and a bioprocessing system, the first instrument including a probe and a detector, the detector being configured to detect changes in a signal within a first time period. The system is configured to supply a fluid from the bioprocessing system to the first instrument. The first instrument is configured to determine a first concentration of an analyte in the fluid when the fluid contacts the probe and flows through the probe based on changes in the signal within the first time period. The system is configured to send an instruction to the bioprocessing system based on the determination of the first concentration.

[0009] In some embodiments, a first instrument is provided. The first instrument includes a probe and an optical detector configured to detect a change in an optical signal over a first time period. The first instrument is configured to determine a first concentration of an analyte in a fluid contacting and flowing through the probe based on the change in the optical signal over the first time period. The optical signal includes light reflected from an interface inside the probe and light reflected from an end of the probe.

[0010] Other advantages and novel features of the present invention will become apparent from the following detailed description of various non-limiting embodiments of the present invention when considered in conjunction with the accompanying drawings. In the event that this specification and a document incorporated by reference include conflicting and / or inconsistent disclosures, this specification shall prevail. If two or more documents incorporated by reference include conflicting and / or inconsistent disclosures relative to each other, the document with the later effective date shall prevail. BRIEF DESCRIPTION OF THE DRAWINGS

[0011] Non-limiting embodiments of the present invention will be described by way of example with reference to the accompanying drawings, which are schematic and are not intended to be drawn to scale. In the drawings, each identical or nearly identical component illustrated is typically represented by a single reference numeral. For clarity, not every component is labeled in every drawing, nor is every component of every embodiment of the invention shown, where illustration is not necessary to allow one of ordinary skill in the art to understand the present invention. In the drawings:

[0012] Figure 1 depicts an apparatus including a probe and an optical detector according to some embodiments;

[0013] Figure 2depicts an apparatus in which a probe is optically coupled to an optical detector via an optical cable according to some embodiments;

[0014] Figure 3 depicts an apparatus including a probe, an optical detector, and a light source according to some embodiments;

[0015] Figure 4 depicts an apparatus in which a light source is optically coupled to a probe according to some embodiments;

[0016] Figure 5 depicts an instrument including a housing in which a probe is positioned according to some embodiments;

[0017] Figure 6 depicts an apparatus including an inlet and an outlet according to some embodiments;

[0018] Figure 7 depicts an instrument including a probe and a microfluidic channel according to some embodiments;

[0019] Figure 8 An apparatus including a source of fluid is depicted according to some embodiments;

[0020] Fig. 9 depicts an instrument including a valve according to some embodiments;

[0021] Fig.10 depicts an instrument including a plurality of valves according to some embodiments;

[0022] Figure 11 to Figure 12 depicts a probe according to some embodiments;

[0023] Fig.13 depicts an instrument enclosed by a housing according to some embodiments;

[0024] Fig.14 depicts an apparatus comprising two or more parts enclosed by separate housings according to some embodiments;

[0025] Fig.15 depicts a process by which the amount of an analyte immobilized on a probe may be detected according to some embodiments;

[0026] Fig.16 depicts a cross-section of a probe including an optical fiber according to some embodiments;

[0027] Figure 17 to Figure 18 depicts a probe including a plastic hub according to some embodiments;

[0028] Figures 19 to 21 shows a simulated optical signal for equilibrium immobilization of an analyte on a probe according to some embodiments;

[0029] Figure 22 to Figure 24 depicts a method according to some embodiments in which a probe is contacted with a fluid that may contain an analyte and is subsequently regenerated and neutralized;

[0030] Fig.25 is a graph showing an optical signal (which is indicative of analyte binding), a first derivative of the optical signal, and method steps in a method including regenerating a probe according to some embodiments;

[0031] Fig.26 depicts an instrument including a microfluidic channel according to some embodiments;

[0032] Figures 27 to 30 depicts an exemplary apparatus according to some embodiments;

[0033] Fig.31 shows a first derivative of an optical signal as a function of time according to some embodiments;

[0034] Fig.32 shows the measured time of column breakthrough of a chromatography system according to some embodiments;

[0035] Fig.33 schematically depicts a biolayer interferometry process according to some embodiments;

[0036] Fig.34 schematically illustrates a process control strategy according to some embodiments;

[0037] Fig.35 is a photograph showing a prototype of an instrument according to some embodiments;

[0038] Fig.36 is a schematic diagram of an apparatus according to some embodiments;

[0039] Fig.37 shows data obtained during a measurement cycle according to some embodiments;

[0040] Fig.38 shows a control strategy according to some embodiments;

[0041] Fig.39 shows data obtained during perfusion cell culture according to some embodiments;

[0042] Fig.40 is a schematic diagram of an apparatus for performing dynamic flow control and dynamic loading according to some embodiments; and

[0043] Figure 41 to Figure 43 Data obtained during a continuous capture process according to some embodiments is shown. DETAILED DESCRIPTION

[0044] Instruments, systems and associated methods are generally provided. Advantageously, some instruments and systems described herein may be capable of and / or configured to rapidly and continuously detect the concentration of an analyte in a flowing fluid, in a fluid containing an analyte with a concentration higher than that which will saturate the fixation capacity of a probe (e.g., the fixation capacity of a probe in equilibrium), and / or in a sample of several fluids and / or fluids. Some methods may include detecting the concentration of an analyte, which is advantageous for one or more of the aforementioned reasons. Some instruments, systems and methods described herein may also lack one of the aforementioned advantages and / or be performed under conditions other than those mentioned above (e.g., to a stationary fluid, to a fluid containing a low concentration of an analyte, and / or to a single fluid).

[0045] Some methods involve using a probe to measure one or more properties of a fluid supplied by a bioprocessing system, and then supplying instructions to the bioprocessing system based on the properties of one or more such measurements, and some systems described herein may be able to and / or be configured to perform such methods. Such methods can be performed for upstream bioprocessing operations and / or downstream bioprocessing operations. Such instructions may include instructions for modifying one or more properties of the fluid in the bioprocessing system (e.g., returning them to a specific range), supplying the fluid to a different location (e.g., when the location to which the fluid is supplied is no longer able to receive more such fluid or when it will be unhelpful to supply more such fluid), pausing (e.g., allowing an operator to troubleshoot, stop supplying fluid until the operator takes action), and / or not taking action (e.g., if the measurement results indicate that the conditions in the bioprocessing system are acceptable, if it is desired to continue to supply fluid to the same location).

[0046] Advantageously, methods involving measuring one or more properties of a fluid supplied by a bioprocessing system and then supplying instructions to the bioprocessing system based on one or more such measured properties can allow one or more features of a bioprocessing system to be monitored during its operation and / or allow one or more features of a bioprocessing system to be maintained within a specific range during the operation of the bioprocessing system. These actions can be performed in an automated manner (e.g., without the need for operator attention and / or action). Allowing automated monitoring and / or control of bioprocessing system features can allow troubleshooting, recording of conditions present during any particular bioprocessing run, and / or quality control. They can also simplify laboratory operations by eliminating the need for an operator to perform functions that are automatically performed.

[0047] Some methods relate to using a single probe to measure the concentration of an analyte in several fluid samples. Some instruments described herein can and / or are configured to perform such measurements. The ability to perform such measurements can be beneficially allowed to perform several measurements without the need to change the probe, which can improve the speed of performing the measurements and / or reduce the cost of performing several measurements by reducing the number of required probes. When it is necessary to perform many measurements relatively quickly, such as when determining the concentration of an analyte in a fluid over time and / or when determining the concentration of an analyte in a fluid supplied from various instruments, performing such measurements may be particularly beneficial.

[0048] In some embodiments, method and / or instrument can utilize the component that promotes the rapid analysis of several fluid samples.As an example, in some embodiments, instrument comprises one or more valves that can be switched in a reversible manner between multiple positions.Each valve may be able to and / or be configured to be placed in a reversible manner one or more sources of fluid in fluid communication with probe.Some instruments may include valves that can be switched in a reversible manner between two or more sources of fluid being placed in fluid communication with probe (for example, at least two of the positions where valves can be switched in a reversible manner are communicated with different source fluids of fluid).Some instruments may include one or more valves that supply fluid directly to probe.Switchable valves and valves that supply fluid directly to probe can increase the rate and / or concentration that can provide fluid to probe compared with other methods that can provide fluid to probe, which can increase the speed that can obtain signals from the interaction between fluid and probe.For example, such valves can supply fluid directly to probe without further dilution by other sources of fluids that supply different (for example, dilution) fluids to probe.

[0049] Some methods involve using several probes. Some instruments described herein can and / or are configured to use several probes. Using several probes can advantageously allow the sample obtained continuously from the continuous source of fluid to be measured. For example, the continuous fluid stream of the expected change in the concentration of the analyte can be measured. The continuous fluid stream can be divided into several samples, and the sample can be supplied to the probe in a manner such that each sample is measured. The presence of several probes can allow one (or more) probes to be used to contact the sample and fix any analyte present therein, while one (or more) probes undergo a regeneration process so that it or they can be used to contact different samples and fix any analyte present therein. Then, the regenerated one (or more) probes can be used to contact the sample and fix any analyte present, while the (multiple) probes previously used to contact (multiple) samples are regenerated. In some such embodiments, any sample being generated can be supplied to the regenerated probe, and any probe that has been exposed to the sample can undergo a regeneration process, while another probe is exposed to a different sample, which can allow any sample generated at the time of generation to be measured.

[0050] Some methods relate to measuring the concentration of analyte based on the speed at which analyte becomes fixed on the probe. Some instruments described herein are configured to and / or can perform such measurements. Measuring the speed at which analyte becomes fixed on the probe can advantageously allow to measure higher analyte concentrations with relatively high accuracy, such as analyte concentrations that will saturate the ability of the probe to fix the analyte, analyte concentrations that are close to such concentrations or exceed such concentrations. An analyte in a concentration that will result in a balance of the same or similar amount on the probe can become fixed on the probe at different rates and / or at a rate that is more easily distinguishable from each other. Therefore, measuring the speed at which analyte becomes fixed on the probe can provide a mode of measuring analyte concentrations with accuracy that may be impossible for other technologies.

[0051] In addition, measuring the rate at which the analyte becomes fixed on the probe can be a relatively fast way to measure the concentration of the analyte in the fluid and / or in the sample of the fluid. In some embodiments, the measurement of the rate at which the analyte becomes fixed on the probe is performed before the analyte reaches its steady-state level fixed on the probe and / or the data obtained before the analyte reaches its steady-state level fixed on the probe are measured. In some embodiments, the time period is relatively short, which can allow the concentration of the analyte in the fluid and / or in the sample of the fluid to be determined relatively quickly.

[0052] Some methods relate to performing measurement when the sample of fluid and / or fluid flows across the probe. Some instruments described herein can and / or are configured to perform measurement in order to the fluid and / or the sample of fluid flowing across the probe. For the application wherein the fluid and / or the sample of fluid supplied from the source of the parts such as instrument and / or instrument are measured, it may be desirable to measure the fluid and / or the sample of fluid flowing across the probe. The fluid and / or the sample of fluid being supplied can flow across the probe, and then enter another or identical instrument, another or identical instrument parts or waste reservoir. This can allow the probe to be integrated into the flow system measuring therein and / or as a part of the fluid flow loop. In addition, it can allow the probe to be used for performing several measurements and / or experiencing several processes (for example, measurement process, regeneration process) when not being translated and / or by using relatively few moving parts.

[0053] It should also be understood that the methods described herein may include performing measurements when the fluid and / or the sample of the fluid is stationary. As an example, a method may include causing the fluid and / or the sample of the fluid to flow to a location so that it contacts the probe and then performs measurements when the fluid and / or the sample of the fluid is stationary. Thereafter, the fluid and / or the sample of the fluid may flow so that it no longer contacts the probe. One or more of the methods described herein may also be without any fluid flow.

[0054] As described above, in some embodiments, an apparatus is provided. In some embodiments, a system including an apparatus is provided. An overview of some exemplary apparatuses is provided below.

[0055] Figure 1 An example of an instrument is depicted. Figure 1 In the present invention, the instrument 100 includes a probe 102 and a detector 104 such as an optical detector. As will be described in further detail below, the probe can have one or more characteristics that allow and / or promote the fixation of one or more analytes thereon. The detector can be configured to detect a signal. When the detector is an optical detector, it can be configured to detect an optical signal, such as interference. In some embodiments, the instrument includes a detector coupled to the probe, such as an optical detector optically coupled to the probe. Figure 2 , which depicts an instrument 200 in which a probe 202 is optically coupled to an optical detector 204 via an optical cable 206. The optical cable can transmit light from the probe to the optical detector. In some embodiments, the instrument includes an optically transparent probe, and the optical signal to be detected travels through the probe, through the optical cable positioned on a side of the probe opposite to the side where the optical signal is generated, and into the optical detector.

[0056] In some embodiments, the instrument includes several probes and / or detectors (e.g., several optical detectors) (not shown). In such embodiments, each detector (e.g., optical detector) may be associated with (e.g., optically coupled to) a different probe, or two or more probes may be coupled (e.g., optically coupled) to a common detector (e.g., a common optical detector). The instrument may also be configured so that one or more probes can be reversibly associated with (e.g., optically coupled to) a detector (e.g., optical detector) (also not shown). In such embodiments, a detector (e.g., a single optical detector) may be capable of and / or configured to be reversibly associated with (e.g., optically coupled to) two or more probes.

[0057] In some embodiments, the instrument includes one or more components in addition to and / or in place of a probe and a detector (e.g., an optical detector). As an example, in some embodiments, the instrument includes a light source (e.g., in addition to the probe, in addition to the probe and the optical detector). Figure 3 An example of an apparatus including a light source is shown. Figure 3 In the embodiment of the present invention, the instrument 300 includes a light source 308. The light source may be capable of and / or configured to illuminate one or more parts of the instrument, such as a probe. In some embodiments, the light source may be capable of and / or configured to supply light to the probe, which is transmitted through the probe. The light source may supply light to the probe via an optical cable. For example, in some embodiments, an optical cable couples the light source to the probe (e.g., the optical cable may transmit light from the light source to the probe). Figure 4 A non-limiting example of such an instrument is shown. Figure 4 , the light source 408 is optically coupled to the probe 402 via an optical cable 410 .

[0058] In some embodiments, the instrument includes multiple light sources (not shown). In such embodiments, each light source may be associated with a different probe (e.g., optically coupled), or two or more probes may be associated with a common light source (e.g., optically coupled). The instrument may also be configured so that one or more probes can be reversibly optically coupled to a light source (also not shown). In such embodiments, a single light source may be capable of and / or configured to reversibly optically couple to two or more probes. This may be accomplished, for example, by an optical switch configured to switch the probes associated with the light source.

[0059] As another example, in some embodiments, an instrument includes a housing in which a probe and / or a detector (eg, an optical detector) is positioned. Figure 5An example of an instrument 500 including a housing 512 is shown, in which a probe, rather than a detector (e.g., an optical detector), is positioned. The housing may be capable of and / or configured to contain one or more fluids and / or samples of one or more fluids, such as one or more fluids contacted by the probe and / or samples of one or more fluids contacted by the probe. In some embodiments, the probe contacts, can contact, and / or is configured to contact a fluid and / or a sample of a fluid positioned in the housing. The fluid may flow into the housing through an inlet and / or flow out of the housing through an outlet. Figure 6 Instrument 600 is depicted including an inlet 614 and an outlet 616. In some embodiments, fluid flows into the inlet (and, in some embodiments, into the housing), traverses the probe, and then flows out through the outlet (and, in some embodiments, out of the housing).

[0060] Some housings can mechanically support the probe and / or position the probe in a location where the probe can contact the fluid and / or a sample of the fluid. For example, in some embodiments, the housing includes an epoxy resin that provides rigid support for the probe and / or protects the probe from damage. In some embodiments, the housing includes an opening into which the probe can be inserted. Additionally or alternatively, the probe may also be mechanically coupled to the housing (e.g., by using a clamp).

[0061] In some embodiments, the housing can form a part of a microfluidic chip and / or a part of a manifold. When the housing forms a part of a manifold, the manifold can supply fluid from the source of the fluid to the probe, be configured to supply fluid from the source of the fluid to the probe and / or can supply fluid from the source of the fluid to the probe. In some embodiments, the housing forms a part of a manifold comprising one or more microfluidic channels. The probe positioned in such housing can be in fluid communication with the microfluidic channel. The microfluidic channel present in the manifold described herein can have a variety of suitable shapes. In some embodiments, the manifold includes a straight microfluidic channel. The manifold is also likely to include a microfluidic channel comprising a step and / or a bend. Figure 7 A non-limiting example of such a microfluidic channel is shown in . Figure 7 An instrument 700 including a probe 702 and a microfluidic channel 718 is depicted. Figure 7 The microfluidic channel shown in FIG. 7 includes a step 720 .

[0062] Some microfluidic channels may be perpendicular to the optical axis of the probe with which they are in fluid communication.

[0063] The manifold may also include one or more components that facilitate fluid communication between one or more instrument components and the manifold. As two examples, the manifold may also include openings and / or tube connectors (e.g., to facilitate fluid communication between a valve and the manifold, to facilitate fluid communication between a source of fluid and the manifold). As another example, the manifold may include and / or may be used in conjunction with an O-ring (e.g., to seal surfaces between the manifold and the probe). As a third example, the manifold may also include a Luer connection (e.g., to facilitate mechanical connection between the probe and the manifold).

[0064] The manifold can be formed from a variety of suitable materials, such as plastic (e.g., molded plastic, machined plastic) and / or metal (e.g., steel, such as stainless steel). In some embodiments, the manifold includes two pieces of plastic attached together (e.g., via glue, via double-sided tape). One or more microfluidic channels can be formed in the top plastic piece. The bottom plastic piece can help isolate the microfluidic channels.

[0065] Another example of an additional component that may be included in the instruments described herein is a source of fluid. The source of fluid may be associated with, capable of being associated with, and / or associated with the instruments described herein. As an example, the source of fluid may be capable of and / or configured to provide fluid (and / or one or more samples thereof) to the housing and / or probe (e.g., they may be positioned upstream of the housing and / or probe). As another example, the source of fluid may be in fluid communication with, capable of being placed in fluid communication with, and / or configured to be placed in fluid communication with the interior of the probe and / or housing. The association, provision of fluid, and / or fluid communication may occur via an inlet. As an example, and as Figure 8 As shown in , a source of fluid can be configured to be provided to the probe and / or the interior of the housing in which the probe is positioned via an inlet. Figure 8 In the embodiment of the present invention, a source 822 of fluid is in fluid communication with the inlet 814 via a conduit 824. A variety of suitable conduits can be used, a non-limiting example of which is a pipeline. In some embodiments, the pipeline can be relatively short. This can facilitate rapid analysis of the fluid and / or sample of the fluid supplied to the probe and / or housing and / or reduce the amount of fluid required to supply the probe.

[0066] In some embodiments, the instrument includes multiple sources of fluids (e.g., more than one source of fluids). For example, the instrument may include two sources of different fluids and / or two sources of the same fluid. In such embodiments, the instrument may include multiple inlets (e.g., more than one inlet). As an example, the instrument may include an inlet associated with each source of fluids and / or with each type of source of fluids. In some embodiments, the instrument includes exactly one inlet and / or includes more sources of fluids than inlets. In such embodiments, the source of fluids may be reversibly associated with the inlet and / or can be reversibly associated with the inlet. Some inlets may be capable of reversibly associated with the source of fluids and / or with more than one source of fluids.

[0067] In some embodiments, the instrument includes multiple inlets and multiple probes, and each inlet is in communication with the probe fluid. Such inlets may also be in reversible fluid communication with one or more sources of fluid. The instrument including such probes and inlets may be configured to and / or enable multiple probes to contact one or more fluids supplied via (multiple) inlets. In some embodiments, the instrument includes multiple probes and multiple inlets, and the instrument is configured to contact each probe alternately with different fluids, each of which is alternately supplied by an inlet in communication with the probe fluid. The instrument may also be configured to contact each probe alternately with different fluids, each of which is supplied by a different inlet in communication with the probe fluid.

[0068] Similarly, the instrument may include one outlet or include more than one outlet.(Multiple) outlets may be associated with a location (e.g., a location downstream of the outlet) to which the probe and / or housing are configured to and / or can eject fluid. As an example, the outlet may place the interior of the probe and / or housing in fluid communication with such a location. For example, in some embodiments, the outlet places the interior of the probe and / or housing in fluid communication with a waste reservoir (e.g., a waste reservoir downstream of the outlet). As another example, in some embodiments, the outlet places the interior of the probe and / or housing in fluid communication with a reservoir, in which the fluid may be stored (e.g., as a final product for further processing). As a third example, in some embodiments, the outlet places the interior of the probe and / or housing in fluid communication with a source of the fluid. In such embodiments, the instrument may be used to recirculate the fluid back to the source from which the fluid comes after the fluid contacts the probe. As a fourth example, in some embodiments, the outlet places the interior of the probe and / or housing in fluid communication with an additional instrument (e.g., an instrument that can further process and / or analyze the fluid). It is also possible that an outlet is reversibly associated and / or reversibly associable with one or more locations (eg, one or more waste receptacles).

[0069] When the instrument includes more than one source of fluid that can be associated with the inlet in a reversible manner and / or more than one location that can be associated with the outlet in a reversible manner, reversible association can be promoted by using a valve. As an example, the instrument may include a valve configured to switch between multiple (e.g., two or more, three or more, four or more, five or more, six or more) positions. Each position (or some positions) can be associated with the source of the fluid. For example, each position can place the source of the fluid in fluid communication with the probe, and the valve is in fluid communication with the probe. Switching the valve to the position associated with the source of the fluid can place the source of the fluid in fluid communication with the probe. Switching the valve from the position associated with the source of the fluid can remove the source of the fluid from being connected with the fluid of the probe. Switching the valve between two positions can remove a source of the fluid from being connected with the fluid of the probe, and different sources of the fluid are placed in fluid communication with the probe.

[0070] The valve can be positioned downstream of the source(s) of the fluid (e.g., the source(s) of the fluid that the valve is capable of and / or is configured to place the probe in fluid communication therewith can be positioned upstream of the valve), and possibly upstream of the inlet. In some embodiments, such a valve supplies the fluid directly to the probe when in a position suitable for doing so. In other words, when the valve places the source of the fluid in fluid communication with the probe, the fluid can flow directly to the probe. When flowing directly from the valve to the probe, the fluid can experience minimal dilution (or no dilution) with other fluids and / or mixing with other fluids.

[0071] Fig. 9 One non-limiting example of an instrument including a valve 926 (labeled therein as a "selector valve") is shown. Fig. 9 An instrument is depicted that includes: three fluid sources (a source of sample 932, labeled "SAMPLE Intake" and "CHROM COLUMN"; a source of neutralizing fluid 928, which is a buffer, labeled "BUFFER"; and a source of regeneration fluid 930, labeled "REGEN", each of which will be described in further detail below), a probe 902 (labeled "BLI Sensor"), an optical detector 908 (labeled "BLI Optics"), and a waste reservoir 934 (labeled "Waste"). Fig. 9 Also depicted is a pump 936 (labeled "peristaltic pump") that can be used to facilitate the flow of fluid from the housing to the waste reservoir.

[0072] In some embodiments, the instrument includes more than one valve. As an example, in some embodiments, the instrument includes multiple valves. Each such valve can be switchable between multiple positions (e.g., as described above), each of which (or some of which) can place the probe in fluid communication with a source of fluid. It is also possible that some or all such valves are switchable only between an open position (i.e., a position that places the probe in fluid communication with a source of fluid) and a closed position (i.e., a position that does not place the probe in fluid communication with the source of fluid).

[0073] Fig.10 One non-limiting example of an instrument suitable for use with a plurality of such valves is shown. Fig.10 , inlets 1038, 1040, and 1042 are each positioned upstream of probe 1002. Each such inlet can be in fluid communication with a valve that includes a position that places the probe in fluid communication with a source of a different fluid (e.g., inlet 1038 can be in fluid communication with a valve that includes a position that places probe 1002 in fluid communication with a source of a sample, inlet 1040 can be in fluid communication with a valve that includes a position that places probe 1002 in fluid communication with a source of a regeneration fluid, and / or inlet 1042 can be in fluid communication with a valve that includes a position that places probe 1002 in fluid communication with a source of a neutralizing fluid). Fig.10 Also depicted are two outlets (outlets 1044 and 1046) that can be in fluid communication with a valve including a position to place probe 802 in fluid communication with a waste reservoir. Fig.10 Shown are valves 1048-1056.

[0074] The flowing fluid can flow directly from the valve through Fig.10 , across the probe, and then flows to one of the two waste receptacles. Thus, it should be understood that fluid can flow through the valves in both directions (e.g., from valves 1040 or 1042 to waste receptacle 1044, from valve 1038 to waste receptacle 1046). Fig.10 In addition, as shown in Fig.10 It will be appreciated that fluid may flow directly from the valve across the probe without undergoing any dilution or mixing. In some embodiments, such flow may push slugs of another type of fluid (e.g., fluid supplied from a different valve) downstream and / or to a waste reservoir without substantial (or any) mixing between the two types of fluids.

[0075] It should also be noted that although Fig. 9 and Fig.10An instrument suitable for use with a valve positioned upstream of the inlet is depicted, but it is also possible for the instrument to include a valve positioned upstream of the probe but downstream of the inlet. In other words, the instrument may include a housing including an inlet (or more than one inlet), and one or more valves may be positioned between the inlet (or inlets) and the probe. In some such embodiments, fluid flows into the housing via the inlet, but contacts the probe only when the valve is in a position to place the fluid from the inlet through which it enters the housing in fluid communication with the probe.

[0076] In some embodiments, the apparatus includes a probe, an inlet, and an outlet arranged in a manner to help prevent the formation of bubbles. The apparatus may also include an article that includes a probe, an inlet, and an outlet arranged in this manner. One such design is Fig.11 and Fig.12 Shown in. Fig.11 An article comprising a probe, an inlet, an outlet, and a housing is depicted. Fig.11 In the embodiment, housing 1112 encloses probe 1102. In addition, inlet 1114 is in fluid communication with probe 1102 and is configured to provide fluid to the probe. Similarly, outlet 1116 is in fluid communication with probe 1102 and is configured to remove fluid from the probe. Fig.11 As shown in , the probe 1102 includes an optical axis 1158, the inlet includes an inlet flow axis 1160, and the outlet includes an outlet flow axis 1162. The optical axis can be aligned along a path through which light can be transmitted through the probe and / or can be aligned along the longest principal axis of the probe. The inlet flow axis can be aligned along the direction of fluid flow through the inlet and / or along the longest principal axis of the inlet. The outlet flow axis can be aligned along the direction of fluid flow through the inlet and / or along the longest principal axis of the outlet. In some embodiments, the optical axis can be aligned along the path through which light can be transmitted through the probe and / or can be aligned along the longest principal axis of the probe. Fig.11 As with the embodiment shown in , the probe, inlet and outlet may be arranged such that the optical axis, the inlet axis and the outlet axis are located in a common plane. It is also possible that the optical axis of the probe is oriented substantially vertically.

[0077] A pump is another example of an additional component that may be included in the apparatus described herein. Fig. 9 An example of an instrument including a pump is depicted. The pump may be employed at a variety of suitable locations to facilitate fluid flow through the instrument (e.g., upstream of the probe, downstream of the probe, upstream of the inlet, downstream of the outlet). A non-limiting example of a suitable type of pump is a peristaltic pump. Some pumps may be of relatively small size (e.g., they may be micro pumps).

[0078] Another example of additional components that can be included in the instrument described in this article is a temperature control system. The temperature control system can be associated with one or more parts of the instrument, such as with a probe, with a manifold, with a pipeline connecting the valve fluid to an inlet and / or a manifold, with a pipeline connecting the valve fluid to a source of a fluid, and / or with a detector (e.g., an optical detector). The instrument may also include two or more temperature control systems, each of which is associated with one or more different parts of the instrument. The temperature control system can be used to heat and / or cool (multiple) parts of the instrument associated therewith. Without wishing to be bound by any particular theory, it is believed that cooling the fluid (and / or a sample of the fluid) can advantageously increase the solubility of the gas therein, which can reduce bubble formation. Similarly, it is believed that the cooling of the detector (e.g., an optical detector) can help it to operate normally. Non-limiting examples of suitable temperature control systems include cooling fans, radiators, and insulation materials.

[0079] Other examples of additional components that can be included in the instrument described herein are filters, such as purification filters and / or degassing filters. In some embodiments, one or more filters are positioned between the source of the sample and the probe (e.g., between the source of the sample and the inlet, between the source of the sample and the valve, between the inlet and the probe, between the valve and the probe). The filter can remove components in the sample of the fluid that will experience one or more undesirable interactions with the probe, such as impurities (e.g., in the case of a purification filter) and / or gases (e.g., in the case of a degassing filter). Non-limiting examples of impurities include particles, such as cell particles. An example of a purification filter is a filter suitable for alternating tangential flow filtration.

[0080] When a pressurized sample of fluid is supplied to the instrument from a pressurized additional instrument, gas may be undesirably present. The pressure drop when the sample of fluid flows to the instrument may result in the formation of bubbles (e.g., microbubbles), which may undesirably affect the generated signal (e.g., optical signal) if the bubbles contact the probe. The degassing filter can use atmospheric pressure and / or subatmospheric pressure to degas the sample of fluid.

[0081] In some embodiments, the apparatus includes a degasser in addition to a degassing filter. As an example, in some embodiments, the apparatus includes a vacuum degasser, an ultrasonic degasser, a heater configured to cause degassing, and / or a cooler configured to perform degassing. The vacuum degasser may include a gas permeable membrane and a reduced pressure source positioned on a side of the permeable membrane opposite to the fluid to be degassed. The ultrasonic degasser may include an ultrasonic source and a gas sink. The heater configured to cause degassing may include a heating element and a gas sink.

[0082] In some embodiments, the fluid (and / or a sample of the fluid) passes through a degasser at a relatively high temperature (e.g., the temperature at which the fluid is received from the source of the sample) and is then cooled before contacting the probe. This can advantageously allow degassing at a temperature at which the gas is difficult to dissolve, and then contact between the fluid and the probe at a temperature at which the gas is more easily soluble. Controllers and computers are some other examples of additional components that can be included in the instrument described herein. In some embodiments, the controller can deliver power and / or instructions to one or more other instrument components (e.g., light sources, valves, pumps, detectors, optical detectors). Such instructions can be provided periodically (e.g., according to a pre-selected schedule) and / or on demand (e.g., by an operator). In some embodiments, the controller delivers instructions related to fluid flow (e.g., to start fluid flow, stop fluid flow, modify the rate of fluid flow, change the location where the fluid flows to, change the location where the fluid flows out, and switch the position of the valve). In some embodiments, the controller delivers instructions related to signal (e.g., optical signal) detection (e.g., to turn on the detector and / or optical detector, turn off the detector and / or optical detector, adjust the detector and / or optical detector to perform detection and / or optical detection). The computer may deliver instructions to the controller and / or receive one or more signals from the controller.The controller and computer may communicate with each other and / or other instrument components in a variety of ways, including via a USB cable and / or via Ethernet.

[0083] In some embodiments, the instrument is enclosed in a housing. As an example, in some embodiments, the instrument is enclosed in a housing including a base, a cover and / or a sidewall. Some or all of these components can be formed by and / or include a light shield. In some embodiments, the housing includes a connector (e.g., an SMA connector, such as an SMA905 connector) that allows an optical connection to be formed between one or more parts of the instrument and a device outside the instrument. Such parts of the instrument can include a light source, an optical detector and / or a probe. Fig.13 One non-limiting example of an instrument enclosed by a housing is depicted.

[0084] In some embodiments, the instrument comprises two or more parts enclosed by a separate housing. An example of such an instrument is Fig.14 In Fig.14 In the invention, the apparatus comprises a first housing enclosing a computer, a lamp and a spectrometer. The first housing also comprises a display and supports three sources of fluid. Fig.14 The instrument shown in also includes a second housing that supports the manifold and the probe. Fig.14 The first housing and the second housing shown in the figure are in fluid, optical and electrical communication via conduits, one or more optical cables and one or more electrical cables, respectively. Fig.14The pipes and cables shown in are positioned in a flexible sleeve. In some embodiments, the instrument includes a first housing and a second housing, each of which includes a connector (e.g., an SMA connector, such as an SMA905 connector) that allows an optical connection to be made. Such an instrument may also include an optical cable optically connected to the two housings via these optical connectors. It is also possible that an instrument including two or more housings may include a first housing and a second housing that differ in one or more aspects. Fig.14 As an example, in some embodiments, the instrument includes a first housing that additionally or alternatively encloses electronics, one or more pumps, a power source, one or more light sources, and / or one or more detectors (e.g., one or more optical detectors). As another example, the instrument can include a first housing that includes multiple sources of fluid other than three (e.g., exactly one source of fluid, exactly two sources of fluid, four or more sources of fluid).

[0085] Fig.14 Optional mechanical supports for the second housing are also depicted. In some embodiments, the instrument includes a second housing that encloses a manifold, one or more probes, one or more valves, a temperature control system, one or more filters (e.g., degassing filters, purification filters), and / or one or more pumps. It is also possible that one or more (or all) of these components are located outside of any housing present in the instrument.

[0086] Some of the instruments described herein may be associated with other instruments.An instrument may also be a source of a fluid and / or one or more samples of a fluid. Fig. 9 An example of an instrument is also shown in FIG. 1 , where the instrument is associated with a chromatographic column (labeled “chromatographic column” and having reference numeral 932 ). In some embodiments, the instrument described herein is in fluid communication with an additional instrument. The fluid communication may be in the manner described elsewhere herein for other sources of fluid and / or sources of samples of fluid, such as tubing. The association may include in-line and / or near-line association.

[0087] In some embodiments, the instrument described herein can be associated with two or more additional instruments, configured to be associated with two or more additional instruments and / or associated with two or more additional instruments. Similarly, such an instrument may be able to be in fluid communication with two or more additional instruments, configured to be in fluid communication with two or more additional instruments and / or in fluid communication with two or more additional instruments. In some embodiments, the system includes an instrument and an additional instrument described herein. The instrument (e.g., instrument and additional instrument) can be of the same type (e.g., two or more bioreactors) or of different types (e.g., a chromatography system and a bioreactor). The association can be reversible. In some such embodiments, a reversible association can be promoted by using a valve that switches between different positions associated with different additional instruments and / or selects which of the additional instruments is in fluid communication with the instrument including the probe and / or supplies fluid to the instrument including the probe.

[0088] Some additional instruments may be capable of and / or configured to supply a fluid (and / or one or more samples of a fluid) to an instrument including a probe. Some methods may include supplying a fluid (and / or one or more samples of a fluid) to an instrument including a probe. The fluid may be supplied to the instrument (and / or in contact with the probe) as an output of the additional instrument. For example, the fluid may have the same composition as it has in the additional instrument. The fluid output by the additional instrument may also have a composition that differs from the fluid in the additional instrument by a relatively small amount (e.g., the concentration of each component in the fluid supplied to the instrument and / or in contact with the probe may differ from its concentration in the fluid in the additional instrument by less than or equal to 20%, 10%, 5%, 2%, 1%, 0.5%, 0.2% or 0.1%; the concentration of each component in the fluid in the additional instrument may differ from its concentration in the fluid supplied to the instrument and / or in contact with the probe by less than or equal to 20%, 10%, 5%, 2%, 1%, 0.5%, 0.2% or 0.1%). In some embodiments, the fluid output by the additional instrument that is supplied to the instrument and / or contacts the probe does not undergo any filtration step, any purification step, any centrifugation step, sterilization step and / or any other step that would remove one or more components from the fluid and / or induce a chemical or biological reaction in the fluid after being removed from the additional instrument.

[0089] In some embodiments, the fluid is supplied to the instrument from the additional instrument in an automated manner. For example, the fluid may be supplied to the instrument from the additional instrument without any input from the operator and / or without requiring the operator to perform any steps.

[0090] In some embodiments, the fluid flowing out of the additional instrument is divided into multiple samples before flowing into the inlet. The additional instrument can be configured to divide the fluid flowing therefrom into multiple samples, or the instrument including the probe can be configured to perform the division.

[0091] As described above, some embodiments relate to methods. Some methods may be performed partially and / or completely by one or more of the instruments described herein. In addition, some instruments may be capable of and / or configured to perform one or more of the methods described herein. An overview of some exemplary methods and steps that may be performed during the method is provided below.

[0092] In some embodiments, a method includes performing one or more steps to determine the concentration of an analyte in a fluid and / or a sample of the fluid. The fluid can be supplied by a bioprocessing system. In some embodiments, such methods also include sending instructions to the bioprocessing system based on the concentration. Some methods include performing one or more steps to determine the affinity of the analyte to the probe and / or the material fixed on the probe.

[0093] An example of such steps is to contact the probe with the fluid that may contain analyte. Analyte can be present in the fluid with a specific concentration (e.g., a concentration of 0M, a concentration higher than 0M). When the sample of fluid and / or fluid contacts the probe, some or all of the analytes present in the sample of fluid and / or fluid can become fixed on the probe. The amount of the analyte fixed on the probe can be affected by the amount of the analyte present in the fluid and / or sample of fluid contacting the probe, the amount of the analyte fixed on the probe and / or the time length of the sample of fluid and / or fluid contacting the probe.

[0094] The probe can contact the sample of the fluid and the fluid in a variety of suitable ways. In some embodiments, the probe contacts the fluid (and / or its sample) by being positioned in the housing, and the fluid (and / or its sample) is introduced into the housing in an amount that makes contact between the fluid (and / or its sample) and the probe. In some embodiments, the probe contacts the fluid (and / or its sample) by being positioned at the location where the fluid (and / or its sample) flows. It can contact the entire probe or some parts, but not other parts. As an example, in some embodiments, a part of the probe having one or more reagents (for example, one or more reagents that the analyte can become fixed thereon) is contacted with the sample of the fluid and / or the fluid. As another example, in some embodiments, the part of the probe away from the part of the probe in contact with the optical cable is contacted with the sample of the fluid and / or the fluid. As a third example, in some embodiments, the face of the probe perpendicular to the optical axis of the probe (for example, the lowest such face, perpendicular to the optical axis of the probe and the face opposite to the face of the contact optical cable) is contacted with the sample of the fluid and / or the fluid.

[0095] The contact between the fluid (and / or its sample) and the probe can occur over a variety of suitable time periods. In some embodiments, the time period can be relatively short (e.g., a few seconds to a few minutes). The time period that the probe contacts the fluid is also likely to be relatively long (e.g., up to one hour, several hours, longer). Additional details about the time range over which the probe can contact the fluid are provided below.

[0096] The concentration of the analyte in the fluid (and / or its sample) can be relatively constant during the time period when it contacts the probe, or it changes during this time. As an example of the latter, in some embodiments, the analyte that becomes fixed on the probe can be removed from the fluid (and / or its sample) when it is fixed on the probe. As another example of the latter, in some embodiments, the fluid (and / or its sample) can flow across the probe in a time period. Different parts of the fluid (and / or its sample) can have different concentrations of analyte therein, and therefore when different parts of the fluid (and / or its sample) flow across the probe sequentially, the concentration of the analyte in the fluid contacting the probe can change. In some embodiments, relative to the total amount of the analyte in the fluid (and / or its sample) contacting the probe, a relatively small amount of analyte is fixed on the probe. In such embodiments, the concentration of the analyte in the fluid can be relatively constant during the time period when the probe contacts the fluid. Similarly, the fluid (and / or its sample) flowing through the probe can have a relatively uniform concentration of analyte therein.

[0097] In some embodiments, a method includes contacting a probe with multiple fluids and / or multiple samples of a fluid. Multiple samples of a fluid can be supplied by a source of a sample. The probe can contact the fluid sequentially and / or in an alternating manner. As an example, in some embodiments, the probe contacts multiple samples of a fluid (e.g., supplied by a source of a sample), and between samples in the multiple samples of the fluid, contacts one or more fluids that are not samples of the fluid. Fluids that are not samples of the fluid can help remove analytes (e.g., analytes derived from samples) that are fixed on the probe between different samples exposed to the fluid.

[0098] In some embodiments, the fluid to which the probe is exposed can be controlled by the position of the valve in communication with the probe fluid and / or by opening which valve in communication with the probe fluid. As an example, in some embodiments, the valve can be switched between positions in which the probe is placed in fluid communication with different sources of fluid. Switching such valves from one position to another position can remove a source of fluid from being communicated with the probe, and another source of fluid is placed in communication with the probe. As an example, in some embodiments, the valve can be switched to remove the source of the sample from being communicated with the probe, and the source of the regenerated fluid is placed in communication with the probe. As another example, in some embodiments, the valve can be switched to remove the source of the regenerated fluid from being communicated with the probe, and the source of the neutralizing fluid is placed in communication with the probe. As a third example, in some embodiments, the valve can be switched to remove the source of the neutralizing fluid from being communicated with the probe, and the source of the sample is placed in communication with the probe.

[0099] Some valves described herein can be switched between an open position and a closed position. Switching a valve from a closed position to an open position can place a probe in fluid communication with a source of the fluid in fluid communication. Switching a valve from an open position to a closed position can remove a probe in fluid communication with a source of the fluid in fluid communication with the valve. Some methods may include opening one or more valves and closing one or more valves to place a source of the fluid in fluid communication with the probe and to remove it from fluid communication with the probe, respectively.

[0100] Another example of the step that can be performed during the method described in this article is a detection signal, such as an optical signal. The signal (e.g., an optical signal) can be associated with the fluid (and / or a sample of the fluid) contacting the probe. For example, the signal (e.g., an optical signal) can be detected at the time point of the fluid (and / or a sample of the fluid) contacting the probe. As another example, the signal can be an optical signal included in the interference between the light reflected from two or more interfaces, such as an interface inside the probe (e.g., between the inner part of the probe and the coating disposed thereon), an interface between the probe and the analyte that is initially present in the fluid (and / or a sample of the fluid) and fixed on the probe, and / or an interface between the analyte and the environment (e.g., fluid, a sample of the fluid) outside the probe. In certain embodiments, the signal (e.g., an optical signal) is affected by the amount of the analyte that is fixed on the probe. Therefore, the analysis of the signal (e.g., an optical signal) can be used to determine the amount of the analyte that is fixed on the probe and / or the concentration of the analyte that is present in the fluid and / or the sample of the fluid that contacts the probe.

[0101] The optical signal may include light and / or light interference (e.g., interference between light supplied by a common light source but traveling through light paths with different optical thicknesses) or the absence of such interference. As two examples, the optical signal may include interference between light reflected from two different interfaces associated with the probe and / or the analyte fixed on the probe (e.g., an interface between the inner portion of the probe and a coating disposed on the inner portion of the probe, an interface between the analyte and the probe, an interface between the analyte and the environment outside the probe, an interface at the end of the probe) or the absence of such interference. The light reflected from the interface may be supplied to the probe from the light source. As described above, the light source may be optically coupled to the probe so that light is transmitted from the light source and across the probe (e.g., parallel to the optical axis of the probe). When reaching the end of the probe, the light may be transmitted out of the probe and / or may be reflected from the interface between the probe and the environment outside the probe (and / or from the end of the probe). If there is any analyte fixed on the probe, some light may be reflected from the interface between the probe and the analyte and / or some light may be transmitted through the analyte. The analyte may also change the effective refractive index at the end and / or change the effective optical path length of the light transmitted through the probe. The light transmitted through the analyte will then encounter the environment with which the analyte is in contact (e.g., a fluid in contact with the probe, a sample of the fluid in contact with the probe). Some of the light that encounters the environment may be transmitted into the environment with which the analyte is in contact (e.g., an environment external to the probe) and / or may be reflected from the interface between the environment and the analyte.

[0102] The probes described herein may also have one or more internal interfaces where reflection can occur. For example, some probes may include one or more internal interfaces where reflection can occur, such as an interface between a coating and an internal portion of the probe on which the coating is disposed.

[0103] Light reflected from one or more of the above-mentioned locations (and / or any other locations) can travel back through the probe. If light is reflected from several locations (e.g., at the interface between the probe and the analyte fixed on the probe, at the interface between the analyte fixed on the probe and the environment outside the probe, at the interface between the coating disposed on the inner part of the probe and the analyte fixed on the probe, at the interface between the inner part of the probe and the coating disposed thereon, from the end of the probe), such light may interfere with each other. Depending on whether the interference is positive or negative (which can depend on the phase shift between several interfering light sources), light interference can cause the intensity of the interfered light to be higher or lower. The phase shift can depend on the difference in the optical path length that the light travels before the interference, the refractive index of (multiple) materials that the light passes through before the interference, and / or the wavelength of the light. Therefore, obtaining information about the intensity of the interfered light across multiple wavelengths can provide information about the thickness of the layer including the analyte fixed on the probe and / or the refractive index of such layer. This information can be used to determine the amount of the analyte fixed on the probe.

[0104] Fig.15 One example of a process by which the amount of analyte immobilized on a probe can be detected is schematically depicted. Fig.15 As shown in , light traveling down the probe can be reflected from the interface between the coating disposed on the inner portion of the probe, and reflected from the interface between the analyte disposed on the probe and the environment outside the probe. The phase shift between the two reflected light sources can depend on the amount of analyte fixed on the probe and the wavelength of the reflected light, which can affect the intensity of the reflected light measured. Therefore, the amount of analyte fixed on the probe can be determined by analysis of the intensity of the reflected light as a function of wavelength.

[0105] It is also possible that the optical signal includes signals other than optical interference. As an example, in some embodiments, the optical signal includes fluorescence, such as fluorescence emitted from a substance fixed on the probe and / or generated from a substance fixed on the probe (e.g., via a reaction with a substance present in a fluid contacting the probe). As another example, in some embodiments, the optical signal includes reflected light. For example, the amount of light reflected at different angles, different angular ranges, and / or within a restricted angular range can be detected. The angle at which surface plasmon resonance occurs can be detected using the intensity of such light at one or more specific angles, the intensity of such light within one or more different angular ranges, and / or (multiple) angles at which the intensity of such light is lower. The angle can be affected by the fixation of the analyte on the probe.

[0106] In some embodiments, a mechanical signal is detected. As a non-limiting example, in some embodiments, a change in the resonance of a quartz crystal resonator is the signal that is detected.

[0107] The measurement of the amount of analyte fixed on the probe can be performed on the signal (e.g., optical signal) detected over time. The time period in which the signal (e.g., optical signal) can be detected can be the same time period in which the probe is in contact with the fluid (and / or its sample), or can be a different time period (e.g., a subset of the time period). The time period may also be a time period in which the analyte is removed from the probe (e.g., during a regeneration step, during a neutralization step). Detecting a signal (e.g., optical signal) over time can include detecting a single value of the signal (e.g., optical signal) from measurements performed within a time period (e.g., detecting a value as an average value of the signal and / or optical signal within the time period) and / or can include detecting several values ​​of the signal and / or optical signal from different measurements occurring within different (overlapping or non-overlapping) time periods.

[0108] In some embodiments, detecting a signal (e.g., an optical signal) over time includes detecting its change over time. The change may include an increase, decrease, or lack of change. In some embodiments, the change includes a first-order derivative of a signal (e.g., an optical signal). The change of a signal (e.g., an optical signal) over a time period can be determined from several measurements of a single signal (e.g., a single optical signal) performed over the time period, which produce several values ​​of the signal (e.g., an optical signal) over the time period. The time period for measuring a signal (e.g., an optical signal) may include a variety of suitable time points during the fixation of an analyte on a probe and / or the removal of an analyte from a probe. For example, at the initial contact of a probe with a sample of a fluid and / or a fluid containing an analyte, at the initial removal of contact between a probe and a sample of a fluid and / or a fluid containing an analyte, when the amount of an analyte fixed on the probe is in one or more specific percentages of the amount of an analyte fixed on the probe in a steady state, when the amount of an analyte fixed on the probe is a steady-state value, or at any time therebetween, the change can be measured.

[0109] The time point at which the change in the signal (e.g., optical signal) is measured may be selected as desired. In some embodiments, the change in the signal (e.g., optical signal) is measured when the amount of the analyte immobilized on the probe is greater than or equal to 0%, greater than or equal to 5%, greater than or equal to 10%, greater than or equal to 15%, greater than or equal to 20%, greater than or equal to 25%, greater than or equal to 30%, greater than or equal to 35%, greater than or equal to 40%, or greater than or equal to 45% of the amount of the analyte immobilized on the probe at steady state. In some embodiments, the change in the signal (e.g., optical signal) is measured when the amount of the analyte immobilized on the probe is less than or equal to 50%, less than or equal to 45%, less than or equal to 40%, less than or equal to 35%, less than or equal to 30%, less than or equal to 25%, less than or equal to 20%, less than or equal to 15%, less than or equal to 10%, or less than or equal to 5% of the amount of the analyte immobilized on the probe at steady state. Combinations of the above-mentioned ranges are also possible (eg, greater than or equal to 0% and less than or equal to 50%, greater than or equal to 0% and less than or equal to 10%, or greater than or equal to 0% and less than or equal to 5%). Other ranges are also possible.

[0110] As described above, the value of the signal (e.g., optical signal) can indicate the amount and / or type of analyte fixed on the probe. At equilibrium, the amount of analyte fixed on the probe can indicate its affinity for the probe and / or the substance fixed on the probe. In addition, the change of the signal (e.g., optical signal) over time can indicate the rate at which the analyte becomes fixed on the probe. The rate at which the analyte becomes fixed on the probe can depend on the amount of the analyte in the fluid to which the probe is exposed and / or the interaction between the analyte and the probe. As an example of the latter, the rate at which the analyte becomes fixed on the probe can depend on the affinity of the analyte to the probe (and / or its surface chemical composition and / or the reagent fixed on the probe) and / or the rate at which the analyte binds to the probe (and / or its surface chemical composition and / or the reagent fixed on the probe). As another example of the latter, the rate at which the analyte is removed from the probe when contacting a fluid other than the fluid containing the analyte (e.g., a different sample of the fluid, a regeneration fluid, a neutralization fluid) can also indicate the affinity of the analyte to the probe (and / or its surface chemical composition and / or the reagent fixed on the probe) and / or the rate at which the analyte is bound to the probe (and / or its surface chemical composition and / or the reagent fixed on the probe). Therefore, the method described herein can be suitable for determining the affinity of the analyte to the probe and / or the material fixed on the probe. The affinity of the analyte to the probe can be parameterized by its association constant and / or its dissociation constant, as described in further detail below. Without wishing to be bound by any particular theory, it is believed that any particular analyte can be most rapidly bound to the probe at the initial contact between the fluid containing the analyte (and / or its sample) and the probe. Therefore, it is also believed that when the time period of the measurement change includes the initial contact between the fluid (and / or its sample) and the probe, the change in the measurement signal (e.g., optical signal) can produce more accurate information and / or can produce information more quickly.

[0111] The change of the signal (e.g., optical signal) can indicate the change of the amount of the analyte fixed on the probe, which itself can indicate the concentration of the change of the analyte in the fluid contacting the probe and / or the sample of the fluid contacting the probe before the amount of the analyte fixed on the probe reaches the steady-state value. In the former case, the rate at which the analyte fixed on the probe approaches its steady-state value can change with the concentration of the analyte in the fluid (and / or the sample of the fluid) with which the probe contacts, and can therefore be used to assess the concentration of the analyte in the fluid and / or the sample of the fluid. In some embodiments, the change in the rate at which the analyte fixed on the probe approaches its steady-state value is greater than the change in the amount of the analyte fixed on the probe in the steady state. Therefore, in some embodiments, measuring the rate at which the analyte becomes fixed on the probe can provide a more sensitive and / or faster way to determine the concentration of the analyte than measuring the amount of the analyte fixed on the probe at the final steady-state value.

[0112] As described above, the fluid and / or sample of the fluid contacting the probe may have a concentration of the analyte therein that changes over time. In such embodiments, any particular determination of the analyte concentration may be an average amount of the analyte in the fluid contacting the probe during the time period in which the determination is made. Several determinations of the analyte concentration carried out on such fluid and / or sample of such fluid may produce different analyte concentrations indicating different analyte concentrations over time in the fluid and / or sample of the fluid.

[0113] In some embodiments, the signal and / or the change of the signal are measured continuously. This can be achieved by contacting the fluid supplied to the instrument with the probe therein and measuring the signal at all times during the continuous signal measurement. In some embodiments, as described in further detail elsewhere herein, several probes can be used to perform such methods. For example, a first probe can be used to measure a first signal and / or a first change in the signal, while a second probe is preparing to do so. When measuring the first signal and / or the first signal change, the fluid can contact the second probe, and the second signal and / or the second signal change can be measured. Such a process can be used with multiple probes so that the fluid (e.g., multiple samples thereof) being supplied by the instrument is in continuous contact with the probe, and the signal and / or its change is continuously measured. In such embodiments, the fluid can be supplied in an online and / or near-line manner.

[0114] In some embodiments, the detected signal (e.g., optical signal) is compared with a model signal profile. The model signal profile can be a model signal profile associated with an expected and / or expected result (e.g., an expected signal profile associated with the presence of an analyte in the fluid contacting the probe; an expected signal profile associated with the presence of such an analyte at an expected time, such as when the column and / or chromatographic medium in the column and / or chromatographic medium in fluid communication with the probe penetrates) or a model signal profile associated with an unexpected and / or unexpected result (e.g., the presence of bubbles in the fluid contacting the probe, instrument failure). Comparing the signal (e.g., optical signal) with the model signal profile can be used to assess whether the instrument and / or probe are operating in a normal manner. As an example, if the signal (e.g., optical signal) does not match the model signal profile associated with the expected result, it can indicate the presence of bubbles in the fluid contacting the probe and / or an instrument failure. On the other hand, if the signal (e.g., optical signal) does match such a model signal profile, it can indicate that the instrument is operating normally. As another example, if a signal (eg, an optical signal) matches a model signal profile associated with the presence of bubbles and / or instrument malfunctions in the fluid in contact with the probe, it may indicate the presence of such bubbles and / or malfunctions.

[0115] In some embodiments, two or more signals (and / or their changes over time) are detected. Different signals can be associated with different samples and / or different fluids of a common fluid. The former can be useful for monitoring the change of one or more properties of a fluid present in an additional instrument from which the fluid is supplied. The latter can be useful for monitoring the properties of the fluid present in different additional instruments. The signal can be of the same type or of different types and can be measured by the same probe or different probes. Similarly, the signal can be measured in different time periods or in the same time period. In some embodiments, the first signal is used to determine the first concentration of a first analyte in a first fluid, and the second signal is used to determine the second concentration of a second analyte in a second fluid.

[0116] Some methods described herein relate to techniques that can be used to determine the concentration of an analyte in a fluid and / or a sample of the fluid flowing through a probe. As described elsewhere herein, some instruments include a source of fluid, an inlet, an outlet, a pump, and other components that facilitate the flow of the fluid (and / or a sample thereof) through the probe.

[0117] Some methods described herein relate to techniques that can be used to measure twice or more using a single probe. In certain embodiments, when the probe is used to perform a first measurement, the analyte can be fixed on the probe. When the analyte remains fixed thereon, performing another measurement with the probe may be challenging or impossible. Therefore, the method of removing the analyte from the probe can facilitate the use of the probe to measure several times.

[0118] In some embodiments, the regeneration fluid can be used to remove the analyte from the probe. As an example, in some embodiments, the probe can be in contact with the fluid (and / or its sample) containing the analyte (and possibly after detecting the signal and / or optical signal associated with the fluid) and the regeneration fluid. The regeneration fluid can be configured to cause the detachment of some or all (e.g., at least a portion) of any analyte fixed on the probe such as the analyte fixed on the probe during contact with the fluid containing the analyte (and / or its sample) and / or during the detection of the signal (e.g., optical signal). The regeneration fluid can cause the detachment of some or all (e.g., at least a portion) of any analyte fixed on the probe in a variety of suitable ways. As an example, in some embodiments, the regeneration fluid can and / or is configured to dissolve some or all of the analyte fixed on the probe. As another example, in some embodiments, the regeneration fluid can and / or is configured to cause a chemical reaction to occur, which cuts off the bond and / or binding interaction between the analyte and the probe (e.g., it can reduce the affinity of the analyte to the probe, the surface chemical composition of the probe and / or the reagent fixed on the probe). As a third example, in some embodiments, the regeneration fluid is capable of and / or is configured to decompose the analyte in a manner such that the decomposition products are soluble in the regeneration fluid. As a fourth example, in some embodiments, the regeneration fluid comprises a substance having a higher affinity for the probe (and / or its surface chemical composition and / or reagents immobilized thereon) than the analyte and / or a substance configured to displace the analyte from the probe.

[0119] The regeneration fluid can perform one or more of the above processes by causing conformational changes of the analyte and / or the reagent fixed on the probe bound to the analyte. The regeneration fluid can cause this change by changing the chemical and / or physical parameters (such as its pH, conductivity and / or temperature) of the fluid to which the probe is exposed. After contacting with the regeneration fluid, a sufficient amount of the analyte can be detached from the probe so that the probe can be used to perform another measurement. For example, in some embodiments, the probe contacts the first fluid (or the first sample of the fluid) containing the analyte, then contacts the regeneration fluid, and then contacts the second fluid (or the second sample of the first fluid or the sample of the second fluid). The signal (e.g., optical signal) can be detected while and / or after the probe contacts the first and / or second fluid (and / or the first and second samples of the fluid).

[0120] Although it is possible to measure a first fluid and a second fluid, it should be understood that reference to a "first" fluid does not necessarily imply the presence of a "second" fluid or any other fluid. Similarly, reference to a "first" fluid does not exclude the presence of a "second", "third" fluid, or other fluids not explicitly mentioned. It should also be understood that reference to other "firsts" (e.g., a first sample of a fluid, a first signal, a first optical signal, a first concentration, a first analyte, etc.) neither implies the presence of a "second" term of a related substance nor excludes the presence of a "second" or other such term.

[0121] In some embodiments, the probe contacts the fresh sample and the regeneration fluid in the multiple samples of the fluid in an alternating manner. In other words, the above process can be repeated for multiple samples of the fluid. In some embodiments, the probe contacts multiple fluids (e.g., fresh sample and regeneration fluid, the first two fluids and neutralization fluid) in a repeating cycle. Repeating the above process can allow the concentration of the analyte in the fluid to be monitored over time. For example, in the case of detecting a signal (e.g., an optical signal) associated with some or all of the multiple samples and determining the concentration of the analyte in the sample associated with each signal (e.g., each optical signal). When the concentration of the analyte in the expected fluid can change over time and / or can change as the fluid is sampled, this may be desirable. In some embodiments, the above process is performed in such a way that the concentration of the analyte in the fluid is repeatedly determined within a predefined time period, determined until the concentration exceeds a predefined limit (e.g., a predefined minimum concentration, a predefined maximum concentration, a predefined concentration range), and / or determined until the change of the signal (e.g., an optical signal) exceeds a predefined limit (e.g., a predefined minimum amount, a predefined maximum amount, a predefined range).

[0122] Some regeneration fluids may be very suitable for removing analytes from the probe, but may put the probe and / or the instrument in which the probe is positioned in a state that is not conducive to further measurement. As an example, in some embodiments, the regeneration fluid may have a pH that will not expect to affect the analyte and / or one or more substances present in the fluid (and / or its sample) in which the analyte is positioned. As another example, in some embodiments, the regeneration fluid may contain substances that will not expect to affect the analyte and / or one or more substances present in the fluid (and / or its sample) in which the analyte is positioned. Such substances can be deposited on the probe surface while and / or after the analyte is removed from the probe surface. Contacting the subsequent fluid (or subsequent sample of the fluid) with the probe can cause the fluid (and / or its sample) to be exposed to such undesirable substances. Similarly, if contacting the fluid and / or the sample of the fluid with the probe includes causing the fluid (and / or its sample) to flow directly across the probe after the regeneration fluid and / or to flow across the probe in a manner that causes the regeneration fluid to shift from the probe, the fluid (and / or its sample) may contact the regeneration fluid and be exposed to such undesirable substances.

[0123] In order to solve the above problems, neutralizing fluid can be adopted.In certain embodiments, the probe contacts with neutralizing fluid after contacting with the regeneration fluid and / or before contacting with the second fluid and / or the second sample of fluid.Neutralizing fluid can be configured to remove any undesirable substances deposited on the probe (and / or the housing in which the probe is positioned therein) from the regeneration fluid (and / or the second fluid and / or the second sample of fluid), and / or remove some or all of the regeneration fluid (and / or the second fluid and / or the second sample of fluid) from the housing in which the probe is positioned therein.Regeneration fluid also has the potential to regulate one or more physical and / or chemical properties (e.g., pH, conductivity and / or temperature) of the probe.

[0124] As mentioned above, Fig. 9 A non-limiting example of an embodiment in which the instrument includes both a source of a neutralizing fluid and a source of a regenerating fluid is shown. As also shown in the figure, a valve can be employed upstream of the inlet of a housing containing a probe, the valve being configured to switch between a source of a regenerating fluid and a source of a neutralizing fluid (e.g., switching between placing the source of a regenerating fluid in fluid communication with the probe and placing the source of a neutralizing fluid in fluid communication with the probe). The same valve can also be used to switch between positions associated with those fluids and one or more positions associated with one or more sources of additional fluids (e.g., fluids that may contain analytes, fluids to be analyzed in the instrument).

[0125] Some methods described herein relate to techniques that can be used to use several probes (e.g., multiple probes) together. The probes in the multiple probes can be arranged in series and / or in parallel. As described above, in some embodiments, it may be desirable that one or more probes contact a series of fluids (e.g., fluid to be analyzed and regeneration fluid, first two fluids and neutralization fluid, several samples of fluid to be analyzed and any one or both of the regeneration fluid and the neutralization fluid). When any particular probe contacts a fluid that is not the fluid to be analyzed, it may be desirable to still analyze the fluid and / or a sample from the fluid. Such measurements can be facilitated by using several probes.

[0126] In some embodiments, a method includes contacting a first probe with a first sequence of fluids, at least one of which includes a fluid that is not a fluid to be analyzed. When the first probe contacts a fluid that is not a fluid to be analyzed (e.g., a regenerated fluid, a neutralized fluid), the second probe may contact the fluid to be analyzed and / or a sample of the fluid to be analyzed. Similarly, when the second fluid contacts the fluid to be analyzed and / or a sample of the fluid to be analyzed, the second probe may contact the fluid that is not a fluid to be analyzed (e.g., a regenerated fluid, a neutralized fluid). In some embodiments, the sample of the fluid to be analyzed and / or the fluid is continuously supplied to a plurality of probes. The probe that provides any specific fluid or sample of the fluid may be a probe that has been contacted with a regenerated fluid, contacted with a neutralized fluid, and / or includes a relatively small amount and / or zero amount of an analyte fixed thereon. After contacting any specific probe with a fluid to be analyzed and / or a sample of the fluid to be analyzed, it may subsequently contact with a regenerated fluid and / or a neutralized fluid, after which it may contact with the fluid to be analyzed and / or a sample of the fluid to be analyzed again.

[0127] In some embodiments, multiple samples of the fluid are supplied to multiple probes in such a manner that each sample of the fluid contacts the probe and each probe contacts the sample of the fluid sequentially. As an example, in some embodiments, the following process can be performed sequentially: first, the first probe can contact the first sample of the fluid; then, the first probe can contact the regeneration fluid and / or the neutralization fluid while the second probe contacts the second sample of the fluid; then, the first probe can contact the third sample of the fluid while the second fluid contacts the regeneration fluid and / or the neutralization fluid; then, optionally, the first probe can contact the regeneration fluid and / or the neutralization fluid while the second probe contacts the fourth sample of the fluid. This process can be repeated and / or performed continuously (e.g., successively adding samples of the fluid).

[0128] It is also possible that two or more probes contact with the common sample of fluid and / or two or more probes contact with the different samples of fluid simultaneously.In certain embodiments, when two or more probes contact with common sample and / or different samples, one or more other probes do not contact with the sample of fluid.Such probes can contact with the fluid (for example, regeneration fluid, neutralization fluid) except sample.In certain embodiments, two or more probes contact with common sample and / or different samples, and one or more probes are regenerated simultaneously.In certain embodiments, a method is included in the time period that the quantity of the probe that contacts with common sample and / or different samples in a plurality of probes is higher than the quantity of the probe that does not contact with any sample in a plurality of probes.

[0129] In some embodiments, contacting two or more probes with a common fluid (and / or a common sample of the fluid) can help detect any anomalies associated with one or more of the probes. As an example, two or more probes can be in contact with a common fluid, and two or more signals (e.g., two or more optical signals) associated with the common fluid can be generated and detected, each signal being generated by a different probe. The signals (e.g., optical signals) generated by different probes can be compared with each other. If they are identical to each other, or within a reasonable error margin between each other, this can indicate that there is no anomaly associated with any probe. On the other hand, if two of the signals (e.g., two of the optical signals) differ from each other by an amount beyond the normal error limit, it can indicate that there is an anomaly associated with one of the probes and / or with a portion of the common fluid (and / or its sample) that contacts one of the probes. Such anomalies can include bubbles, etc.

[0130] As described above, it may be possible that a plurality of probes present in the instrument only include probes that are not different from each other and / or only include probes that can and / or are configured to detect a common analyte. It is also possible that a plurality of probes include two or more probes that are different from each other in one or more aspects. As an example, it is possible that a plurality of probes include two or more probes that can and / or are configured to detect different analytes. When it is desired to analyze the concentration of more than one analyte in a fluid (and / or a sample of a fluid) and / or analyze the concentration of different analytes in different fluids (and / or samples of a fluid) supplied to the probes in the plurality of probes, such probes may be useful. In certain embodiments, a plurality of probes include two probes that are not different from each other (e.g., two or more probes) and two probes that are different from each other (e.g., two or more probes).

[0131] Some instruments described herein can and / or are configured to output one or more signals. Similarly, some methods described herein include outputting one or more signals. Advantageously, such signals can provide information about one or more features of the fluid and / or sample of the fluid that the probe contacts.

[0132] A variety of signals can be output by the instrument described herein. In certain embodiments, the instrument can and / or is configured to output an electrical signal. Similarly, some methods may include outputting an electrical signal. The electrical signal may indicate the concentration of the analyte in the amount of the analyte fixed on the probe and / or the fluid contacting the probe and / or the sample of the fluid. As another example, the electrical signal may indicate that the analyte fixed on the probe and / or present in the fluid (and / or its sample) exceeds a predefined amount. The electrical signal may also indicate that the analyte fixed on the probe and / or present in the fluid (and / or its sample) is in an amount higher than the limit of the amount of the analyte that the instrument can accurately determine in the fluid (and / or its sample). In certain embodiments, the change of the signal (e.g., optical signal, signal associated with the combination of the analyte and the probe) associated with the fixation of the analyte on the probe exceeds a predefined amount.

[0133] As described elsewhere herein, some of the instruments described herein can be associated with, configured to be associated with, and / or be in fluid communication with, an additional instrument. Some methods may include determining the concentration of an analyte in a fluid supplied by and / or received from an additional instrument and / or in one or more samples of a fluid supplied by and / or received from an additional instrument. Some systems may include additional instruments.

[0134] As also described elsewhere herein, the instrument described herein may also be able to and / or be configured to output one or more signals. In some embodiments, such signals are transmitted to additional instruments. As an example, the signal may be transmitted to a computer electrically connected to the instrument described herein (e.g., via a standard specified in an open platform communication). Then, the computer may display information to the operator and / or record the information to a file. As another example, the signal may be output to an additional instrument (e.g., an additional instrument connected to the instrument fluid, an additional instrument not connected to the instrument fluid). Such signals may include instructions for performing actions and / or may instruct additional instruments to perform actions. In some embodiments, the instrument described herein sends instructions and / or a method includes sending instructions based on the determination of the concentration of the analyte in the fluid contacting the probe.

[0135] Non-limiting examples of instructions may include instructions to take no action, stop, pause, modify one or more properties of a fluid in an additional instrument, change the flow rate of a fluid flowing out of and / or within an additional instrument, supply the fluid to a different location, and / or provide the fluid flowing out of the additional instrument to a different reservoir (e.g., a different housing containing a different probe, a different inlet, a waste reservoir, a container temporarily containing the fluid, another column and / or chromatographic medium present in the instrument). It should be noted that while present in the additional instrument, the fluid may undergo one or more processes that modify one or more of its properties (e.g., the concentration of one or more substances therein). Such processes may occur upstream of the probe, but downstream of the location of the fluid subject to the instructions sent to the additional instrument. Thus, instructions sent to an additional instrument based on the concentration of an analyte in a fluid supplied by and / or received from the additional instrument may include: modifying one or more properties of a fluid present in the additional instrument and different in one or more aspects from the fluid in which the concentration is measured; changing the flow rate of a fluid flowing out of and / or within the additional instrument and different in one or more aspects from the fluid in which the concentration is measured; supplying a fluid different in one or more aspects from the fluid in which the concentration is measured to a different location; and / or providing a fluid flowing out of the additional instrument and different in one or more aspects from the fluid in which the concentration is measured to a different reservoir. As an example, a measurement of the concentration of an analyte in a fluid supplied by a column and / or chromatographic medium in a chromatographic system may serve as a basis for sending instructions regarding whether a fluid upstream of the column and / or chromatographic medium should continue to be supplied to the column and / or chromatographic medium and / or be supplied to another column and / or chromatographic medium. The fluid upstream of the column and / or chromatographic medium may differ from the fluid being measured in one or more ways, such as the concentration of the analyte therein (e.g., after passing through the column and / or chromatographic medium, the concentration of the analyte may be much lower than upstream of the column and / or chromatographic medium).

[0136] Taking no action may include continuing to operate the additional instrument in the manner in which it was operating prior to sending the instruction (e.g., supplying flow from the additional instrument at the same rate and to the same location, maintaining properties of a fluid in the additional instrument that is the same or different than the fluid contacting the probe constant, etc.).

[0137] Modifying one or more properties of a fluid in an additional instrument may include modifying the temperature, pressure, flow rate, pH, conductivity, dissolved oxygen content, and / or concentration of one or more substances (e.g., nutrients, including sugars such as glucose, amino acids, and / or fatty acids; and / or metabolites such as lactate) of such fluid. As noted above, the fluid may be the same as the fluid contacting the probe, or may differ therefrom in one or more aspects. In some embodiments, modifying one or more properties of a fluid in an additional instrument may be performed as part of a process intended to achieve desired critical quality attributes by providing appropriate critical process parameters. For example, modifying one or more properties of a fluid in an additional instrument may include achieving and / or maintaining desired culture conditions, enhancing one or more characteristics of a product produced by a biological process occurring in an additional instrument (e.g., yield, productivity, concentration of the product), and / or reducing impurities associated with the product and / or process.

[0138] Supplying fluid to different locations can include supplying the fluid to a different probe, to a different location instead of the probe (e.g., to a column and / or chromatographic media in a column or other chromatographic system, to a waste reservoir, to a valve, to an outlet, to an analytical system), to the same probe but at a different location downstream of the probe (e.g., to a different column and / or chromatographic media in a column or other chromatographic system, to a waste reservoir instead of a column and / or chromatographic media in a column or other chromatographic system or back to a bioprocessing system, to a column and / or chromatographic media in a column or other chromatographic system instead of a waste reservoir, back to a bioprocessing system instead of a waste reservoir, to a valve, to an outlet, to an analytical system), to the same probe but after passing through a different location upstream of the probe (e.g., to a different column, chromatographic media, combination of columns, and / or combination of chromatographic media present in a chromatographic system). The different locations to which the fluid can be supplied can be different bioprocessing systems or different locations within the same bioprocessing system. As noted above, the fluid can be the same as the fluid that contacts the probe, or can differ therefrom in one or more aspects.

[0139] The pause may include pausing one or more operations of the bioprocessing system and / or pausing the supply of fluid to the probe. The pause may occur for a defined period of time and / or may be indefinite (e.g., until an operator triggers a restart, a shutdown, a change in one or more operations, a change in one or more properties of the fluid in the bioprocessing system, and / or a change in the location to which the fluid is supplied). In some embodiments, the pause may allow one or more internal adjustments to be made to the bioprocessing system that supplies fluid to the probe so that the bioprocessing system stops supplying fluid to the probe, so that a new bioprocessing system supplies fluid to the probe, and / or so that the fluid supplied to the probe is switched from a fluid supplied by one bioprocessing system to a fluid supplied by another bioprocessing system.

[0140] In some embodiments, the instruments described herein are capable of and / or configured to interface with additional instruments in a manner that does not negatively affect the operation of the additional instruments (or in some embodiments, does not affect the functionality at all). As an example, in some embodiments, the instruments are configured to receive and / or are capable of receiving fluid and / or a sample of fluid from an additional instrument in a manner that maintains the sterility of the fluid remaining in the additional instrument.

[0141] In some embodiments, the instruments described herein are capable and / or configured to interface with additional instruments (such as a bioprocessing system) that are capable and / or configured to perform a bioprocess and / or in which a bioprocess is being performed. In such embodiments, a first instrument (e.g., the above-described instrument) may be capable and / or configured to monitor a bioprocess and / or report the results of measurements performed on a fluid that undergoes a bioprocess and / or is obtained from a bioprocessing system but is different in one or more aspects from a fluid present in one or more parts of the bioprocessing system. Measurements may be performed on samples of a fluid that undergoes a bioprocess and / or is obtained from a fluid that is present in a bioprocessing system but is different in one or more aspects from a fluid present in one or more parts of the bioprocessing system. In some embodiments, the reporting of the measurement results may have a relatively low time lag (e.g., a time lag that is low enough to enable bioprocess control).

[0142] Bioprocessing system can be a system in which a bioprocess is being performed, in which a bioprocess can be performed and / or configured to perform a bioprocess. Non-limiting examples of bioprocesses include biotechnology and biopharmaceutical processes, such as those involved in the manufacture of desired therapeutic biological products. Non-limiting examples of suitable therapeutic biological products include biologics, vaccines, components for cell or gene therapy and non-therapeutic biological products such as pigments, biofuels and / or nutritional supplements. Bioprocesses can involve expressing therapeutic biological products by microorganisms or mammalian cells, and / or the cells themselves can be desired therapeutic biological products. In certain embodiments, the desired therapeutic biological product can be the result of a cell-free production process based on one or more natural or non-naturally obtained cellular components.

[0143] In some embodiments, the bioprocess performed in the bioprocess system (and / or the bioprocess that the bioprocess system can perform and / or is configured to perform) is an upstream process. The upstream process may include actions and / or workflows performed during the development, optimization, screening and / or selection of strains and / or cell lines, cell culture, production of desired products with cells and / or cell components, and / or processes performed between such actions. By applying different operating modes (e.g., batch, fed-batch, perfusion, continuous and / or combinations thereof), different reactor settings and geometries (e.g., rocking motion, stirred tank, bubbling column, fixed bed) can be used to perform cultivation at various scales (e.g., μL-several thousand L). The cultivation process can generally be monitored, analyzed and / or controlled based on different sensor technologies (e.g., soft, electrochemical, biochemical, optical; offline, online, in-line, near-line). In some upstream processes, after the cultivation of the biological agent, it is purified (e.g., via a downstream process). During purification, the culture fluid can be separated from the desired product, which can be cells and / or other expressed components (e.g., monoclonal antibodies, polyketides, enzymes, vaccines). A non-limiting example of a bioprocessing system that can be employed in the upstream process is a bioreactor. Non-limiting examples of suitable bioreactors include fed-batch bioreactors, fed-batch bioreactors, and perfusion bioreactors.

[0144] In some embodiments, the bioprocess performed in the bioprocessing system (and / or the bioprocess that the bioprocessing system can perform and / or is configured to perform) is a downstream process. Downstream processes may include various techniques and methods for recovering, purifying, analyzing and / or characterizing desired products. Downstream processes may involve cell disruption, sedimentation, centrifugation, precipitation, crystallization, extraction, filtration, adjustment of pH and conductivity of liquids, enzyme or chemical modification, dilution, buffer exchange, evaporation, adsorption and / or chromatography. In some embodiments, the downstream process includes analysis and / or characterization steps. Such steps can help recover purified products that meet one or more quality attributes (e.g., glycosylation pattern of antibodies, concentration of endotoxins). A formulation step may be performed to make the purified product reach a suitable state for storage and distribution before it is filled and packaged, and the formulation step may involve buffer exchange, drying, freeze drying or crystallization. Non-limiting examples of bioprocessing systems that can be used in downstream processes include chromatography systems (e.g., batch chromatography systems, continuous chromatography systems), filtration systems (e.g., tangential flow filtration systems, ultrafiltration / diafiltration systems), centrifugal systems and centrifuges.

[0145] As described elsewhere herein, in some embodiments, the apparatus described herein is associated with an additional apparatus that includes and / or is a chromatography system. The chromatography system may include a column and / or a chromatography medium (e.g., a chromatography medium contained in a column). Non-limiting examples of suitable chromatography media include resins, membrane adsorbers, and monoliths.

[0146] In embodiments involving a chromatographic system, the chromatographic system and / or one or more components thereof (e.g., a column therein, a chromatographic medium therein) can supply a fluid to a probe. In some embodiments, a method includes performing one or more operations on a chromatographic system and / or a portion thereof. As an example, in some embodiments, a method includes loading a column and / or a chromatographic medium into a chromatographic system. As another example, in some embodiments, a method includes washing a column and / or a chromatographic medium in a chromatographic system (e.g., after it has supplied a fluid to a probe, to prepare it to be eluted, to prepare it to be regenerated). As another example, in some embodiments, a method includes eluting a column and / or a chromatographic medium (e.g., after it has been loaded with an analyte, such as after it has been supplied with a fluid containing an analyte, such as after it has supplied a fluid to a probe). As a third example, in some embodiments, a method includes regenerating a column and / or a chromatographic medium (e.g., after it has been eluted, after it has been washed, to prepare it to load an analyte from a fluid).

[0147] In some embodiments, a method includes detecting when an analyte first begins to elute / flow through a chromatographic system, a column in a chromatographic system, and / or a chromatographic medium present in a chromatographic system (e.g., a chromatographic medium present in a column) from a chromatographic system, a column in a chromatographic system, and / or a chromatographic medium present in a chromatographic system (e.g., a chromatographic medium present in a column). The analyte may be a substance that is desired to be recovered from the chromatographic system, or may be an impurity that is desired to be eliminated from a sample of a fluid flowing through the chromatographic system. The method may include dividing the fluid flowing out of the chromatographic system (e.g., from a first column therein, from a first chromatographic medium therein) into a plurality of samples, and then contacting each sample with a regeneration probe. Before any analyte is detected in the sample of the fluid, the sample of the fluid may flow to a first location (e.g., a reservoir, a waste reservoir, in which it may be stored) after contacting the probe. At the time of initial analyte detection, the chromatography system may adjust flow so that fluid supplied thereto and / or fluid upstream of the first column and / or chromatography medium (and potentially different in one or more respects from fluid downstream of the first column, fluid downstream of the first chromatography medium, and / or fluid in contact with the probe) is supplied to the second column and / or second chromatography medium rather than the first column and / or chromatography medium. At this point in time, the instrument may continue to be used to determine the amount of analyte in a sample of fluid eluting from the chromatography system as a whole (e.g., a sample of fluid that has flowed through the second column and / or second chromatography medium).

[0148] In some embodiments, the above process is repeated several times. As an example, in some embodiments, the chromatographic system includes three or more columns and / or chromatographic media. After the penetration of the second column and / or chromatographic medium is detected in the sample of the fluid received from the second column and / or chromatographic medium, the chromatographic system can adjust the flow so that the fluid supplied to it and / or the fluid upstream of the second column and / or the second chromatographic medium is supplied to the third column and / or the third chromatographic medium, rather than the second column and / or the second chromatographic medium. At this time point, the instrument can continue to be used to determine the amount of analytes in the sample of the fluid eluted from the chromatographic system as a whole (e.g., the sample of the fluid that has flowed through the third column and / or the third chromatographic medium). In some embodiments, during the time period when the fluid is not supplied to the first column and / or the first chromatographic medium (e.g., when the fluid is supplied to the second and / or third column and / or the chromatographic medium instead), the first column and / or the first chromatographic medium can be washed, eluted and / or regenerated. The above process can be repeated with more than one column and / or chromatographic medium (e.g., four or more columns and / or chromatographic medium) and / or can be performed so that samples of the fluid flowing out of the column are provided to three or more columns and / or chromatographic media in a repeated sequence. The above process can be completed by using countercurrent chromatography and / or simulated moving bed chromatography. This can allow the implementation of a continuous chromatographic process and possibly therefore an integrated continuous bioprocess (ICB). For example, it can allow the connection of a continuous USP with a continuous DSP, as described herein.

[0149] Advantageously, the above process may be able to compensate for variations in the amount of analyte supplied to the chromatography system (e.g., variations in the analyte produced therein when the fluid is supplied by another bioprocessing system such as a bioreactor) and / or may compensate for variations in the capacity of the column and / or chromatography medium. Both features may reduce analyte losses during its purification and / or may be suitable for enhancing the use of the resin present in the column and / or chromatography medium (e.g., enhancing the dynamic binding capacity).

[0150] In some embodiments, the sample of the fluid in contact with the probe can be recirculated by the chromatographic system. Such samples can be samples containing analytes and / or samples lacking analytes. The instrument described herein can be used with a variety of suitable chromatographic systems and in a variety of suitable locations in the chromatographic process. As an example, in some embodiments, the instrument described herein can be used to detect column and / or chromatographic medium penetration, such as penetration of a substance bound to a column and / or chromatographic medium (i.e., the transport of the substance loaded thereon leaving the column and / or chromatographic medium). In such embodiments, the concentration of the analyte in the sample of the fluid flowing through the column and / or chromatographic medium can be determined to assess when and / or if there is any penetration. As another example, in some embodiments, the instrument described herein can be used to detect the elution of the analyte from the column and / or chromatographic medium. In such embodiments, the concentration of the analyte in the sample of the fluid flowing through the purification column and / or chromatographic medium can be determined to assess when elution starts and when elution ends. As another example, the instrument described herein can be used to determine the binding capacity of the column and / or chromatographic medium to the analyte and / or generate a penetration curve of the analyte.

[0151] A non-limiting example of a suitable chromatographic system is a continuous simulated moving bed chromatography system. A variety of suitable columns can be used, such as capture columns, purification columns, finishing columns, cation exchange columns, anion exchange columns, affinity columns, hydrophobic interaction columns and / or mixed mode columns. The column can include a chromatographic medium, such as a resin, a membrane absorbent and / or a monolith.

[0152] As also described elsewhere herein, in some embodiments, the instrument described herein is associated with an additional instrument including a bioreactor and / or a bioreactor. In some embodiments, a method includes detecting the concentration of analyte in the bioreactor over time. Advantageously, before the detection of analyte concentration, such method can be performed without additional cell removal steps. The sample of the fluid present in the bioreactor can be obtained from it, and then contacted with the probe. After contacting with the probe, the sample of the fluid can be returned to the bioreactor or can be provided to a waste reservoir. The former situation can advantageously allow repeated sampling of a small-scale (e.g., milliliter scale) bioreactor without consuming the entire working volume of the bioreactor. In some embodiments, the sample of the fluid is received from the bioreactor in a manner that keeps the sterility of the fluid remaining in the bioreactor. The sample of the fluid is also likely to be received from the bioreactor and in a manner that keeps its sterility by an instrument including a probe (e.g., so that it can be returned to the bioreactor in a sterile situation).

[0153] Additional instruments may also include vessels (eg, mixing vessels) for receiving fluids from one or more of the above instruments.

[0154] A sample of the fluid may be contacted with the probe as frequently as desired (e.g., every few hours) in order to determine the rate of production of the analyte. The process may also be used to determine when the concentration of the analyte is above a predefined value and / or when a change in a signal (e.g., an optical signal) associated with the fixation of the analyte on the probe exceeds a predefined amount. For example, a method may include determining when the concentration of the analyte is at a level indicating that growth in the bioreactor can be terminated and a desired product (e.g., analyte) can be obtained therefrom. As another example, a method may include determining when the concentration of the analyte is at a level that is not desirable for cell growth. In this case, the method may include outputting a signal indicative of this fact, which may automatically trigger adjustment of growth conditions and / or alert an operator to take action.

[0155] In some embodiments, the instrument described herein is configured to be associated with two or more additional instruments (such as two or more bioprocessing systems and / or two or more bioreactors) in a reversible manner, can be associated with a reversible manner and / or can be associated with a reversible manner. Such instruments can be configured to be in fluid communication with two or more additional instruments, bioprocessing systems and / or bioreactors, can be in fluid communication and / or fluid communication. In some embodiments, the association and / or fluid communication is reversible. For example, the association and / or fluid communication can occur through a single inlet. In such embodiments, a valve can be used to switch positions between positions in which a probe is placed in fluid communication with two or more bioreactors. When it is desired to determine the concentration of an analyte in an additional instrument, a bioprocessing system and / or a bioreactor at relatively infrequent intervals compared to the amount of time required to determine the concentration of an analyte and / or regenerate a probe, it may be advantageous to use two or more bioreactors to supply a single inlet. In such embodiments, a single instrument can advantageously be used to monitor the concentration of an analyte in two or more additional instruments, bioprocessing systems, and / or bioreactors over time, requiring fewer instruments to perform these measurements than would be required if each bioreactor was associated with a different instrument.

[0156] Similarly, some methods include contacting the probe with a fluid supplied from two or more additional instruments, and some systems may include two or more additional instruments, each additional instrument being configured to supply and / or capable of supplying fluid to the instrument (e.g., a first fluid output from a first additional instrument and a second fluid output from a second additional instrument).

[0157] In some embodiments, two or more additional instruments are two or more bioprocessing systems. As an example, in some embodiments, a method includes contacting a probe with a fluid supplied from two bioprocessing systems, a system includes two bioprocessing systems, and / or an instrument is configured to be associated with two or more bioprocessing systems in a reversible manner, can be associated in a reversible manner, and / or associated in a reversible manner. In some embodiments, one of the bioprocessing systems is an upstream bioprocessing system, and one of the bioprocessing systems is a downstream bioprocessing system. As an example, in some embodiments, one of the bioprocessing systems includes a bioreactor, and one of the bioprocessing systems includes a chromatographic system. In such embodiments, it may be possible that a method includes using a bioreactor to perform a biological process that causes the generation of an analyte, and also includes using a chromatographic system to capture the analyte. This can be performed in an automated manner and / or without operator input. For example, based on the measurement of the concentration of the analyte in the fluid supplied by the bioreactor, an instruction can be sent to the bioreactor to continue to perform the biological process and / or supply the fluid to the chromatographic system. As another example, based on the measurement of the concentration of the analyte in the fluid supplied by the chromatography system, instructions can be sent to the chromatography system to continue loading columns and / or chromatography media therein, to elute columns and / or chromatography media, and / or to direct fluid (e.g., supplied by a bioreactor, supplied by columns and / or chromatography media in the chromatography system) to a particular column and / or chromatography media. In some embodiments, a common probe can be employed to perform all such concentration measurements, possibly without the need for threshold adjustment.

[0158] It is also possible that two or more of the biological treatment systems are upstream biological treatment systems and / or that two or more of the biological treatment systems are downstream biological treatment systems.

[0159] In some embodiments (where two or more additional instruments are present, supply fluid, are capable of supplying fluid, and / or are configured to supply fluid), a detector present in the instrument may be capable of detecting and / or configured to detect a signal when the probe contacts the fluid supplied by each additional instrument. For example, the detector may be configured to detect and / or be capable of detecting a change in a first signal when the probe contacts the fluid supplied by a first additional instrument, and also configured to detect and / or be capable of detecting a change in a second signal when the probe contacts the fluid supplied by a second additional instrument.

[0160] In some embodiments (where two or more additional instruments are present, supply fluids, are capable of supplying fluids, and / or are configured to supply fluids), the instrument and / or system may be capable of sending instructions to one of the additional instruments based on the concentration of the analyte in the fluid supplied by another additional instrument and / or is configured to send instructions to one of the additional instruments. Similarly, some methods include determining the concentration of the analyte in the fluid supplied by the first additional instrument and sending instructions to the second additional instrument based on the determination. Such instructions may include the above instructions (e.g., modifying one or more properties of the second fluid in the bioprocessing system, continuing to supply the second fluid to the probe, supplying the second fluid to a different location, and / or taking no action). As a non-limiting example, in some embodiments, instructions may be sent to a chromatography system based on the concentration of the analyte in the fluid supplied by the bioreactor, instructions may be sent to the bioreactor based on the concentration of the analyte in the fluid supplied by the chromatography system, and / or instructions may be sent to a chromatography system based on the concentration of the analyte in the fluid supplied by the first chromatography system (e.g., to supply the fluid to different locations, such as different columns and / or chromatography media in the chromatography system, to recycle the fluid, to supply the fluid to a waste reservoir).

[0161] Non-limiting further examples of additional instrumentation that may be in fluid communication with the instrumentation described herein include filtration devices, centrifuges, pumps, and valves.

[0162] As described above, in some embodiments, the apparatus includes a probe. The probe can help detect the concentration of an analyte in a fluid and / or a sample of the fluid that contacts the probe.

[0163] The probes described herein can have a variety of suitable designs. In some embodiments, the probe is an optical probe. As an example, the probe can be a fiber optic probe and / or include an optical fiber. Fig.16 One non-limiting embodiment of a cross-section of a probe comprising an optical fiber is shown.

[0164] In some embodiments, the probe includes one or more components that allow the probe to be optically coupled to an optical cable. As an example, in some embodiments, the probe includes a component such as a plastic hub that is compatible with an SMA connector (e.g., an SMA905 connector), a BNC connector, a connector with push, lock and / or twist functions, and / or a compression spring. Figure 17 to Figure 18 An example of such a component in combination with an optical cable is shown. In some embodiments, the probe is coupled to the optical cable via a ferrule. The ferrule may include an optical fiber including a polished tip, which may facilitate optical communication with the probe. The optical cable may include one or more components to help relieve strain at the location of the coupling.

[0165] In some embodiments, the probe is transparent and / or transmissive to light of multiple wavelengths (e.g., visible wavelengths, near infrared wavelengths). In some embodiments, this can be facilitated by the presence of one or more polished ends (e.g., a polished end perpendicular to the optical axis of the probe).

[0166] In some embodiments, the probe comprises a functionalized surface and / or a surface having a surface chemical composition that assists in the fixation of an analyte. For example, the surface functionalization and / or chemical composition can promote the bonding of one or more analytes thereto. In some embodiments, the probe comprises a surface on which one or more reagents (e.g., one or more reagents suitable for fixing the analyte) are fixed. The reagent(s) can be fixed on the probe in a variety of suitable ways. As an example, the reagent(s) can be bonded to the probe. Bonding can include covalent bonding, ionic bonding, polar bonding, van der Waals bonding, hydrophobic bonding, and / or hydrogen bonding.

[0167] In some embodiments, one or more reagents can be fixed on the probe so that they do not experience significant (and / or any) detachment from the probe when in contact with the fluid to be analyzed (and / or a sample thereof), in contact with a regeneration fluid, in contact with a neutralization fluid, and / or any other process typically performed during one or more of the above methods. For example, the reagent(s) can be fixed on the probe in a manner that is stable to water, aqueous solutions, buffers, acids, bases, and / or body fluids.

[0168] Additionally or alternatively, one or more reagents may be fixed on the probe in a manner that allows the probe to be refunctionalized. The method may also include refunctionalizing the probe. Refunctionalization may include removing one or more reagents from the probe. For example, in some embodiments, refunctionalization includes exposing the probe having one or more reagents fixed thereon to a fluid (e.g., a buffer, such as an acidic buffer), which causes one or more of those reagents to detach from the probe. Thereafter, the probe may be exposed to a fluid containing one or more new reagents to be fixed on the probe. Refunctionalizing the probe may advantageously allow the probe to be adopted and / or fixed to more than one type of analyte during more than one method. As an example, before determining the concentration of a first analyte in a fluid and / or a sample of a fluid, a first reagent and / or a reagent set may be fixed on the probe. In some cases, it may be desirable to reuse the probe to determine the concentration of a second analyte in a fluid and / or a sample of a fluid (e.g., the same fluid as before, a different fluid, the same sample as before, a different sample). Thus, following detection of the concentration of a first analyte, the probe may be refunctionalized to produce a probe to which a new reagent and / or set of reagents may be immobilized, thereby allowing the probe to be used to detect the concentration of a second analyte.

[0169] It is also possible that some probes will not be re-functionalized and / or are not capable of being re-functionalized.

[0170] A variety of suitable reagents can be fixed on the surface of the probe described herein. Some reagents can be substances that can participate in one or more chemical reactions (e.g., one or more chemical reactions that cause the analyte to be fixed on the probe). For example, the probe can include a reagent that can bond to the analyte (e.g., covalently, ionically, by polar interactions, by van der Waals interactions, hydrophobically, by hydrogen bonding, by complexation), absorb the analyte, and / or adsorb the analyte. In some embodiments, one or more of the chemical reactions previously described can cause the analyte that reacts with the reagent to become fixed thereon. Selected non-limiting examples of suitable reagents include biomolecules (e.g., proteins, glycoproteins, peptides, nucleic acids (e.g., DNA, RNA, mRNA), antibodies (e.g., antibodies to exosomes such as anti-CD63 and / or anti-CD9, antibodies to proteins, antibodies to viruses, antibodies to virus-like particles), antibody fragments, antigens, polysaccharides, carbohydrates, hormones, streptavidin, glutathione), ligands (e.g., ligands of proteins such as protein A), small molecules, viruses, cells, inorganic compounds (e.g., aminopropylsilane), chelating compounds, capsids, bacteria, resins (e.g., Ni-NTA), plasmids, nutrients, metabolites, metabolic byproducts, and combinations thereof. Non-limiting examples of proteins include protein A, protein G, protein L, and lectins. A non-limiting example of a combination of two or more of the previously described reagent types is a reagent comprising protein A and antibodies to exosomes and / or viruses. The antibodies may be immobilized on protein A immobilized on the probe surface and may be capable of immobilizing exosomes and / or viruses. In such embodiments, as well as other embodiments, two or more agents are immobilized on the probe (and, in some embodiments, one or more such agents may be a combination of two or more agents).

[0171] In certain embodiments, the reagent fixed on the surface of the probe is suitable for participating in chemical and / or biological reactions including binding. The probe may also be suitable for participating in chemical and / or biological reactions that do not include binding. When present, binding may include a reaction between a target and a binding partner that specifically binds to the target (e.g., an agent or molecule that specifically binds to the target). Binding may also include fixing the target (e.g., analyte) on the binding partner. In certain embodiments, the binding partner may specifically bind to an epitope on a target molecule (e.g., analyte). Non-limiting examples of specific pairs of binding partners and targets include antibodies and antigens, antibody fragments and antigens, antibodies and haptens, antibodies and peptides, antibodies and small molecules, antigens and fusion proteins, antibody fragments and haptens, enzymes and enzyme substrates, enzymes and inhibitors, enzymes and cofactors, binding proteins and substrates, carrier proteins and substrates, proteins and small molecules, lecithin and carbohydrates, receptors and hormones, receptors and effectors, complementary chains of nucleic acids, combinations of proteins and nucleic acid repressors and inducers, ligands and cell surface receptors, viruses and ligands, and receptors and ligands.

[0172] Non-limiting examples of antibodies that can be binding partners or antibodies include complete (i.e., full-length) polyclonal and monoclonal antibodies, antigen-binding fragments of polyclonal and monoclonal antibodies (such as Fab, Fab', F(ab')2 or Fv), single chains (scFv), single-chain mutants, fusion proteins including antibody portions, humanized antibodies, chimeric antibodies, double antibodies, linear antibodies, single-chain antibodies, multispecific antibodies (e.g., bispecific antibodies) and modified configurations of immunoglobulin molecules including antigen recognition sites of desired specificity. Non-limiting examples of antibodies belonging to the last category include glycosylation variants of antibodies, amino acid sequence variants of antibodies, and covalently modified antibodies. In addition, the binding partner can be an antibody of any class, such as IgD, IgE, IgG, IgA or IgM (or its subclass, e.g., IgG1, IgG2, IgG3, IgG4, IgA1 and / or IgA2).

[0173] An antigen can be a molecule or part of a molecule against which antibodies can be generated. Antigens can be peptides, polysaccharides, and / or lipids. Some antigens can originate from within the body ("self antigens"), and some antigens can originate from the external environment ("non-self antigens").

[0174] In some embodiments, antibodies suitable for performing chemical and / or biological reactions specifically bind to epitopes on their target molecules. An epitope (which may be referred to as an antigenic determinant) may be part of an antigen recognized (or bound) by an antibody. For example, an epitope may be a specific fragment of an antigen to which an antibody binds. The part of an antibody that binds to an epitope may be referred to as a paratope. An epitope may be a conformational epitope (consisting of discontinuous amino acids or segments of an antigen) or a linear epitope (consisting of continuous amino acids). Some proteins may share segments with high sequence homology and / or structural similarity. These similar proteins may have a common epitope (in other words, epitopes on different antigens may be bound by the same antibody). In addition, proteins that have been differentially treated (such as proteins that have undergone further enzymatic processes) may share some but not all epitopes with their pre-treated forms. Non-limiting examples of different epitopes that may be added or removed during processing include N-terminal signal peptides (as seen, for example, on pre-propeptides) and changes seen when inactive proteins (e.g., propeptides) are converted to active forms by post-translational modifications.

[0175] When an antibody specifically binds to an epitope, it can participate in a binding reaction that can discriminate between a target molecule (e.g., an analyte) and a non-target molecule (e.g., a molecule other than the analyte of interest). For example, a binding partner can specifically bind to a target molecule with an affinity greater than or equal to 2 times greater than that for a non-target molecule, greater than or equal to 4 times greater than that for a non-target molecule, greater than or equal to 5 times greater than that for a non-target molecule, greater than or equal to 6 times greater than that for a non-target molecule, greater than or equal to 7 times greater than that for a non-target molecule, greater than or equal to 8 times greater than that for a non-target molecule, greater than or equal to 9 times greater than that for a non-target molecule, greater than or equal to 10 times greater than that for a non-target molecule, greater than or equal to 20 times greater than that for a non-target molecule, greater than or equal to 25 times greater than that for a non-target molecule, greater than or equal to 50 times greater than that for a non-target molecule, or greater than or equal to 100 times greater than that for a non-target molecule.

[0176] The binding affinity of an antibody can be measured by its affinity (K D ) parameterized. K D is the ratio of the dissociation constant to the association constant (K D =K d / K a ). In some embodiments, the binding partners described herein have less than or equal to 10 -5 M, less than or equal to 10 -6 M, less than or equal to 10 -7 M, less than or equal to 10 -8 M, less than or equal to 10 -9 M, less than or equal to 10 -10 M, less than or equal to 10 -11 M, or less than or equal to 10 -12 The affinity (K D ). Increased affinity K D Corresponding to a decreased dissociation constant Kd or an increased association constant (K a ). Higher affinity binding of a binding partner (e.g., an antibody) to a first molecule relative to a second molecule can be indicated by a higher affinity binding to the first molecule compared to the K for binding to the second target. a (or K D and / or K d The higher the K for binding to the first target a (or K D and / or K d In this case, the antibody has a higher specificity for the first molecule (e.g., a protein in a first conformation or a mimetic thereof) relative to the second molecule (e.g., the same protein in a second conformation or a mimetic thereof, or a second protein). The difference in binding affinity (e.g., specificity) can be greater than or equal to 1.5 times, greater than or equal to 2 times, greater than or equal to 3 times, greater than or equal to 4 times, greater than or equal to 5 times, greater than or equal to 10 times, greater than or equal to 15 times, greater than or equal to 20 times, greater than or equal to 37.5 times, greater than or equal to 50 times, greater than or equal to 70 times, greater than or equal to 80 times, greater than or equal to 90 times, greater than or equal to 100 times, greater than or equal to 500 times, greater than or equal to 1000 times, greater than or equal to 10,000 times, greater than or equal to 10 5 times.

[0177] In certain embodiments, reagent can be fixed on the surface of probe via covalent bond.Before such fixing, the surface of probe can be functionalized so that it includes multiple functional groups suitable for forming such covalent bonds.For example, the surface of probe can be functionalized by reacting with a bifunctional reagent, and the bifunctional reagent includes a siloxane group promoting the attachment to the probe and a functional group promoting the formation of a covalent bond with the reagent to be fixed on the probe.As another example, the surface of probe can be exposed to plasma or other treatments, and its original position generates a functional group, which promotes the formation of a covalent bond with the reagent to be fixed on the probe.The non-limiting example of the functional group of the suitable type promoting the formation of a covalent bond with the reagent to be fixed on the probe includes hydroxyl, amine and carboxyl.

[0178] The probes described herein can be formed of a variety of suitable materials and / or include coatings formed of a variety of suitable materials. In some embodiments, the probes include glass and / or polymers and / or include coatings of glass and / or polymers. Non-limiting examples of suitable glass include SiO2 and Ta2O5. Non-limiting examples of suitable polymers include polystyrene and polyethylene.

[0179] The probes described herein can include optical fibers having a variety of suitable diameters. In some embodiments, the probes include optical fibers having a core having a diameter greater than or equal to 400 microns, greater than or equal to 500 microns, greater than or equal to 600 microns, greater than or equal to 700 microns, greater than or equal to 800 microns, greater than or equal to 900 microns, greater than or equal to 1000 microns, greater than or equal to 1100 microns, greater than or equal to 1200 microns, greater than or equal to 1300 microns, greater than or equal to 1400 microns, greater than or equal to 1500 microns, greater than or equal to 1600 microns, greater than or equal to 1700 microns, greater than or equal to 1800 microns, or greater than or equal to 1900 microns. In some embodiments, the probe comprises an optical fiber having a core having a diameter of less than or equal to 2000 microns, less than or equal to 1900 microns, less than or equal to 1800 microns, less than or equal to 1700 microns, less than or equal to 1600 microns, less than or equal to 1500 microns, less than or equal to 1400 microns, less than or equal to 1300 microns, less than or equal to 1200 microns, less than or equal to 1100 microns, less than or equal to 1000 microns, less than or equal to 900 microns, less than or equal to 800 microns, less than or equal to 700 microns, less than or equal to 600 microns, or less than or equal to 500 microns. Combinations of the above-mentioned ranges are also possible (e.g., greater than or equal to 400 microns and less than or equal to 2000 microns). Other ranges are also possible.

[0180] A variety of suitable detectors can be used in the instrument described herein. In some embodiments, the instrument includes an optical detector. Non-limiting examples of suitable types of optical detectors include photon counting devices, spectrophotometers, spectrometers (e.g., Raman spectrometers, infrared spectrometers), polarization detectors, photodiodes, CCD / CMOS sensors, and imaging sensors. Such optical detectors can be configured to and / or detect changes in optical signals in one or more time periods. For example, such optical detectors may be able to perform relatively fast measurements of optical signals and / or measure optical signals in relatively short time periods. Some optical detectors may also be configured to and / or detect multiple optical signals (e.g., multiple optical signals each associated with a sample of a fluid and / or a fluid). In some embodiments, the optical detector is configured to and / or detect the intensity of light as a function of position (which in turn can allow detection of the intensity of light as a function of the angle at which it is reflected from the probe) and / or detect the intensity of light across a limited angular range.

[0181] In some embodiments, the instrument includes a mechanical detector, such as a quartz crystal microbalance.

[0182] As mentioned above, in some embodiments, the apparatus includes a light source. The light source can be used as a source of light that stimulates emission of the optical signal.

[0183] In some embodiments, the light source supplies light of multiple wavelengths. For example, the instrument may include a light source that includes an incandescent bulb. As another example, the instrument may include a light source that includes a lamp, such as a halogen lamp, a xenon lamp, a mercury lamp, an LED and / or an arc lamp. When the instrument includes a light source that supplies light of multiple wavelengths, the instrument may also include one or more optical filters. (Multiple) such optical filters may be positioned between the light source and the location of the substance generating the optical signal and / or between the light source and the detector. If the light emitted by the light source includes at least one wavelength that will stimulate the generation of an optical signal other than the desired optical signal (for example, in the case where the light of the relevant wavelength will stimulate the emission from a variety of substances, including substances that are always fixed on the probe and / or present in the fluid and / or its sample that contacts the probe), the former situation may be beneficial. It is also possible that the light source supplies light within a limited wavelength range (for example, the light source may include a laser or other narrowband source).

[0184] The light sources described herein may also supply light in a single polarization state and / or in multiple polarization states. When the light source supplies light in multiple polarization states, the instrument may also include one or more polarization filters. (Multiple) such polarization filters may be positioned between the light source and the location of the substance generating the optical signal and / or between the light source and the detector.

[0185] In some embodiments, the light source supplies light at multiple (eg, all or substantially all) angles. It is also possible that the light source supplies light within a restricted range of angles.

[0186] As described above, in some embodiments, the amount of an analyte in a fluid and / or a sample of a fluid is determined.Additional details regarding possible fluids, samples of fluids, and analytes are provided below.

[0187] In certain embodiments, fluid (and / or its sample) may contain analyte.Some methods may include determining whether such fluid (and / or the sample of fluid) actually contains analyte and / or the amount of analyte contained in fluid (and / or the sample of fluid).Therefore, some fluids and / or the sample of fluid may contain analyte (with a variety of suitable amounts), and some fluids and / or the sample of fluid may lack analyte.In addition, it should also be understood that the analyte concentration mentioned in fluid (and / or the sample of fluid) covers the concentration of zero as well, and covers the concentration greater than zero.

[0188] The fluids described herein can contain a variety of suitable analytes, non-limiting examples of which include proteins (e.g., protein A, protein G, protein L, host cell proteins, Fc receptors, streptavidin), peptides, antibodies (e.g., IgG), antigens, small molecules, viruses, capsids, cells (e.g., Chinese hamster ovary cells), differentiated cell types, polysaccharides, bacteria, nucleic acids (e.g., DNA, RNA, mRNA), exosomes, extracellular vesicles, and ions (e.g., nickel ions). In some embodiments, the fluid contains an analyte that is a labeled protein, such as a tagged protein by recombinant modification. Non-limiting examples of tagged proteins include His-tagged proteins and biotin-tagged proteins.

[0189] Analytes can be labeled or unlabeled. Unlabeled analytes can lack a label that facilitates detection (e.g., a label that facilitates optical detection, a fluorescent label, etc.), can have the same chemical composition (e.g., the same chemical formula) as they do in the attached instrument from which they are supplied, and / or can have the same chemical composition as they do once purified to form a final product. In some embodiments, advantageously, a method includes determining the concentration of an unlabeled analyte in a fluid and / or an instrument is configured to determine and / or is capable of determining the concentration of an unlabeled analyte in a fluid. This can allow for easy label-free detection, and / or can allow for determination of analyte concentrations and / or properties without the need for a labeling step and / or without the influence of an attached label.

[0190] The fluids and samples of fluids described herein may contain analytes at a variety of suitable concentrations. In some embodiments, the fluid and / or sample of the fluid comprises a concentration of at least 0.000001 g / L, at least 0.000002 g / L, at least 0.000005 g / L, at least 0.0000075 g / L, at least 0.00001 g / L, at least 0.00002 g / L, at least 0.00005 g / L, at least 0.000075 g / L, at least 0.0001 g / L, at least 0.00002 g / L, at least 0.00005 g / L, at least 0.000075 g / L, at least 0.001 g / L, at least 0.002 g / L, at least 0.0005 g / L, at least 0.00075 g / L, at least 0.01 g / L, at least 0.002 g / L, at least 0.005 g / L, at least 0.0075 g / L, at least 0.01 g / L, greater than or equal to 0.02 g / L, greater than or equal to 0.05 g / L, greater than or equal to 0.075 g / L, greater than or equal to 0.1 g / L, greater than or equal to 0.2 g / L, greater than or equal to 0.5 g / L, greater than or equal to 0.75 g / L, greater than or equal to 1 g / L, greater than or equal to 1.5 g / L, greater than or equal to 2 g / L, greater than or equal to 2.5 g / L, greater than or equal to 3 g / L, greater than or equal to 3.5 g / L, greater than or equal to 4 g / L, greater than or equal to 4.5 g / L, greater than or equal to 5 g / L, greater than or equal to 6 g / L, greater than or equal to 7.5 g / L, greater than or equal to 10 g / L, greater than or equal to 15 g / L, greater than or equal to 20 g / L, greater than or equal to 30 g / L, or greater than or equal to 40 g / L.In some embodiments, the fluid and / or sample of the fluid comprises a concentration of 5 g / L or less, 50 g / L or less, 40 g / L or less, 30 g / L or less, 20 g / L or less, 15 g / L or less, 10 g / L or less, 7.5 g / L or less, 6 g / L or less, 5 g / L or less, 4.5 g / L or less, 4 g / L or less, 3.5 g / L or less, 3 g / L or less, 2.5 g / L or less, 2 g / L or less, 1.5 g / L or less, 1 g / L or less, 0.75 g / L or less, 0.5 g / L or less, 0.2 g / L or less, 0.1 g / L or less, 0.075 g / L or less, 0.05 g / L or less, 0.02 0.0001 g / L, less than or equal to 0.00075 g / L, less than or equal to 0.005 g / L, less than or equal to 0.002 g / L, less than or equal to 0.001 g / L, less than or equal to 0.00075 g / L, less than or equal to 0.0005 g / L, less than or equal to 0.0002 g / L, less than or equal to 0.0001 g / L, less than or equal to 0.000075 g / L, less than or equal to 0.00005 g / L, less than or equal to 0.00002 g / L, less than or equal to 0.00001 g / L, less than or equal to 0.0000075 g / L, less than or equal to 0.000005 g / L, or less than or equal to 0.000002 g / L. Combinations of the above-mentioned ranges are also possible (eg, greater than or equal to 0.000001 g / L and less than or equal to 50 g / L). Other ranges are also possible.

[0191] In some embodiments, in addition to possibly containing an analyte, the fluid and / or the sample of the fluid also contains an additional substance. For example, as described above, in some embodiments, the fluid and / or the sample of the fluid is supplied by an additional instrument. In such embodiments, the fluid and / or the sample of the fluid may also contain one or more substances that promote the use of the additional instrument and / or exist during the process being performed in the additional instrument. As an example, in some embodiments, the fluid to be analyzed is a crude sample and / or the sample of the fluid to be analyzed is a crude sample. As an additional example (for example, in the case where the additional instrument is a chromatography system), the fluid and / or the sample of the fluid includes a buffer. As a third example (for example, in the case where the additional instrument is a bioreactor), the fluid and / or the sample of the fluid includes one or more components of a cell culture medium, non-limiting examples of which include glucose, lactate, amino acids (for example, one or more types), salts (for example, one or more types), proteins (for example, one or more types, such as protein A, protein G, protein L, host cell proteins), peptides, one or more types of nucleic acids and / or one or more types of cells. The fluid and / or the sample of the fluid may also have one or more features that are helpful and / or necessary for the operation of the additional instrument, such as being sterile.

[0192] Some fluids and / or samples of fluids may contain body fluids and / or biological materials. In some embodiments, fluids and / or samples of fluids contain analytes as biological materials (e.g., located in biological fluids, located in buffers). As an example, in some embodiments, fluids and / or samples of fluids contain cells (e.g., living cells) and / or reagents (e.g., biomolecules) as analytes and / or as substances other than analytes. Fluids and / or samples of fluids may contain some or all of the reagents described elsewhere herein for reagents that may be fixed on the surface of the probe and / or may contain reagents other than the reagents described as such. Such reagents may be analytes to be detected, or may be present in fluids and / or samples of fluids that may contain such analytes. Non-limiting examples of such reagents include proteins, glycoproteins, peptides, ligands, antibodies, antigens, hormones, nucleic acids (e.g., DNA, RNA), polysaccharides, carbohydrates, small molecules, inorganic compounds, chelating compounds, viruses, extracellular vesicles, exosomes, capsids, cells, differentiated cell types, and bacteria.

[0193] It is also possible to perform measurements on fluids that are standards. For example, in some embodiments, measurements are performed on positive standards and / or negative standards. Positive standards can be configured to always generate a signal (e.g., an optical signal) and / or always generate a known signal (e.g., a known optical signal) when the instrument is correctly performed. Some positive standards include analytes of known concentrations in the fluid. Negative standards can be configured to always generate a signal (e.g., an optical signal) indicating that the analyte fixation of the instrument is not correctly performed. Some negative standards lack any analyte. Performing methods on positive standards and / or negative standards can be used to calibrate the results obtained from the instrument and / or confirm that the instrument is operating normally. Some embodiments may include contacting a probe with multiple fluids including a sample of a fluid to be analyzed and / or a fluid (and optionally lacking a standard), and contacting a second probe with multiple fluids including a standard (and optionally lacking a sample of a fluid to be analyzed and / or a fluid). Embodiments may also include contacting two or more standards (e.g., with two or more probes, such that each probe contacts a single standard, such that one probe contacts two standards, such that two probes contact two standards), such as a positive standard and a negative standard and / or two or more positive standards comprising different concentrations of an analyte.

[0194] In some embodiments, fluid and / or a sample of fluid is supplied through relatively short tubing from a source of fluid in fluid communication with an instrument described herein. The tubing may have a length greater than or equal to 0.1 cm, greater than or equal to 0.2 cm, greater than or equal to 0.5 cm, greater than or equal to 0.75 cm, greater than or equal to 1 cm, greater than or equal to 2 cm, greater than or equal to 5 cm, greater than or equal to 7.5 cm, greater than or equal to 10 cm, greater than or equal to 12.5 cm, greater than or equal to 15 cm, greater than or equal to 17.5 cm, greater than or equal to 20 cm, greater than or equal to 22.5 cm, greater than or equal to 25 cm, greater than or equal to 27.5 cm, greater than or equal to 30 cm, greater than or equal to 32.5 cm, greater than or equal to 35 cm, greater than or equal to 37.5 cm, greater than or equal to 40 cm, greater than or equal to 42.5 cm, greater than or equal to 45 cm, greater than or equal to 47.5 cm, greater than or equal to 50 cm, greater than or equal to 55 cm, greater than or equal to 60 cm, greater than or equal to 75 cm, greater than or equal to 1 m, greater than or equal to 2 m, greater than or equal to 5 m, greater than or equal to 7.5 The length of m. The tubing may have a length of less than or equal to 10 m, less than or equal to 7.5 m, less than or equal to 5 m, less than or equal to 2 m, less than or equal to 1 m, less than or equal to 75 cm, less than or equal to 60 cm, less than or equal to 55 cm, less than or equal to 50 cm, less than or equal to 47.5 cm, less than or equal to 45 cm, less than or equal to 42.5 cm, less than or equal to 40 cm, less than or equal to 37.5 cm, less than or equal to 35 cm, less than or equal to 32.5 cm, less than or equal to 30 cm, less than or equal to 27.5 cm, less than or equal to 25 cm, less than or equal to 22.5 cm, less than or equal to 20 cm, less than or equal to 17.5 cm, less than or equal to 15 cm, less than or equal to 12.5 cm, less than or equal to 10 cm, less than or equal to 7.5 cm, less than or equal to 5 cm, less than or equal to 2 cm, less than or equal to 1 cm, less than or equal to 0.75 cm, less than or equal to 0.5 cm, or less than or equal to 0.2 The length of the above mentioned ranges is also possible (for example, greater than or equal to 0.1 cm and less than or equal to 10 m, greater than or equal to 5 cm and less than or equal to 2 m, greater than or equal to 5 cm and less than or equal to 50 cm, or greater than or equal to 10 cm and less than or equal to 50 cm). Other ranges are also possible.

[0195] In some embodiments, fluid and / or a sample of fluid is supplied from a source of fluid in fluid communication with an instrument fluid described herein through a tubing having a relatively low linear volume. The tubing can have a linear volume of greater than or equal to 10 microliters, greater than or equal to 20 microliters, greater than or equal to 30 microliters, greater than or equal to 40 microliters, greater than or equal to 50 microliters, greater than or equal to 80 microliters, greater than or equal to 100 microliters, greater than or equal to 200 microliters, greater than or equal to 500 microliters, greater than or equal to 800 microliters, greater than or equal to 1 mL, greater than or equal to 2 mL, greater than or equal to 5 mL, greater than or equal to 8 mL, greater than or equal to 10 mL, greater than or equal to 20 mL, greater than or equal to 30 mL, greater than or equal to 40 mL, greater than or equal to 50 mL, greater than or equal to 80 mL, greater than or equal to 100 mL, greater than or equal to 125 mL, greater than or equal to 150 mL, or greater than or equal to 175 mL. The tubing can have a linear volume of less than or equal to 200 mL, less than or equal to 175 mL, less than or equal to 150 mL, less than or equal to 125 mL, less than or equal to 100 mL, less than or equal to 80 mL, less than or equal to 50 mL, less than or equal to 40 mL, less than or equal to 30 mL, less than or equal to 20 mL, less than or equal to 10 mL, less than or equal to 8 mL, less than or equal to 5 mL, less than or equal to 2 mL, less than or equal to 1 mL, less than or equal to 800 microliters, less than or equal to 500 microliters, less than or equal to 200 microliters, less than or equal to 100 microliters, less than or equal to 80 microliters, less than or equal to 50 microliters, less than or equal to 40 microliters, less than or equal to 30 microliters, or less than or equal to 20 microliters. Combinations of the above-mentioned ranges are also possible (eg, greater than or equal to 10 microliters and less than or equal to 200 mL, greater than or equal to 40 microliters and less than or equal to 40 mL, or greater than or equal to 80 microliters and less than or equal to 10 mL). Other ranges are also possible.

[0196] As described above, some apparatus include a source of a regeneration fluid, and some methods include contacting the probe with the regeneration fluid.Additional details regarding some suitable regeneration fluids are provided below.

[0197] In some embodiments, the regeneration fluid includes a buffer. The regeneration fluid may also include salts (e.g., acetates such as sodium acetate, citrates, phosphates, Tris buffer salts, sodium hydroxide) and / or organic molecules (e.g., glycine, biotin, histidine). Salts can help buffer the regeneration fluid. In some embodiments, the regeneration fluid includes a substance (such as a small molecule or salt) that can and / or is configured to bind an analyte (such as an analyte fixed on a probe). As an example, the regeneration fluid may include biotin to regenerate a probe for determining the concentration of a streptavidin analyte. As another example, the regeneration fluid may include histidine to regenerate a probe for determining the concentration of a nickel ion analyte. The substance present in the regeneration fluid may also be bound to a reagent fixed on the probe, thereby displacing the analyte fixed thereon (e.g., the biotin in the regeneration fluid may be bound to a streptavidin reagent fixed on the probe, thereby displacing the analyte from it).

[0198] The regenerative fluid described herein can have a variety of suitable pH. In certain embodiments, the regenerative fluid is acidic. Acidic regenerative fluids can be particularly suitable for probes used together with fluids and / or samples of fluids that may contain such analytes: the analytes are antibodies, proteins (e.g., protein A, protein G, protein L) and / or nucleic acids (e.g., DNA, RNA). The regenerative fluid can have a pH greater than or equal to 1, greater than or equal to 1.5, greater than or equal to 2, greater than or equal to 2.5, greater than or equal to 3, greater than or equal to 3.5, greater than or equal to 4, or greater than or equal to 4.5. The regenerative fluid can have a pH less than or equal to 5, less than or equal to 4.5, less than or equal to 4, less than or equal to 3.5, less than or equal to 3, less than or equal to 2.5, less than or equal to 2, or less than or equal to 1.5. The combination of the above-mentioned ranges is also possible (e.g., greater than or equal to 1 and less than or equal to 5). Other ranges are also possible. For example, the regenerative fluid is also likely to have a neutral or alkaline pH.

[0199] As described above, some apparatus include a source of a neutralizing fluid, and some methods include contacting the probe with the neutralizing fluid.Additional details regarding some suitable neutralizing fluids are provided below.

[0200] In some embodiments, the neutralizing fluid comprises a buffer. Non-limiting examples of suitable buffers include phosphate buffered saline and Tris buffer.

[0201] Neutralization fluid described herein can have multiple suitable pH.In certain embodiments, neutralization fluid has neutral or near neutral pH.Neutralization fluid can have the pH that is greater than or equal to 6, greater than or equal to 6.5, greater than or equal to 7, greater than or equal to 7.5, greater than or equal to 8, greater than or equal to 8.5 or greater than or equal to 9.Neutralization fluid can have the pH that is less than or equal to 9, less than or equal to 8.5, less than or equal to 8, less than or equal to 7.5, less than or equal to 7 or less than or equal to 6.5.The combination of the above-mentioned scope is also possible (for example, greater than or equal to 6 and less than or equal to 9 or greater than or equal to 6 and less than or equal to 8).Other scopes are also possible.

[0202] As described above, in some embodiments, the instrument includes a source of fluid other than the source of the sample, the source of the regenerating fluid and / or the source of the neutralizing fluid. Similarly, in some embodiments, the instrument includes a valve, which includes one or more positions that are connected to the source fluid of the fluid other than the source of the sample, the source of the regenerating fluid and / or the source of the neutralizing fluid. Non-restrictive other examples of the source of the fluid include the source of the fluid containing the first antibody, the source of the fluid containing the second antibody, the source of the washing buffer source and the source of the fluid containing the substrate for the second antibody. It is not desirable to be bound by theory, when the instrument is used to form an analyte, these sources of fluid may be beneficial. For example, the first antibody present in the fluid of the contact probe can become fixed on the probe. Such a first antibody may be suitable for fixing the analyte present in the sample of the fluid. As another example, the second antibody present in the fluid of the contact probe may become fixed on the analyte fixed on the probe. The second antibody may promote the detection of the analyte. Similarly, the fluid containing the substrate for the second antibody may promote the detection of the analyte by interaction with the second antibody. As a third example, the washing buffer may be suitable for removing one or more components from the probe.

[0203] Another example of the source of the fluid that can be present in the instrument described herein is the source of diluent.The source of diluent can be positioned so that it is configured to supply diluent to mix with one or more fluids (e.g., a sample of fluid) supplied by the source of fluid.The source of diluent can be positioned upstream of valve, and this valve may be able to supply, be configured to supply and / or supply the fluid of dilution to probe.Instrument can be configured to mix diluent with associated fluid.In certain embodiments, this mixing can occur upstream of valve, and this valve can supply, be configured to supply and / or supply the fluid of dilution to probe.Then, a mixed fluid comprising diluent and the fluid supplied from the source of fluid can flow through valve, and then contact probe.

[0204] As described elsewhere herein, the instruments described herein may include microfluidic channels.

[0205] The microfluidic channel described herein can have a variety of suitable sizes perpendicular to the fluid flow. Such sizes can be referred to as "width" elsewhere in this article, even if they are vertically oriented. In certain embodiments, one or more or each microfluidic channel in the instrument independently has a width of one or more in the following ranges: greater than or equal to 0.5 mm, greater than or equal to 0.75 mm, greater than or equal to 1 mm, greater than or equal to 2 mm, greater than or equal to 5 mm, or greater than or equal to 7.5 mm. In certain embodiments, each microfluidic channel in the instrument independently has a width of less than or equal to 10 mm, less than or equal to 7.5 mm, less than or equal to 5 mm, less than or equal to 2 mm, less than or equal to 1 mm, or less than or equal to 0.75 mm. The combination of the above-mentioned ranges is also possible (e.g., greater than or equal to 0.5 mm and less than or equal to 10 mm). Other ranges are also possible.

[0206] As described above, in some embodiments, the probe contacts a fluid and / or a sample of a fluid. The probe may also contact multiple fluids in a repeating cycle, such as multiple fluids including multiple fluids that may contain analytes and / or samples of multiple fluids. Additional details about this type of contact are provided below.

[0207] Fluids and samples of fluids can be contacted with the probe for a variety of suitable time periods. In some embodiments, contacting the probe with the fluid (and / or a sample thereof) includes contacting the probe with the fluid (and / or a sample thereof) for a period of time greater than or equal to 1 second, greater than or equal to 2 seconds, greater than or equal to 5 seconds, greater than or equal to 10 seconds, greater than or equal to 15 seconds, greater than or equal to 20 seconds, greater than or equal to 25 seconds, greater than or equal to 30 seconds, greater than or equal to 40 seconds, greater than or equal to 1 minute, greater than or equal to 2 minutes, greater than or equal to 5 minutes, greater than or equal to 10 minutes, greater than or equal to 20 minutes, greater than or equal to 30 minutes, greater than or equal to 45 minutes, greater than or equal to 1 hour, greater than or equal to 1.5 hours, greater than or equal to 2 hours, greater than or equal to 2.5 hours, greater than or equal to 3 hours, greater than or equal to 3.5 hours, or greater than or equal to 4 hours. In some embodiments, contacting the probe with the fluid (and / or its sample) includes contacting the probe with the fluid (and / or its sample) for a period of less than or equal to 5 hours, less than or equal to 4 hours, less than or equal to 3.5 hours, less than or equal to 3 hours, less than or equal to 2.5 hours, less than or equal to 2 hours, less than or equal to 1.5 hours, less than or equal to 1 hour, less than or equal to 45 minutes, less than or equal to 30 minutes, less than or equal to 20 minutes, less than or equal to 10 minutes, less than or equal to 5 minutes, less than or equal to 2 minutes, less than or equal to 1 minute, less than or equal to 40 seconds, less than or equal to 30 seconds, less than or equal to 25 seconds, less than or equal to 20 seconds, less than or equal to 15 seconds, less than or equal to 10 seconds, less than or equal to 5 seconds, or less than or equal to 2 seconds. Combinations of the above-mentioned ranges are also possible (e.g., greater than or equal to 1 second and less than or equal to 5 hours, greater than or equal to 1 second and less than or equal to 1 hour, or greater than or equal to 10 seconds and less than or equal to 30 seconds). Other ranges are also possible.

[0208] Can carry out the repetitive cycle that wherein possibly comprises a plurality of fluids of analyte and / or the sample of a plurality of fluids and probe contacts in multiple suitable cycle time.In certain embodiments, the time of completing circulation is greater than or equal to 30 seconds, greater than or equal to 40 seconds, greater than or equal to 50 seconds, greater than or equal to 60 seconds, greater than or equal to 70 seconds or greater than or equal to 80 seconds.In certain embodiments, the time of completing circulation is less than or equal to 90 seconds, less than or equal to 80 seconds, less than or equal to 70 seconds, less than or equal to 60 seconds, less than or equal to 50 seconds or less than or equal to 40 seconds.The combination of the above-mentioned scope is also possible (for example, greater than or equal to 30 seconds and less than or equal to 90 seconds).Other scopes are also possible.

[0209] Repeated cycles of contacting a plurality of fluids and / or samples of a plurality of fluids, which may contain analytes, with the probe may be performed at a variety of suitable intervals. In some embodiments, the interval is greater than or equal to 30 seconds, greater than or equal to 1 minute, greater than or equal to 2 minutes, greater than or equal to 5 minutes, greater than or equal to 10 minutes, greater than or equal to 20 minutes, greater than or equal to 30 minutes, greater than or equal to 45 minutes, greater than or equal to 1 hour, greater than or equal to 1.5 hours, greater than or equal to 2 hours, greater than or equal to 3 hours, greater than or equal to 4 hours, greater than or equal to 6 hours, greater than or equal to 8 hours, greater than or equal to 12 hours, or greater than or equal to 16 hours. In some embodiments, the interval is less than or equal to 24 hours, less than or equal to 16 hours, less than or equal to 12 hours, less than or equal to 8 hours, less than or equal to 6 hours, less than or equal to 4 hours, less than or equal to 3 hours, less than or equal to 2 hours, less than or equal to 1.5 hours, less than or equal to 1 hour, less than or equal to 45 minutes, less than or equal to 30 minutes, less than or equal to 20 minutes, less than or equal to 10 minutes, less than or equal to 5 minutes, less than or equal to 2 minutes, or less than or equal to 1 minute. Combinations of the above-mentioned ranges are also possible (e.g., greater than or equal to 30 seconds and less than or equal to 24 hours). Other ranges are also possible.

[0210] Repeated cycles in which multiple fluids and / or samples of multiple fluids, which may contain analytes, are contacted with the probe can be performed for a variety of suitable total times. In some embodiments, repeated cycles are performed (e.g., continuously, at preset intervals) for a period of time greater than or equal to 0.5 minutes, greater than or equal to 1 minute, greater than or equal to 2 minutes, greater than or equal to 5 minutes, greater than or equal to 7.5 minutes, greater than or equal to 10 minutes, greater than or equal to 15 minutes, greater than or equal to 20 minutes, greater than or equal to 30 minutes, greater than or equal to 45 minutes, greater than or equal to 1 hour, greater than or equal to 2 hours, greater than or equal to 3 hours, greater than or equal to 6 hours, greater than or equal to 9 hours, greater than or equal to 12 hours, greater than or equal to 15 hours, greater than or equal to 18 hours, greater than or equal to 1 day, greater than or equal to 1.5 days, greater than or equal to 2 days, greater than or equal to 5 days, greater than or equal to 1 week, greater than or equal to 2 weeks, or greater than or equal to 1 month. In some embodiments, the repetitive cycle is performed for a period of less than or equal to 3 months, less than or equal to 1 month, less than or equal to 2 weeks, less than or equal to 1 week, less than or equal to 5 days, less than or equal to 2 days, less than or equal to 1.5 days, less than or equal to 1 day, less than or equal to 18 hours, less than or equal to 15 hours, less than or equal to 12 hours, less than or equal to 9 hours, less than or equal to 6 hours, less than or equal to 3 hours, less than or equal to 2 hours, less than or equal to 1 hour, less than or equal to 45 minutes, less than or equal to 30 minutes, less than or equal to 20 minutes, less than or equal to 15 minutes, less than or equal to 10 minutes, less than or equal to 7.5 minutes, less than or equal to 5 minutes, less than or equal to 2 minutes, or less than or equal to 1 minute. Combinations of the above-mentioned ranges are also possible (e.g., greater than or equal to 0.5 minutes and less than or equal to 3 months). Other ranges are also possible.

[0211] In some embodiments, the methods described herein are performed with the assistance of a computer and / or processor, such as via a computer-implemented control system. In addition, some systems and apparatus described herein include computers and / or processors. Such methods, systems, and apparatus are not limited in their implementation to any particular computer system described herein, as many other different machines may be used.

[0212] The computer-implemented control system described herein may be part of an instrument and / or system or may be operably associated with an instrument and / or system, configured and / or programmed to control and adjust operating parameters of the instrument and / or system, and / or analyze, calculate and / or determine values ​​(e.g., concentrations). In some embodiments, the computer-implemented control system may send and receive reference signals to set and / or control operating parameters of the instrument and / or system, such as when a defined value or threshold is reached. In some embodiments, the computer-implemented control system may be separate from the instrument and / or remotely located relative to the instrument and / or may be configured to receive data from one or more remote sample instruments via indirect and / or portable means (such as via a portable electronic data storage device (such as a disk)) or via communications over a computer network (such as the Internet or a local intranet).

[0213] The computer-implemented control system may include components and circuits such as a processing unit (i.e., a processor), a memory system, input and output devices and interfaces (e.g., interconnect mechanisms), and / or other components such as transmission circuits (e.g., one or more buses), video and audio data input / output (I / O) subsystems, dedicated hardware, and / or other components and circuits, as described in more detail below. In addition, the computer-implemented control system may be a multi-processor computer system and / or may include multiple computers connected via a computer network.

[0214] The computer-implemented control system may include a processor, for example, a commercially available processor such as one of the x86 series, Celeron and Pentium processors available from Intel, similar devices from AMD and Cyrix, the 680X0 series microprocessor available from Motorola, the PowerPC microprocessor available from IBM, and an ARM processor. Many other processors are available, and the computer system is not limited to a particular processor.

[0215] In some embodiments, the processor executes a program called an operating system, of which Windows NT, Windows 95 or 98, Windows 7, Windows 8, UNIX, Linux, DOS, VMS, MacOS, and OSX, and iOS are examples, which can control the execution of other computer programs and / or can provide scheduling, debugging, input / output control, accounting, compilation, storage allocation, data management and / or memory management, communication control, and / or other related services. The processor and operating system together can define a computer platform for which applications are written in a high-level programming language. The computer-implemented control system is not limited to a specific computer platform.

[0216] In some embodiments, the processor is in electronic communication with, capable of electronic communication with, and / or configured to be in electronic communication with one or more other components present in the systems described herein.For example, the processor may be in electronic communication with the detector.

[0217] In some embodiments, the processor is programmed to perform one or more methods described herein and / or determine one or more values ​​by using the processor. As an example, in some embodiments, the processor is programmed to determine the concentration of an analyte in a fluid (e.g., a first fluid, a second fluid) (e.g., a first concentration of a first analyte, a second concentration of a first analyte, a second concentration of a second analyte). The determination can be performed based on a change in a signal (e.g., a signal detected by a detector, such as an optical signal detected by an optical detector) over a period of time. As another example, the processor can be programmed to determine whether a threshold has been reached based on a change in a signal (e.g., a signal detected by a detector, such as an optical signal detected by an optical detector) over a period of time. The threshold value can indicate a certain value of the first derivative of the signal, such as the value of the first derivative of the signal as a limit that the instrument can detect and / or is configured to detect.

[0218] The computer-implemented control system may include a memory system, which may include a computer-readable and writable non-volatile recording medium, examples of which are magnetic disks, optical disks, flash memory, and magnetic tapes. Such recording media may be removable, such as a floppy disk, a read / write CD, or a memory stick, or may be permanent, such as a hard drive.

[0219] Such recording media may typically store signals in binary form (i.e., in a form interpreted as a sequence of 1s and 0s). A disk (e.g., a magnetic disk or an optical disk) may have a plurality of tracks on which such signals may be stored, typically in binary form (i.e., in a form interpreted as a sequence of 1s and 0s). Such signals may define a software program (e.g., an application) to be executed by a microprocessor or information to be processed by an application.

[0220] The memory system of the computer-implemented control system may also include an integrated circuit memory element, which is typically a volatile random access memory, such as a dynamic random access memory (DRAM) or a static random access memory (SRAM). In operation, the processor may cause programs and data to be read from the non-volatile recording medium into the integrated circuit memory element, which may allow program instructions and data to be accessed by the processor faster than the non-volatile recording medium.

[0221] The processor can manipulate the data within the integrated circuit memory element according to the program instructions. It can then copy the manipulated data to a non-volatile recording medium after the processing is completed. The computer-implemented control system is not limited to a specific memory system.

[0222] At least a portion of such a memory system described above may be used to store one or more data structures (e.g., a lookup table) or equations described above. For example, at least a portion of the non-volatile recording medium may store at least a portion of a database including one or more of such data structures. Such a database may be any of a variety of types of databases, such as a file system including one or more flat file data structures, in which data is organized into data units separated by delimiters; a relational database, in which data is organized into data units stored in tables; an object-oriented database, in which data is organized into data units stored as objects; another type of database; or any combination thereof.

[0223] The computer-implemented control system may include a video and audio data I / O subsystem. The audio portion of the subsystem may include an analog-to-digital (A / D) converter that can receive analog audio information and convert it into digital information. The digital information may be compressed using a known compression system for storage on a hard disk for use at another time. The video portion of the I / O subsystem may include a video image compressor / decompressor. Such a compressor / decompressor may convert analog video information into compressed digital information, and / or vice versa. The compressed digital information may be stored on a hard disk for later use.

[0224] The computer-implemented control system may include one or more output devices. Example output devices include cathode ray tube (CRT) displays, liquid crystal displays (LCDs) and other video output devices, printers, communication devices such as modems or network interfaces, storage devices such as disks or tapes, and audio output devices such as speakers. Such output devices may include output interfaces that can output information to operators, instruments, components of systems, and / or components of different systems that can receive and / or be configured to receive such information. In some embodiments, the information may take the form of signals, such as electronic signals encoding such information, visual signals notifying operators of such information, and / or electronic signals encoding instructions (e.g., instructions supplied to additional instruments such as bioprocessing systems based on the determination of the concentration of the analyte in the fluid). As an example, in some embodiments, the output interface can indicate and / or be configured to indicate the concentration of the analyte in the fluid.

[0225] In some embodiments, the output interface includes a display interface. The display interface can display information to the operator. In some embodiments, the display information includes a digital indication of the information provided on the display interface. For example, the display interface can indicate the concentration of the analyte in the fluid by providing its numerical indication on the display interface. Additionally or alternatively, the display interface can display other information, such as the state of the instrument, a signal (e.g., an optical signal indicating a combination, such as a binding signal) and / or a first-order derivative of a signal (e.g., a first-order derivative of an optical signal indicating a combination such as a binding signal). Such a display interface can display information obtained simultaneously (e.g., a signal obtained simultaneously and / or the value of its first-order derivative).

[0226] The computer-implemented control system may also include one or more input devices. Example input devices include keyboards, keypads, trackballs, mice, pens and tablet computers, communication devices such as those described above, and data input devices such as audio and video capture devices and sensors. Such input devices may include input interfaces that may receive information from components of operators, instruments, systems and / or components of different systems that may provide and / or be configured to provide such information. In certain embodiments, information may take the form of signals, such as signals from which the concentration of an analyte in a fluid may be determined. Information may be received over a network or may be directly (e.g., mechanically) input to an input interface.

[0227] It should be understood that one or more of any type of computer-implemented control system can be used to implement the various embodiments described herein. Aspects of the present invention can be implemented in software, hardware, or firmware, or any combination thereof. A computer-implemented control system can include specially programmed dedicated hardware, such as an application specific integrated circuit (ASIC). Such dedicated hardware can be configured to implement one or more of the above methods, steps, simulations, algorithms, systems, and system elements, as part of the above-mentioned computer-implemented control system or as a stand-alone component.

[0228] The computer-implemented control system and its components may be programmable using any of a variety of one or more suitable computer programming languages. Such languages ​​may include: procedural programming languages, such as C, Pascal, Fortran, and BASIC; object-oriented languages, such as C++, Java, and Eiffel; and other languages, such as scripting languages ​​or even assembly languages.

[0229] Methods, steps, simulations, algorithms, systems, and system elements can be implemented using any of a variety of suitable programming languages ​​that can be executed by such computer systems, including procedural programming languages, object-oriented programming languages, other languages, and combinations thereof. Such methods, steps, simulations, algorithms, systems, and system elements can be implemented as separate modules of a computer program, or can be implemented separately as separate computer programs. Such modules and programs can be executed on separate computers.

[0230] Such methods, steps, simulations, algorithms, systems, and system elements may be implemented, alone or in combination, as a computer program product tangibly embodied as a computer-readable signal on a computer-readable storage medium (e.g., a non-volatile recording medium, an integrated circuit memory element, or a combination thereof). For each such method, step, simulation, algorithm, system, or system element, such a computer program product may include a computer-readable signal tangibly embodied on a computer-readable storage medium, the computer-readable signal defining instructions (e.g., encoded therein), e.g., as part of one or more programs, that instruct a computer to perform the method, step, simulation, algorithm, system, or system element as a result of execution by the computer.

[0231] Paragraph 1: In some embodiments, a method is provided. The method includes: contacting a probe with a fluid for a first time period, wherein the fluid is supplied by a bioprocessing system, wherein the fluid is flowing through the probe, wherein an analyte is present in the fluid at a first concentration, and wherein at least a portion of the analyte becomes immobilized on the probe; detecting a change in a signal during the first time period; determining a first concentration based on the change in the signal during the first time period; and sending instructions to the bioprocessing system based on the determination of the first concentration.

[0232] Paragraph 2: In some embodiments, a system is provided. The system includes: a first instrument including a probe and a detector configured to detect a change in a signal within a first time period; and a bioprocessing system, wherein the system is configured to supply a fluid from the bioprocessing system to the first instrument, wherein the first instrument is configured to determine a first concentration of an analyte in the fluid when the fluid contacts and flows through the probe based on the change in the signal within the first time period, wherein the system is configured to send instructions to the bioprocessing system based on the determination of the first concentration.

[0233] Paragraph 3: In some embodiments, a method includes: contacting a probe with a fluid for a first time period, wherein the fluid is flowing through the probe, wherein an analyte is present in the fluid at a first concentration, and wherein at least a portion of the analyte becomes immobilized on the probe; detecting a change in an optical signal during the first time period; and determining a first concentration based on the change in the optical signal during the first time period, wherein the optical signal includes light reflected from an interface inside the probe and light reflected from an end of the probe.

[0234] Paragraph 4: In some embodiments, a first instrument is provided. The first instrument includes: a probe; and an optical detector configured to detect a change in an optical signal within a first time period, wherein the first instrument is configured to determine a first concentration of an analyte in a fluid contacting and flowing through the probe based on the change in the optical signal within the first time period, and wherein the optical signal includes light reflected from an interface inside the probe and light reflected from an end of the probe.

[0235] Paragraph 5: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the fluid is an output of the bioprocessing system when contacted with the probe.

[0236] Paragraph 6: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the fluid is supplied to the first instrument as an output from the bioprocessing system.

[0237] Paragraph 7: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the fluid is supplied to the first instrument in an automated manner.

[0238] Paragraph 8: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the instructions include modifying one or more properties of a fluid in the bioprocessing system.

[0239] Paragraph 9: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the system includes a second biological processing system.

[0240] Paragraph 10: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the second biological processing system is configured to supply the second fluid output from the second biological processing system to the first instrument.

[0241] Paragraph 11: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the detector is configured to detect a change in the second signal within the second time period.

[0242] Paragraph 12: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, the first instrument is configured to determine a second concentration of a second analyte in the second fluid when the second fluid contacts and flows through the probe based on a change in the second signal over a second time period.

[0243] Paragraph 13: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the system is configured to send a second instruction to the bioprocessing system based on the determination of the second concentration.

[0244] Paragraph 14: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, the second instruction includes modifying one or more properties of a fluid in a bioprocessing system, continuing to supply a second fluid to a probe, supplying the second fluid to a different location and / or taking no action.

[0245] Paragraph 15: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the bioprocessing system comprises a chromatography system.

[0246] Paragraph 16: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the system further comprises a second biological treatment system, and wherein the second biological treatment system comprises a bioreactor.

[0247] Paragraph 17: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the bioprocessing system includes a bioreactor.

[0248] Paragraph 18: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the bioreactor is a fed-batch bioreactor.

[0249] Paragraph 19: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the bioreactor is a fed-batch bioreactor.

[0250] Paragraph 20: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the bioreactor is a perfusion bioreactor.

[0251] Paragraph 21: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the biological processing system includes a filtration system.

[0252] Paragraph 22: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the filtration system is a tangential flow filtration system and / or an ultrafiltration / diafiltration system.

[0253] Paragraph 23: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the bioreactor comprises a centrifugation system and / or a centrifuge.

[0254] Paragraph 24: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the signal is an optical signal.

[0255] Paragraph 25: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the optical signal includes light reflected from an interface inside the probe and light reflected from the end of the probe.

[0256] Paragraph 26: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the optical signal comprises light reflected from the surface of the probe within a restricted angular range.

[0257] Paragraph 27: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the signal is a mechanical signal.

[0258] Paragraph 28: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the first apparatus comprises a light source.

[0259] Paragraph 29: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the light source supplies light within a restricted wavelength range.

[0260] Paragraph 30: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the light source includes an LED.

[0261] Paragraph 31: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is unlabeled.

[0262] Paragraph 32: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the fluid is supplied from a column in a chromatography system.

[0263] Paragraph 33: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the different locations are different columns and / or chromatographic media in a chromatography system.

[0264] Paragraph 34: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the fluid is supplied from the probe to the waste reservoir.

[0265] Paragraph 35: In some embodiments, a method as described in any of the preceding paragraphs further comprises washing a column from which the fluid is supplied, and / or a system and / or the first instrument as described in any of the preceding paragraphs is further configured to wash a column from which the fluid is supplied.

[0266] Paragraph 36: In some embodiments, a method as described in any of the preceding paragraphs further comprises eluting a column from which a fluid is supplied, and / or a system and / or a first instrument as described in any of the preceding paragraphs is further configured to elute a column from which a fluid is supplied.

[0267] Paragraph 37: In some embodiments, a method as described in any of the preceding paragraphs further comprises regenerating a column from which fluid is supplied, and / or a system and / or the first instrument as described in any of the preceding paragraphs is further configured to regenerate a column from which fluid is supplied.

[0268] Paragraph 38: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, wherein the system includes a processor in electronic communication with the detector, and wherein the processor is programmed to determine the first concentration based on a change in the signal over a first time period.

[0269] Paragraph 39: In some embodiments, a computer for implementing the method described in any of the preceding paragraphs is provided, and / or the system and / or the first apparatus described in any of the preceding paragraphs includes a computer. The computer includes an input interface configured to receive a signal, at least one processor programmed to determine a first concentration based on a change in the signal within a first time period, and an output interface configured to send instructions to a bioprocessing system.

[0270] Paragraph 40: In some embodiments, in the computer, the system or the first apparatus as described in any of the preceding paragraphs, the input interface is configured to receive a signal via at least one network.

[0271] Paragraph 41: In some embodiments, in the computer, system, or first instrument as described in any of the preceding paragraphs, the output interface is configured to indicate a first concentration of an analyte in the fluid.

[0272] Paragraph 42: In some embodiments, in a computer, system or first instrument as described in any of the preceding paragraphs, the output interface includes a display interface, and wherein indicating the first concentration of the analyte in the fluid includes providing a digital indication of the first concentration on the display interface.

[0273] Paragraph 43: In some embodiments, in the computer, system or first apparatus as described in any of the preceding paragraphs, the signal is received using an input interface, and wherein the first concentration is determined by using at least one processor.

[0274] Paragraph 44: In some embodiments, in a method, system or first apparatus as described in any of the preceding paragraphs, a computer-readable storage medium is encoded with a plurality of instructions that, when executed by a computer, perform the method as described in any of the preceding paragraphs.

[0275] Paragraph 45: In some embodiments, in the method described in any of the preceding paragraphs, the fluid in contact with the probe is a first sample supplied by a source of the sample, and further comprising: switching a valve positioned upstream of the probe to remove the source of the sample from fluid communication with the probe, and placing a source of a regeneration fluid in fluid communication with the probe; and contacting the probe with the regeneration fluid. In some embodiments, a system and / or first instrument described in any of the preceding paragraphs is configured to perform the method.

[0276] Paragraph 46: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, the system and / or first instrument also includes a valve positioned upstream of the probe, and a source of regeneration fluid positioned upstream of the valve, wherein: the valve is switchable between multiple positions, each of the multiple positions placing the probe in fluid communication with a source among multiple sources, the multiple sources including a source of regeneration fluid, and the multiple sources including a source of sample.

[0277] Paragraph 47: In some embodiments, in the method described in any of the preceding paragraphs, the fluid in contact with the probe is a first sample supplied by a source of the sample, and the method further comprises: closing the first valve to remove the source of the sample from fluid communication with the probe; opening the second valve to place a source of a regeneration fluid in fluid communication with the probe; and contacting the probe with the regeneration fluid, wherein opening the first valve supplies the sample directly to the probe and / or opening the second valve supplies the regeneration fluid directly to the probe. In some embodiments, a system and / or first instrument described in any of the preceding paragraphs is configured to perform the method.

[0278] Paragraph 48: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, a system and / or first instrument also includes a plurality of valves positioned upstream of the probe, wherein: the plurality of valves include a first valve positioned between the source of the sample and the probe and a second valve positioned between the source of the regeneration fluid and the probe, and opening the first valve supplies the sample directly to the probe and / or opening the second valve supplies the regeneration fluid directly to the probe.

[0279] Paragraph 49: In some embodiments, in the method as described in any of the preceding paragraphs, the method is performed in a first instrument, the fluid is a first sample, the probe is a first probe, and the method further comprises performing the following steps in the first instrument: contacting the first probe with a first sequence of fluids, wherein the first sequence of fluids comprises a first sample and a regeneration fluid; contacting the second probe with a second sequence of fluids, wherein the second sequence of fluids comprises a second sample and a regeneration fluid; and after contacting the first probe with the regeneration fluid, contacting the first probe with a third sample. In some embodiments, a system and / or first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0280] Paragraph 50: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, the system and / or first instrument further comprises: a plurality of probes, wherein the plurality of probes comprises probes; a plurality of inlets; and a source of regeneration fluid, wherein: each inlet is fluidically connected to a probe in the plurality of probes, each inlet is configured to be reversibly fluidically connected to a source of regeneration fluid and / or a source of sample, and the first instrument is configured to alternately contact each probe with the regeneration fluid and a sample in a plurality of samples supplied from the source of sample.

[0281] Paragraph 51: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the signal or optical signal is associated with the sample.

[0282] Paragraph 52: In some embodiments, in the method as described in any of the preceding paragraphs, the method further comprises comparing the signal to a model signal profile. In some embodiments, a system and / or a first apparatus as described in any of the preceding paragraphs is configured to perform the method.

[0283] Paragraph 53: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, claim 51, the model signal profile is associated with normal operation of the first instrument.

[0284] Paragraph 54: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the model signal profile is associated with a fault of the first instrument.

[0285] Paragraph 55: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the model signal profile is associated with the presence of bubbles in the fluid contacting the probe.

[0286] Paragraph 56: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the change in the signal is its first-order derivative.

[0287] Paragraph 57: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the fluid is a first sample of a plurality of samples, and wherein the analyte is present in the first sample at a first concentration.

[0288] Paragraph 58: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the change in the signal indicates an association constant between the analyte and the reagent immobilized on the probe.

[0289] Paragraph 59: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the change in the signal indicates a dissociation constant between the analyte and the reagent immobilized on the probe.

[0290] Paragraph 60: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the change in the signal indicates the affinity between the analyte and the reagent immobilized on the probe.

[0291] Paragraph 61: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the signal comprises fluorescence.

[0292] Paragraph 62: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid is configured to cause detachment of at least a portion of the analyte immobilized on the probe.

[0293] Paragraph 63: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid comprises a buffer.

[0294] Paragraph 64: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid buffer has a pH greater than or equal to 1 and less than or equal to 5.

[0295] Paragraph 65: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid buffer comprises glycine.

[0296] Paragraph 66: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid buffer comprises sodium acetate.

[0297] Paragraph 67: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid buffer comprises citrate.

[0298] Paragraph 68: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid buffer comprises phosphate, Tris buffer and / or sodium hydroxide.

[0299] Paragraph 69: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid comprises biotin.

[0300] Paragraph 70: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the regeneration fluid comprises histidine.

[0301] Paragraph 71: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the regeneration fluid comprises nickel ions.

[0302] Paragraph 72: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the first apparatus comprises a source of neutralizing fluid.

[0303] Paragraph 73: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the neutralization fluid comprises a buffer.

[0304] Paragraph 74: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the neutralizing fluid buffer has a pH greater than or equal to 6 and less than or equal to 8.

[0305] Paragraph 75: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the neutralization fluid has a pH greater than or equal to 9.

[0306] Paragraph 76: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the neutralizing fluid buffer is phosphate buffered saline.

[0307] Paragraph 77: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the neutralizing fluid buffer is a Tris buffer.

[0308] Paragraph 78: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument includes a valve configured to switch between a source of fluid, a source of regeneration fluid and a source of neutralization fluid.

[0309] Paragraph 79: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the valve is positioned upstream of the inlet.

[0310] Paragraph 80: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of sources includes a source of a neutralizing fluid.

[0311] Paragraph 81: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of sources includes a source of fluid comprising a first antibody.

[0312] Paragraph 82: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of sources includes a source of fluid comprising a second antibody.

[0313] Paragraph 83: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of sources includes a source of wash buffer.

[0314] Paragraph 84: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of sources includes a source of fluid comprising a substrate for the second antibody.

[0315] Paragraph 85: In some embodiments, a method as in any of the preceding paragraphs further comprises switching a valve to remove a source of regeneration fluid from fluid communication with the probe and to place a source of neutralization fluid in fluid communication with the probe. In some embodiments, a system and / or first apparatus as in any of the preceding paragraphs is configured to perform the method.

[0316] Paragraph 86: In some embodiments, a method as described in any of the preceding paragraphs further comprises contacting the probe with a neutralizing fluid. In some embodiments, a system and / or first apparatus as described in any of the preceding paragraphs is configured to perform the method.

[0317] Paragraph 87: In some embodiments, a method as described in any of the preceding paragraphs further comprises switching a valve to remove a source of neutralizing fluid from fluid communication with the probe and place a source of sample in fluid communication with the probe. In some embodiments, a system and / or first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0318] Paragraph 88: In some embodiments, a method as described in any of the preceding paragraphs further comprises contacting a second sample supplied by a source of samples with the probe. In some embodiments, a system and / or first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0319] Paragraph 89: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument includes a waste container.

[0320] Paragraph 90: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the waste receptacle is positioned downstream of the outlet.

[0321] Paragraph 91: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the first apparatus further comprises a purification filter.

[0322] Paragraph 92: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the purification filter is positioned between the source of the sample and the probe.

[0323] Paragraph 93: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument further comprises a degassing filter.

[0324] Paragraph 94: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, a degassing filter is positioned between the source of the sample and the probe.

[0325] Paragraph 95: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument further comprises a vacuum degasser.

[0326] Paragraph 96: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument further comprises an ultrasonic degasser.

[0327] Paragraph 97: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument also includes a heater and / or a cooler configured to perform degassing.

[0328] Paragraph 98: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument includes a manifold.

[0329] Paragraph 99: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the manifold supplies fluid from a source of fluid to the probe.

[0330] Paragraph 100: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the probe is in fluid communication with a microfluidic channel positioned in the manifold.

[0331] Paragraph 101: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the microfluidic channel includes a bend.

[0332] Paragraph 102: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the microfluidic channel includes a step.

[0333] Paragraph 103: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument further comprises a temperature control system.

[0334] Paragraph 104: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, a temperature control system is associated with the probe.

[0335] Paragraph 105: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, a temperature control system is associated with a conduit connecting the probe fluid to the valve.

[0336] Paragraph 106: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, a temperature control system is associated with the manifold.

[0337] Paragraph 107: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the first apparatus further comprises a source of diluent.

[0338] Paragraph 108: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument is configured to mix a diluent with the plurality of samples upstream of the valve.

[0339] Paragraph 109: In some embodiments, a method as described in any of the preceding paragraphs further comprises contacting the probe with a plurality of fluids in repeated cycles. In some embodiments, a system and / or first apparatus as described in any of the preceding paragraphs is configured to perform the method.

[0340] Paragraph 110: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the second probe is contacted with the second sample while the probe is contacted with the regeneration fluid.

[0341] Paragraph 111: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the second probe is contacted with the second sample while the probe is contacted with the neutralizing fluid.

[0342] Paragraph 112: In some embodiments, a method as described in any of the preceding paragraphs further comprises contacting two or more probes with a common sample simultaneously. In some embodiments, a system and / or first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0343] Paragraph 113: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument further comprises at least one probe which is not in contact with the sample, while the two or more probes are in contact with a common sample.

[0344] Paragraph 114: In some embodiments, a method as described in any of the preceding paragraphs further comprises detecting a signal generated from each probe contacting the common sample. In some embodiments, a system and / or first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0345] Paragraph 115: In some embodiments, a method as described in any of the preceding paragraphs further comprises comparing signals generated from probes contacting a common sample. In some embodiments, a system and / or first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0346] Paragraph 116: In some embodiments, a method as described in any of the preceding paragraphs further comprises determining, based on the signal comparison, whether there is an anomaly associated with one or more of the probes contacting the common sample. In some embodiments, a system and / or first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0347] Paragraph 117: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the at least one probe is in contact with a fluid other than a sample.

[0348] Paragraph 118: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of fluids comprises a fresh sample of the fluid.

[0349] Paragraph 119: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of fluids includes a regeneration fluid.

[0350] Paragraph 120: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of fluids comprises a buffer.

[0351] Paragraph 121: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of probes comprises probes that are different from each other.

[0352] Paragraph 122: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of probes comprises two or more probes that are not different from each other.

[0353] Paragraph 123: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the probes in the plurality of probes are not different from each other.

[0354] Paragraph 124: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of probes comprises probes connected in series with each other.

[0355] Paragraph 125: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the plurality of probes comprises probes in parallel with each other.

[0356] Paragraph 126: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, contacting the probe with the fluid includes contacting the probe with the fluid for a period of time greater than or equal to 1 second and less than or equal to 5 hours.

[0357] Paragraph 127: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, contacting the probe with the fluid includes contacting the probe with the fluid for a time period greater than or equal to 5 seconds and less than or equal to 1 minute.

[0358] Paragraph 128: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the repeated cycles occur within a time period greater than or equal to 30 seconds and less than or equal to 90 seconds.

[0359] Paragraph 129: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the change in the signal over time indicates the binding rate of the analyte to the probe.

[0360] Paragraph 130: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the fluid is a crude sample.

[0361] Paragraph 131: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises a buffer.

[0362] Paragraph 132: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises one or more components of a cell culture medium.

[0363] Paragraph 133: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises glucose.

[0364] Paragraph 134: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises lactate.

[0365] Paragraph 135: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises one or more types of amino acids.

[0366] Paragraph 136: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises one or more types of salts.

[0367] Paragraph 137: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises one or more types of proteins.

[0368] Paragraph 138: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the one or more types of proteins include protein A.

[0369] Paragraph 139: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the one or more types of proteins include host cell proteins.

[0370] Paragraph 140: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises peptides.

[0371] Paragraph 141: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises one or more types of nucleic acids.

[0372] Paragraph 142: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the crude sample further comprises one or more types of cells.

[0373] Paragraph 143: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the first apparatus is in fluid communication with an additional apparatus.

[0374] Paragraph 144: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument is configured to separate the fluid flowing out of the second instrument into a plurality of samples.

[0375] Paragraph 145: In some embodiments, a method as described in any of the preceding paragraphs further comprises: outputting a signal if the amount of the analyte exceeds a predefined amount. In some embodiments, a system and / or a first instrument as described in any of the preceding paragraphs is configured to perform the method.

[0376] Paragraph 146: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the signal is an electrical signal.

[0377] Paragraph 147: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the signal is transmitted via a standard specified in open platform communications.

[0378] Paragraph 148: In some embodiments, in a method, system or first apparatus as described in any of the preceding paragraphs, the signal instructs an additional apparatus to perform an action.

[0379] Paragraph 149: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the action is stopping.

[0380] Paragraph 150: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the action is to change the flow rate of the fluid flowing out of the additional apparatus.

[0381] Paragraph 151: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the action is providing the fluid flowing out of the additional apparatus to a different reservoir.

[0382] Paragraph 152: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the action is to change the flow rate of a fluid flowing in the additional apparatus.

[0383] Paragraph 153: In some embodiments, in a method, system, or first apparatus as described in any of the preceding paragraphs, the fluid is received from the additional apparatus in a manner that maintains the sterility of the fluid remaining in the additional apparatus.

[0384] Paragraph 154: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the additional apparatus is a chromatography system.

[0385] Paragraph 155: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the additional apparatus is a bioreactor.

[0386] Paragraph 156: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the additional apparatus is a filtering device.

[0387] Paragraph 157: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the additional apparatus is a centrifuge.

[0388] Paragraph 158: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the additional apparatus is a pump.

[0389] Paragraph 159: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the additional apparatus is a valve.

[0390] Paragraph 160: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is immobilized on the probe.

[0391] Paragraph 161: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is a protein.

[0392] Paragraph 162: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the protein is protein A.

[0393] Paragraph 163: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the protein is protein G.

[0394] Paragraph 164: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the protein is protein L.

[0395] Paragraph 165: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the agent is a peptide.

[0396] Paragraph 166: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is an antibody.

[0397] Paragraph 167: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is an antigen.

[0398] Paragraph 168: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the agent is a small molecule.

[0399] Paragraph 169: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the agent is a virus.

[0400] Paragraph 170: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is a cell.

[0401] Paragraph 171: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the agent is a differentiated cell type.

[0402] Paragraph 172: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is a polysaccharide.

[0403] Paragraph 173: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the agent is a bacterium.

[0404] Paragraph 174: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is a nucleic acid.

[0405] Paragraph 175: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the nucleic acid is DNA.

[0406] Paragraph 176: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is streptavidin.

[0407] Paragraph 177: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the reagent is aminopropylsilane.

[0408] Paragraph 178: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is Ni-NTA.

[0409] Paragraph 179: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is a lectin.

[0410] Paragraph 180: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reagent is glutathione.

[0411] Paragraph 181: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument includes an optical cable, and wherein the optical cable transmits light to the optical detector.

[0412] Paragraph 182: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument includes a plurality of optical detectors.

[0413] Paragraph 183: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, each optical detector of the plurality of optical detectors is associated with a probe.

[0414] Paragraph 184: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the probe is an optical probe.

[0415] Paragraph 185: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the probe is a fiber optic probe.

[0416] Paragraph 186: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the first apparatus comprises an optical cable.

[0417] Paragraph 187: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the probe transmits light through one or more apertures.

[0418] Paragraph 188: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the one or more apertures are positioned on a side of the probe opposite the optical cable.

[0419] Paragraph 189: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the optical cable is configured to transmit light to the probe.

[0420] Paragraph 190: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, an optical cable transmits light from the light source to the probe.

[0421] Paragraph 191: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the light source supplies light at multiple wavelengths.

[0422] Paragraph 192: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the light source is a halogen lamp.

[0423] Paragraph 193: In some embodiments, in a method, system or first apparatus as in any preceding paragraph, the first apparatus comprises a plurality of light sources, each light source being associated with a different probe.

[0424] Paragraph 194: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, two or more probes are associated with a single light source.

[0425] Paragraph 195: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument includes an optical switch configured to switch the probe associated with the light source.

[0426] Paragraph 196: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, the optical cable is configured to transmit light from the probe.

[0427] Paragraph 197: In some embodiments, in the method, system, or first apparatus as described in any of the preceding paragraphs, an optical cable transmits light from the probe to the optical detector.

[0428] Paragraph 198: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the optical detector is a spectrometer.

[0429] Paragraph 199: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a protein.

[0430] Paragraph 200: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the protein is protein A.

[0431] Paragraph 201: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the protein is a host cell protein.

[0432] Paragraph 202: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the protein is an Fc receptor.

[0433] Paragraph 203: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a peptide.

[0434] Paragraph 204: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is an antibody.

[0435] Paragraph 205: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the antibody is IgG.

[0436] Paragraph 206: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is an antigen.

[0437] Paragraph 207: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a small molecule.

[0438] Paragraph 208: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a virus.

[0439] Paragraph 209: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a capsid.

[0440] Paragraph 210: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a cell.

[0441] Paragraph 211: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a differentiated cell type.

[0442] Paragraph 212: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a polysaccharide.

[0443] Paragraph 213: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is bacteria.

[0444] Paragraph 214: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a nucleic acid.

[0445] Paragraph 215: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the nucleic acid is DNA.

[0446] Paragraph 216: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is RNA.

[0447] Paragraph 217: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is mRNA.

[0448] Paragraph 218: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is an exosome.

[0449] Paragraph 219: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is an extracellular vesicle.

[0450] Paragraph 220: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a plasmid.

[0451] Paragraph 221: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is an antibody fragment.

[0452] Paragraph 222: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a nutrient.

[0453] Paragraph 223: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a metabolite.

[0454] Paragraph 224: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a metabolic byproduct.

[0455] Paragraph 225: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte is a hormone.

[0456] Paragraph 226: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument also includes a controller.

[0457] Paragraph 227: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the controller provides instructions periodically.

[0458] Paragraph 228: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the controller provides instructions on demand.

[0459] Paragraph 229: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the controller provides instructions, and wherein the instructions are related to fluid flow.

[0460] Paragraph 230: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the controller provides instructions, and wherein the instructions are related to optical signal detection.

[0461] Paragraph 231: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument is interfaced with an additional instrument that performs a biological process.

[0462] Paragraph 232: In some embodiments, in the method, system or first instrument as described in any of the preceding paragraphs, the first instrument monitors a biological process.

[0463] Paragraph 233: In some embodiments, in the method, system, or first instrument as described in any of the preceding paragraphs, the first instrument reports results of measurements performed on a fluid undergoing a biological process.

[0464] Paragraph 234: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the measurement is performed on a sample of a fluid undergoing a biological process.

[0465] Paragraph 235: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the reporting of the measurement results has a sufficiently low time lag to enable bioprocess control.

[0466] Paragraph 236: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the analyte becomes immobilized on the probe while the fluid is flowing through the probe.

[0467] Paragraph 237: In some embodiments, in a method, system or first apparatus as described in any of the preceding paragraphs, the instructions include instructions to modify one or more properties of a fluid in a bioprocessing system, supply the fluid to a different location, pause and / or take no action.

[0468] Paragraph 238: In some embodiments, in the method, system or first apparatus as described in any of the preceding paragraphs, the fluid in the bioprocessing system is different from the fluid in one or more aspects.

[0469] Paragraph 239: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, the system includes a processor in electronic communication with the detector, and wherein the processor is programmed to determine whether a threshold has been reached based on a change in the signal over a first time period.

[0470] Paragraph 240: In some embodiments, in a method, system or first instrument as described in any of the preceding paragraphs, the output interface includes a display interface, and wherein the display interface is configured to provide a digital indication of the signal and / or a first-order derivative of the signal.

[0471] Paragraph 241: In some embodiments, a method as described in any of the preceding paragraphs further comprises: outputting a signal if the change in the derivative of the optical signal exceeds a predefined amount. In some embodiments, a system and / or a first apparatus as described in any of the preceding paragraphs is configured to perform the method.

[0472] Example 1

[0473] In this example, advantages associated with detecting changes in the optical signal over time are presented.

[0474] Fig.19 The K D =1 nM for an analyte with a binding constant to the probe, used to simulate the optical signal of equilibrium fixation of the analyte on the probe. Fig.19 As can be seen, there is a range of analyte concentrations in the fluid (enclosed in the shaded rectangle) that produce optical signals that can be easily distinguished. Analyte concentrations above or below this value produce optical signals that are more difficult to distinguish. This is Fig. 20 Schematically shown in , some of these concentrations are enclosed in shaded boxes.

[0475] However, if the change in the optical signal over time is measured instead, the concentrations of the analytes within the range shown in the shaded box can be easily resolved from one another. Fig.21 As shown schematically in Fig.21 As can be seen in , fluids with different concentrations of analyte that have very similar equilibrium immobilization levels on the probe exhibit analyte immobilization on the probe at different rates. Fig.21 In the embodiment of the present invention, concentration C1 is higher than concentration C2, but the fluids with both analyte concentrations show very similar equilibrium levels of analyte fixation. However, the fluid with analyte concentration C1 exhibits faster analyte fixation than the fluid with analyte concentration C2. Therefore, measuring the change of the optical signal over time can be used to easily determine the analyte concentration in such fluids with relatively high accuracy.

[0476] Example 2

[0477] In this example, a method for regenerating a probe is described.

[0478] Figure 22 to Figure 24 A method is schematically depicted in which a probe is contacted with a fluid that may contain an analyte and then regenerated. As shown in these figures, a three-way valve is positioned upstream of an inlet of a housing containing the probe. The three-way valve switches between positions that place the probe in fluid communication with a source of fluid (in this case, a chromatography column, labeled "Sample from chromatography column"), a regeneration fluid, and a neutralization fluid (labeled "Buffer"). A pump and a waste reservoir (labeled "Waste") are positioned downstream of the probe, and the pump pumps fluid from the housing containing the probe to the waste reservoir. As shown in the Fig. 22 As shown in , the first step is to contact a sample of fluid from a chromatographic column with a probe by flowing it across the probe. During this step, changes in the optical signal are detected and used to determine the concentration of the analyte in the sample of fluid. Then, as Fig.23 As shown in , the three-way valve selects the regeneration fluid for contact with the probe and supplies the regeneration fluid, which then flows across the probe and then into the waste reservoir. Finally, as Fig.24 As shown in , a three-way valve selects the neutralizing fluid for contact with the probe and supplies the neutralizing fluid, which then flows across the probe and into the waste reservoir. Fig.24 After following the steps shown in Fig. 22 The steps shown in (and possible Fig.23 and Fig.24 ).

[0479] Fig.25The amount of analyte binding to the probe during each of the above steps is shown when employed in a system to which the column supplies a fluid containing the analyte as a monoclonal antibody and for which the probe is functionalized with Protein A. Fig.25 As can be seen in Figure 1, during contact of the probe with the analyte-containing fluid (method step No. 0), both the optical signal and its first derivative (as smoothed by a numerical filter) increase, with the latter increasing faster than the former. Then, when the probe is contacted with the regeneration fluid (method step No. 1), the optical signal drops to a value close to zero and its first derivative becomes zero. This is believed to be due to a decrease in the pH of the fluid in contact with the probe during regeneration, which is believed to cause a decrease in the affinity of the monoclonal antibody for protein A and thereby cause the monoclonal antibody to detach from the probe. Upon subsequent exposure of the probe to a neutralizing fluid (method step No. 2), the optical signal and its first derivative remain relatively constant. The increase in the pH of the fluid in contact with the probe during neutralization is believed to allow protein A to bind during subsequent contact of the probe with a sample of the fluid.

[0480] Example 3

[0481] The method described in Example 2 can also be performed in an instrument that includes one or more microfluidic channels instead of tubing. Fig.26 A non-limiting example of such an instrument is depicted in FIG. Fig.26 As shown in, the instrument may include a housing including a microfluidic channel, a probe in fluid communication with the microfluidic channel, and a switchable valve positioned upstream of the probe. The switchable valve positioned upstream of the probe may include three positions: a position in which the probe is placed in fluid communication with a post, a position in which the probe is placed in fluid communication with a source of a buffer, and a position in which the probe is placed in fluid communication with a source of a regenerative fluid. The switchable valve may be switched between these three positions so that the probe is placed in fluid communication with these three sources of fluid (possibly in the order of a post, then the source of the regenerative fluid, and then the source of the buffer). The valve may be switched between these three positions in a repetitive manner so that the probe is alternately contacted with a sample of the fluid supplied by the post and the probe is regenerated. During the contact period between the probe and the sample of the fluid, the amount of the analyte in the sample of the fluid may be detected. The process may repeat a preset time period until the analyte exceeds a preset amount, and / or until the operator stops the operation.

[0482] Example 4

[0483] In this example, an instrument including multiple probes is described.

[0484] An instrument similar to the instrument including a microfluidic channel described in Example 2 may be provided, except that it may include multiple valves and multiple probes. Fig. 27The plurality of valves may include an upstream-most switchable valve including a plurality of positions, each of the plurality of positions placing the column in fluid communication with a downstream switchable selector valve of the plurality of downstream switchable selector valves.

[0485] The most upstream switchable valve can be switched between different positions to place different downstream selector valves in fluid communication with the column. Each downstream switchable selector valve can be associated with a probe of the plurality of probes and can include three positions: a position that places the probe associated therewith in fluid communication with the most upstream switchable valve, a position that places the probe in fluid communication with a source of buffer, and a position that places the probe in fluid communication with a source of regeneration fluid.

[0486] The downstream switchable selector valve and the upstreammost switchable valve can be switched together to place each probe in fluid communication with these three sources of fluid (possibly in the order of column, then source of regeneration fluid and then source of buffer). Such switching can also cause samples of fluid from the column to be continuously provided to the instrument, and at least one probe of the plurality of probes is always in fluid communication with the column.

[0487] Example 5

[0488] In this example, an instrument is described that includes a number of different types of probes.

[0489] Fig.28 One non-limiting example of an instrument including a plurality of different types of probes is shown. Fig.28 The instrument shown in is similar to the instrument including the microfluidic channel described in Example 2, except that it includes three different types of probes. The three different types of probes are arranged in series downstream of the valve. The fluid flowing through the instrument can flow through each of these types of probes continuously. For example, when a sample of the fluid contains more than one analyte whose concentration is desired to be detected, such an instrument may be useful. Different types of probes can be configured to detect different types of analytes, and therefore can allow detection of several types of analytes in a single instrument and / or a single flowing fluid.

[0490] Example 6

[0491] In this example, an instrument including two filters, a source of diluent, and a temperature control system is described.

[0492] Fig.29 One non-limiting example of an apparatus is shown including a purification filter, a degassing filter, a source of diluent, and a temperature control system. Fig.29The apparatus shown in is similar to the apparatus including the microfluidic channel described in Example 2, except that it includes these additional components. The purification filter can be placed upstream of the source of diluent, and the degassing filter can be placed downstream of the switchable valve. The temperature control system can be adapted to control the temperature of the switchable valve, the degassing filter and / or the housing.

[0493] Example 7

[0494] In this example, an apparatus is described which comprises a switchable valve comprising seven positions.

[0495] Fig.30 A non-limiting example of an instrument comprising a switchable valve comprising seven positions is shown. Fig.30 The instrument shown in is similar to the instrument including a microfluidic channel described in Example 2, except that the switchable valve has more positions. Fig.30 The switchable valve shown in can reversibly place the probe in fluid communication with the column, a source of the primary antibody, a source of the secondary antibody, a wash buffer, a regeneration fluid, and a substrate for the secondary antibody. Fig.30 An instrument such as that shown in may be adapted to perform assays on a sample of fluid obtained from the column.

[0496] Example 8

[0497] In this example, a method of detecting breakthrough of an analyte from a chromatography column is described.

[0498] Monoclonal antibodies are produced in an apparatus for performing continuous perfusion culture of a Chinese hamster ovary cell line. Cells are removed from the perfusion permeate using alternating tangential flow filtration and collected in a preparation vessel. The preparation vessel is used as a feed solution for affinity chromatography performed in a continuous simulated moving bed chromatography system. The continuous simulated moving bed chromatography system is in fluid communication with an instrument comprising a probe functionalized with protein A as a reagent. The operation is similar to that of the instrument described in Example 2. Here, a continuous simulated moving bed chromatography system comprising a built-in chromatographic column is used as a chromatographic column, a regeneration fluid is a 10 mM glycine buffer at a pH of 2, and a neutralizing fluid is a phosphate buffered saline at a pH of 7.4. The circulation of these three fluids in contact with the probe occurs within one minute.

[0499] Fig.31The first derivative of the optical signal measured over a period of 27 cycles (labeled "Gradient") is shown. For the first 800 seconds, the optical signal has a constant and low first derivative below 0.4 nm / min. This supports the proposition that no significant penetration of the monoclonal antibody occurred during this time period. Then, the first derivative of the optical signal starts to increase, which indicates monoclonal antibody penetration. Finally, the first derivative of the optical signal increases above the previously defined threshold of 1 nm / min (at Fig.31 ), which triggers column switching, wherein the fluid flowing out of a column in the continuous simulated moving bed chromatography system and contacting the probe is diverted to flow to another column therein instead. At this point in time, the feed solution from the preparation tank is transferred to another column according to the simulated moving bed chromatography process.

[0500] Offline measurements were performed on the diverted stream and showed that the concentration of the monoclonal antibody in the fluid at the time the threshold was reached was 0.02 g / L, indicating that the loss of the monoclonal antibody was insignificantly low. After the column switch was triggered, the stream from the other column was not supplied to the probe for 108 minutes, a period of time shorter than the shortest possible penetration time of the other column. Subsequently, the stream from the other column was supplied to the probe, the optical signal associated with the probe was measured, the instrument was again operated as described above, and the time before the column was penetrated was recorded.

[0501] The procedure described in the previous paragraph was repeated over a three-day period and the amount of time to column breakthrough was measured for each run of the instrument. Fig.32 The total yield of monoclonal antibody (i.e., 100% multiplied by the ratio of monoclonal antibody in the final eluate to all monoclonal antibody recovered from the continuous simulated moving bed chromatography system) was 96.9%, and the concentration of monoclonal antibody in the final eluate was 15.1 g / L (the approximate concentration of monoclonal antibody in the feed solution was 0.7 g / L). In addition, DNA and HCP impurities were largely removed (i.e., 2.1 log removal to 30 ppm and 3.6 log removal to 38 ppm, respectively).

[0502] Example 9

[0503] summary

[0504] Biopharmaceuticals, such as monoclonal antibodies (mAbs), are used to treat many serious diseases, such as cancer, infections, autoimmune diseases and inflammatory diseases. The market for mAbs continues to grow due to high specificity, activity and fewer side effects compared to conventional drugs. To improve manufacturing economics, flexibility and obtain more consistent product quality, continuous or semi-continuous biomanufacturing for process intensification would be desirable. However, there are still many challenges to overcome due to high process complexity, difficulties in (digital) process integration and response to process changes.

[0505] In this study, fully integrated and continuous upstream and capture steps with an overall control strategy for the production of mAbs are shown. Advanced control strategies are achieved by docking related equipment as well as novel process analytical technologies with an overall custom software component. The custom software component is used to trigger and control specific equipment actions based on monitored process data. Starting from a perfusion process with an alternating tangential flow module for cell retention, mAbs are captured from the permeate by simulated moving bed (SMB) affinity chromatography. Set point changes and variations throughout the upstream process are addressed by dynamic flow control. In addition, dynamic loading of the SMB is achieved by a newly developed sensor based on continuous biolayer interferometry to detect mAb penetration within the flow-through. This novel approach provides several benefits, such as high specificity and low background signals, leading to desired (e.g., high) resin utilization while reducing (and in some cases avoiding) product losses.

[0506] Aided by an overall control strategy, a robust continuous process operated for several days with high yield and purity of mAb. The results of this study and the novel analytical approach employed offer great potential for establishing adaptive continuous manufacturing of biopharmaceuticals.

[0507] introduction

[0508] Monoclonal antibodies (mAbs) are used to treat many serious diseases, such as cancer, infection, autoimmune diseases, and inflammatory diseases. Due to their high specificity, activity, and fewer side effects compared to conventional drugs, the market for mAbs continues to grow, accounting for more than 60% of the global biopharmaceutical industry revenue.

[0509] To reduce manufacturing costs, which would allow for wider patient access, continuous or semi-continuous biomanufacturing for process intensification would be desirable. Improvements would be desirable for continuous upstream process (USP) cultures. Some USP cultures undesirably require continuous addition of unspent media, removal of spent media containing mAbs by extraction of permeate, and retention of cells in the bioreactor. Therefore, implementation of USP in the highly regulated biomanufacturing industry remains challenging due to the complexity of process development and the required automated control strategies. As a result, it has not been widely used in the industry for mAb production.

[0510] In order to avoid bottlenecks and fully exploit the possible benefits of such continuous USP, it would be beneficial to strengthen the downstream process (DSP). Some DSP processes undesirably exhibit limited loading capacity and high costs. Mitigating such shortcomings by cycling several times may negatively lead to reduced yields, longer processing times and associated potential impacts on product quality.

[0511] The application of continuous simulated moving bed (SMB) chromatography as a method of DSP intensification provides increased productivity while reducing buffer consumption and manufacturing facility footprint, while maintaining product yield and purity at laboratory and pilot scales. The implementation of SMB technology allows the resin particles to remain in the packed bed while "delivery" of the resin is achieved with the aid of switching column inlets and outlets. By using a multi-column chromatography (MCC) approach, the product flowthrough of one column is loaded onto another column, avoiding product losses while increasing resin utilization beyond the dynamic binding capacity. This allows for significant improvements as large batch columns can sometimes be loaded to only 65% ​​of their static binding capacity. Once fully loaded, a column switch is applied and the column is washed, eluted, and regenerated before entering the next loading cycle. Using a countercurrent sequence, the efficiency of the process is further improved due to the enhanced driving force for mass transfer throughout the contact zone. As a result, mass transfer can exceed the thermodynamic limits of batch or simultaneous chromatography processes.

[0512] For continuous SMB process, it may be undesirable to rely on predefined schemes about loading volume and flow rate and therefore for post switching time. This requires several assumptions, such as constant and known product concentration in feed solution, all posts have the same binding capacity, and the binding capacity remains constant in the whole process. Any deviation from these assumptions leads to an inefficient process with low productivity or a low productivity caused by product loss. Dynamic loading can be obtained by the penetration detection of mAb in the flow-through of the last post in the loading cycle, which then triggers the post switching. This provides several benefits, such as the ability to compensate for variable mAb concentrations in the feed solution (e.g., by changes in cell culture) and the reduction of product losses caused by changes in the column capacity.

[0513] To perform (near) real-time process monitoring and control, several process analytical technology (PAT) tools can be used for rapid mAb quantification, such as IR or Raman spectroscopy. UV spectroscopy is an example of another technique that can be used for mAb breakthrough detection. One approach is to use UV absorption at 280 nm to calculate the difference signal of two detectors located at the column inlet and column outlet. Another approach is to use partial least squares regression modeling of the UV / Vis absorption spectrum instead of single wavelength measurements. However, these methods offer several disadvantages, such as low specificity of the UV signal (mAb and impurities contribute to absorption at 280 nm) and very high background signals due to media components in the feed solution. This poses a challenge for detecting very low mAb concentrations within the flow-through to avoid product losses.

[0514] A promising approach to overcome these limitations could be biolayer interferometry (BLI). This label-free technique is based on interference patterns obtained from a combination of white light reflected from an internal reference surface and the biolayer ( Fig.33). The high affinity of the analyte to the immobilized molecules at the biocompatible surface and thus the binding leads to an increase in thickness at the surface of the biosensor, which in turn is measured as a concentration-dependent signal by a change in optical interference ( Fig.33 ). To quantify mAbs, specific biosensors with protein A immobilized on their surface can be used.

[0515] On-line or near-line measurements would facilitate the application of process control strategies such as dynamic loading of continuous SMB chromatography.

[0516] In this study, a novel BLI-based prototype was proposed that allows continuous near-line measurement of mAbs for breakthrough detection in a continuous SMB chromatography process. This approach was implemented in an overall control strategy for dynamic loading and dynamic flow control. Continuous mAb perfusion culture was combined with a continuous capture step and control was performed fully autonomously over 3 days by the established overall control strategy.

[0517] In addition, surface plasmon resonance (SPR) technology can be used to implement one or more process control strategies disclosed herein, such as dynamic loading and dynamic flow control of continuous SMB chromatography. Like BLI, SPR is a label-free binding technology that can measure the binding kinetics of biomolecular interactions in real time. In SPR, a sensor chip is used to immobilize one or more binding partners to its surface. SPR technology can achieve continuous online or near-line measurement of mAbs for breakthrough detection of continuous SMB chromatography processes to help avoid product loss.

[0518] SPR technology also provides benefits for mAb penetration detection. As with BLI, one of the benefits provided by SPR technology is increased specificity, which results in lower background signals, which allows for lower detection limits for earlier detection of mAb penetration. This is particularly important for detecting very low mAb concentrations to avoid product loss.

[0519] Materials and methods

[0520] Perfusion culture

[0521] A 2 L Univessel® glass bioreactor (Sartorius, Germany) was inoculated at 0.2∙106 cells / mL from a standard batch seed culture of the Cellca CHO DG44 cell line (Sartorius, Germany) expressing an IgG1 type mAb. The process was controlled at 36.8 °C, pH 7.1 and DO 60%. After a three-day batch phase, the pH was changed to 6.95 and perfusion was started at 1 vessel volume per day (VVD) using a proprietary perfusion media formulation. An ATF2 device (Repligen, USA) was connected to the bioreactor bottom drain to retain the cells. During the initial cell growth phase, the perfusion rate was increased as needed to maintain a cell-specific perfusion rate (CSPR) of 50 μL / cell / day. The process control strategy was implemented in Fig.34 Figure 2. In summary, the perfusion rate was controlled using a gravimetric feed flow controller in combination with removal of the cell-free permeate to maintain a constant working volume of 2 L. Automatic cell drain was used to maintain the target viable cell concentration (VCC). This was achieved using a PID controller in the BioPAT® MFCS (Sartorius, Germany) that controlled the drain pump speed based on an in-line biomass measurement (BioPAT® ViaMass, Sartorius, Germany).

[0522] Continuous capture

[0523] The cell-free perfusion permeate was transferred to a 2-L intermediate preparation tank and from there it was processed continuously through a BioSMB PD chromatography system (Sartorius, Germany). A 5 mL MabSelect SuRe™ pre-packed HiTrap column (2.5 cm column height, 1.6 cm column diameter, Cytiva, USA) was used for affinity mAb capture. The initial protocol for all stages was: loading of perfusion permeate, interconnecting wash of 3 column volumes (CV), wash of 8.5 CV, elution of 4 CV, equilibration of 5 column CVs, cleaning in place (CIP) of 5 CVs and equilibration of 5 CVs. All used buffer chemicals for equilibration and washing (PBS, pH 7.4), elution (50 mM C2H3NaO2, pH 3.0) and CIP (0.1 M NaOH) were purchased from Carl Roth (Germany). The flow rate was kept constant at 1.3 mL / min for all steps except loading.

[0524] For advanced control strategies, the dynamic flow control of the BioSMB PD system as well as the dynamic loading function were used with the corresponding OPC UA interface. Three phases with different loading flow rates (low = 2.1 mL / min, medium = 2.4 mL / min, and high = 2.7 mL / min) but based on the same protocol with the same number of transitions and relative duration of each step were used for the dynamic flow rate function to allow for changes between phases during operation. Based on the dynamic loading function, the perfusion permeate was continuously loaded over a minimum loading volume of 52 CV until mAb was detected in the flow-through of the last column in the loading cycle.

[0525] Continuous Biolayer Interferometry

[0526] mAb breakthrough in the flow-through of the SMB capture process measured by a continuous BLI prototype ( Fig.35 For specific mAb measurements, a biosensor with immobilized protein A was used ( Figure 35 to Figure 36 , Octet ProA biosensor, Sartorius, Germany).

[0527] One measurement cycle consists of the following steps: sample application (step 1; flow-through from the last sequentially connected column during the loading step), regeneration (step 2; 10 mM glycine, adjusted to pH 2.0 with HCl), and neutralization (step 3; PBS, pH 7.4). One complete cycle lasts 60 s ( Fig.37 Left). The different solutions required for each step are provided by using valves upstream of the biosensor and pumps downstream ( Fig.35 Left, Fig.36 ). For all steps, the pump rate was 120 rpm, resulting in a flow rate of 1.09 mL / min. The biosensor was illuminated by a lamp with white light, and the interference of the reflected light from the internal coating within the biosensor and the end of the probe was detected by a spectrometer ( Fig.36 According to the principle of BLI, the immobilization of mAb to the protein A biosensor results in an increase in thickness at the end of the probe, which leads to a wavelength shift and an increase in the binding signal ( Fig.37 Left). This in turn is proportional to the mAb concentration in solution.

[0528] To obtain a concentration-dependent signal with a low lag time, the binding rate corresponding to step 1 of the first derivative of the binding signal was used. Fig.37 Middle left, exemplary trajectories of binding signal and binding rate for three steps of three consecutive cycles are shown. As becomes apparent from the figure, the maximum binding rate value is obtained more quickly ( ) than the binding signal itself, which reaches a maximum plateau only after an extended period of time. Fig.37Left). For purified mAb samples diluted in PBS, the maximum on-rates obtained as a function of mAb concentration reveal a clear nonlinear dependence ( Fig.37 right).

[0529] Control strategy architecture

[0530] The process control components for orchestrating the instruments embedded in the continuous bioprocess were implemented using the Node-RED integrated development environment (version 1.3.4, OpenJS Foundation, CA, USA). All devices were part of the same network infrastructure. The communication nodes for interacting with the laboratory equipment were “node-red-contrib-opcua” for interacting with the OPC UA interface of BioSMB and the permeate blending tank balance (Cubis II, Sartorius, Germany) implemented into the BioPAT® MFCS and the built-in TCP nodes for interacting with the continuous BLI prototype (all from Sartorius Stedim Biotech GmbH, Göttingen, Germany). Timer-related events were implemented using the “node-red-contrib-looptimer-advanced” node. In addition, built-in core nodes were used to establish the control scripts ( Fig.38 The software components were deployed on a Raspberry Pi 4 B 4GB single-board computer running Raspberry Pi OS (Debian 11; kernel 5.15, RaspberryPi Foundation, United Kingdom).

[0531] analyze

[0532] To determine mAb concentrations, size exclusion chromatography (SEC) was used as a high-performance liquid chromatography (HPLC) with a Dionex UltiMate 3000 HPLC system (ThermoFisher Scientific, Waltham, USA) and a Yarra 3 μm SEC 3000 column (Phenomenex, Torrance, USA) at a flow rate of 1 mL / min. A SEC buffer solution containing 0.1 M Na2SO4 and 0.05 M Na2HPO4 with a final pH of 6.6 was used (all chemicals were purchased from Carl Roth (Karlsruhe, Germany)). The SEC method was previously validated with analytical protein A HPLC to ensure appropriate mAb determination (data not shown). If necessary, samples were diluted with SEC buffer before analysis and filtered through a Minisart RC4 0.2 μm syringe filter (Sartorius, Göttingen, Germany). mAb concentrations were determined based on the peak area (at 220 nm) of a calibration curve obtained using known reference mAb materials.

[0533] HCP concentrations were determined by CHO HCP-ELISA (Cygnus Technologies, Southport, USA) according to the manufacturer’s instructions. If necessary, samples were diluted in ELISA buffer (20 mM TRIS, 50 mM NaCl; all chemicals were purchased from Karl Roth (Karlsruhe, Germany)). Measurements were performed with an Infinite M Nano Plus microplate reader (Tecan Trading AG, Switzerland) with a detection limit of 1 ng / mL.

[0534] The concentration of DNA was measured by Quant-iT™ PicoGreen™ dsDNA Assay Kit (ThermoFisher Scientific, Waltham, USA). If necessary, samples were diluted in TE buffer (10 mM TRIS, 1 mM EDTA, 0.1% SDS; all chemicals were purchased from Karl Roth (Karlsruhe, Germany)). The measurement was performed by an Infinite M NanoPlus microplate reader with a detection limit of 31.25 ng / mL.

[0535] The parts per million (ppm) values ​​of HCP and DNA were calculated according to Equation 1. imp ), where c imp is the concentration of the corresponding impurity, and cmAb is the concentration of mAb.

[0536]

[0537] Results and discussion

[0538] Continuous USP Perfusion Culture

[0539] To allow for continuous production of mAbs, a 2-L stirred tank bioreactor was operated in perfusion mode. By utilizing a membrane-based cell retention device, product can be continuously withdrawn from the bioreactor and transferred to an intermediate formulation tank and then further processed using a continuous chromatography system. Fig.34 A schematic overview of the perfusion setup and the main control loop is shown, which is implemented to enable a fully automated and robust process even at high cell concentrations. A gravimetric flow controller is used to maintain a steady addition of fresh perfusion medium. A permeate controller will be coupled to the bioreactor weight to maintain a constant working volume. Since the working volume is not only affected by the addition of feed, but also by the current discharge rate and the addition of corrective agents (e.g., for foam or pH control), this results in the permeate flow rate being more unpredictable and prone to fluctuations. In order to compensate for the resulting fluctuations in the permeate flow rate and to enable a robust integrated process, dynamic flow rate regulation is implemented as part of the overall DSP control strategy. This control strategy is very advantageous due to the reliable culture conditions and optimal nutrient supply obtained.

[0540] Cell growth and viability in perfused cell culture Fig.39 As a result of the culture conditions of the applied control loop, high viability and similar rapid cell growth as previously reported for this cell line were observed during the initial growth phase. Just before the target VCC of 45∙106 cells / mL was achieved, automated cell draining was initiated on day 5, which facilitated a smooth transition to the quasi-steady-state phase of the process ( Fig.39 For the rest of the perfusion procedure, the target VCC was well controlled, with only one significant deviation on day 10. Here, the actual VCC was about 30% lower than the target VCC ( Fig.39 ), which is believed to be caused by changes in the VCC-capacitance-correlation and thus the deviation of the online and offline VCC measurements. Although the process quickly stabilized after the recalibration was performed, due to the control strategy implemented above, this deviation affected the current discharge flow rate and therefore also the permeate flow rate. However, continuous product capture from the perfused permeate was achieved between culture days 12 and 16. During this period, the average mAb concentration in the permeate stream was about 0.7 g / L.

[0541] Adaptive control strategies for continuously captured dynamic flows and loads

[0542] For continuous capture of mAbs directly from perfusion culture, continuous affinity SMB chromatography was used. To establish a robust process and be able to respond to fluctuations in USP, an overall advanced control strategy was developed.

[0543] The cell-free perfusion permeate is collected in a preparation tank placed on a balance. The preparation tank is directly connected to the load inlet of the SMB chromatography system. The balance signal is transmitted via an OPC UA interface. For dynamic flow control (which can compensate for changes in the perfusion flow rate from USP), the loading flow rate of the SMB chromatography system is adjusted to maintain a constant weight of approximately 1 kg of the preparation tank. The preparation tank weight as well as the current loading flow rate are constantly retrieved by the overall control strategy. A preparation tank weight of less than 0.9 kg causes a switch from a medium loading flow rate to a low flow rate, while a weight greater than 1.1 kg triggers a high flow rate ( Fig.38 and Fig.40 ).

[0544] To compensate for titer variations within the USP and different breakthrough times resulting from different loading flow rates, a dynamic loading function was also implemented in the overall control strategy. Based on the initial chromatographic protocol, loading and sequential connection of the flow-through from one column to another were continued until mAb breakthrough was detected in the flow-through of the subsequent column by sequential BLI prototyping ( Fig.40 ). After breakthrough detection, the continuous BLI measurement was in standby mode for 108 min. This corresponds to the minimum loading time of the SMB chromatogram based on the highest expected titer throughout the USP to avoid unnecessary measurements.

[0545] To obtain synchronization between the SMB chromatography system and the continuous BLI prototype, the status of the chromatography system is continuously polled by the overall control strategy software component. A pause / resume function of the overall control script and the associated wait time before the measurement of the continuous BLI prototype are implemented to ensure a stable process even in the case of unexpected events such as potential overpressure in the chromatography system ( Fig.38 ).

[0546] During the entire continuous capture process, a total of 34 loading steps were performed by the SMB chromatography system in approximately 3 days ( Fig.41 ). To start the process and initial loading of the column, the first 3 loading steps were performed according to the predefined initial protocol without a dynamic control strategy. Therefore, the loading time for loading steps 1 to 3 was exactly 108 min, which is the loading time of the initial protocol and corresponds to the highest expected mAb titer of 1 g / L across the USP ( Fig.41 ).

[0547] Starting from the second cycle corresponding to the fourth loading step, after 108 min loading time, continuous BLI measurements were automatically started by the overall control strategy. The mAb breakthrough of the flow-through of the last (in this setup, the second) column in series during the interconnected loading steps was monitored. Fig.41 In (top), the binding rate signal from the continuous BLI prototype is exemplarily shown for the seventh loading step. Due to the cyclic measurement principle, the binding rate signal is obtained every minute. The binding rate remains at a low baseline level below 0.4 nm until 800 s measurement time, which indicates that no significant amount of mAb is present in the flow-through ( Fig.41 ). From that point on, the value continued to increase, which represented the gradual breakthrough of the mAb from the column. At the 27th cycle of the continuous BLI measurement (starting after 1560 s), the predefined threshold of the binding rate of 1 nm / min was exceeded ( Fig.41 ), which leads to the stopping of the measurement and the column switching of the SMB chromatography through the overall control strategy ( Fig.38 ). For the 7th and 27th consecutive BLI measurements, the mAb concentration in the flow-through at the end of the loading step was exemplarily determined to be below 0.02 g / L, indicating no significant product loss due to dynamic loading.

[0548] During the whole process, mAb breakthrough was observed only after 108 min ( Fig.41 , lower panel), which confirms the calculated minimum expected loading time. The loading time of the fourth loading step was significantly longer compared to the other loading steps, which is due to underloading of the column in the initial startup cycle of SMB chromatography, which is not controlled by the dynamic loading strategy. Later in the process, due to the decrease in mAb titer in the permeate (Table 1) and due to the reduction of the loading flow rate in part by the dynamic flow control in this time frame ( Fig.42 ), resulting in longer loading times and, consequently, later mAb penetration ( Fig.41 , figure below).

[0549] After the initial filling of the dispensing tank at the beginning of the process, a first cycle corresponding to the first three loading steps is performed based on a predefined protocol with a medium loading flow rate ( Fig.42 For the next cycle, starting from a process time of 5.4 h, the dynamic flow control strategy was already in effect, resulting in a switch to a fast flow rate after exceeding the threshold of 1.1 kg after approximately 9 h ( Fig.42 However, due to the slightly increased VCC at the start of continuous capture integration ( Fig.39) and the resulting higher permeate flow rate, the level in the dispense tank was further increased to 1.2 kg. However, after the VCC had been readjusted back to the target value of approximately 45∙106 cells / mL and the cell-specific perfusion rate was maintained, the rapid loading flow rate was sufficient to reduce the dispense tank weight back to the desired range. After approximately 45 h of process time, the weight dropped below 1 kg, which led to a switch to a moderate flow rate and a subsequent increase in the dispense tank level ( Fig.42 ). During the subsequent process time, the blending tank weight varied between 1 and 1.1 kg, which is within the desired range according to the control strategy ( Fig.42 ).

[0550] Table 1. mAb concentrations for the permeate and different chromatography outlet pools throughout the 3 process days.

[0551]

[0552] The different outlets of the chromatography system were combined on each process day and analyzed together with the permeate sample from the blending tank (Table 1, Fig.43 ). The mAb concentration in the permeate as feed for continuous SMB chromatography varied between 0.81 g / L and 0.55 g / L throughout the 3 process days, likely due to minor changes in VCC and product sieving effects during the USP perfusion process. However, a non-decreasing, consistent mAb concentration in the eluate with an average value of 15.1 g / L was obtained. This demonstrates optimal resin utilization of the dynamic loading control strategy despite changes in product concentration within the USP.

[0553] Throughout the process, only trace amounts of mAb were detected in the flow-through (0.013 g / L, representing the detection limit of the SEC used for quantification), again highlighting the lack of significant product loss through the control strategy. While the combined waste fractions also did not show significant mAb concentrations, small amounts of product were detected in the wash fractions, likely due to too short interconnecting column wash steps. However, for the entire process, a high mAb yield of 96.9% was obtained relative to the total mass of mAb recovered in all outlets.

[0554] At the same time, process-related impurities were significantly removed throughout the process. DNA was removed to an average of 30.3 ppm, which represents a 2.1 log reduction ( Fig.43 In addition, a 3.6 log reduction was obtained for HCP, resulting in an average amount of 37.5 ppm in the eluate ( Fig.43 ).

[0555] Discussion and Conclusion

[0556] Due to the implemented USP control strategy for perfusion feed, cell drain and perfusion permeate, culture conditions with adequate nutrient supply were obtained, resulting in a robust and well-controlled process enabling the maintenance of high cell densities while maintaining high viability.

[0557] The resulting changes in mAb concentration and potential changes or differences in column binding capacity are addressed by the overall control strategy, which allows the benefits of such enhanced USP to be delivered to the DSP. Due to dynamic loading control, column loading is automatically adjusted to obtain good resin utilization without significant product loss. In addition, a robust continuous process is provided by dynamic flow control, which maintains the permeate blend tank within the desired range throughout the process. The resulting changes in loading flow rate are also addressed by dynamic loading, which in turn changes the breakthrough time point during the loading step. This further highlights the interaction and mutual benefit of the two DSP control strategies applied.

[0558] The advantages become even more apparent when the results of this study are compared to a similar process without adaptive control. Compared to a conservative predefined protocol, a more than 100% increase in mAb concentration in the eluate was obtained through good resin utilization due to dynamic loading, while impurity levels remained equal. This also led to an increase in productivity of the subsequent DSP unit operation.

[0559] The novel continuous BLI prototype used in this study was able to reliably detect mAb breakthrough at each loading step. Only very low background signals were obtained, which probably represent small amounts of mAb leached during loading. Throughout the entire process, no threshold adjustment or biosensor replacement was required, despite more than 1000 measurement cycles being performed.

[0560] In conclusion, the novel prototype for continuous BLI showed multiple benefits. SPR technology can also be used for advanced control of bioprocessing unit operations such as mAb capture. Moreover, the use of different biosensors with other immobilized ligands on the surface offers great potential for monitoring and process control of several biopharmaceuticals such as recombinant proteins, viruses, exosomes, etc. Moreover, quality attributes such as HCP content, glycosylation pattern or binding kinetics can be studied near-line using appropriate biosensors and system settings.

[0561] Although several embodiments of the present invention have been described and illustrated herein, a person of ordinary skill in the art will easily envision a variety of other devices and / or structures for performing the functions and / or obtaining the results and / or one or more advantages described herein, and each of such changes and / or modifications is considered to be within the scope of the present invention. More generally, it will be readily understood by those skilled in the art that all parameters, dimensions, materials, and configurations described herein are intended to be exemplary, and that the actual parameters, dimensions, materials, and / or configurations will depend on one or more specific applications using the teachings of the present invention. Those skilled in the art will recognize or be able to use no more than routine experiments to determine many equivalents of the specific embodiments of the present invention described herein. Therefore, it should be understood that the foregoing embodiments are presented only by way of example, and within the scope of the appended claims and their equivalents, the present invention can be practiced in a manner different from that specifically described and claimed. The present invention is directed to each individual feature, system, article, material, kit, and / or method described herein. In addition, if two or more such features, systems, articles, materials, kits, and / or methods are not mutually inconsistent, any combination of such features, systems, articles, materials, kits, and / or methods is included within the scope of the present invention.

[0562] All definitions, as defined and used herein, should be understood to control over dictionary definitions, definitions in documents incorporated by reference, and / or ordinary meanings of the defined terms.

[0563] Unless explicitly stated to the contrary, the indefinite articles "a" and "an" as used herein in the specification and claims should be understood to mean "at least one".

[0564] The phrase "and / or" as used herein in the specification and in the claims should be understood to mean "either or both" of the elements so combined, i.e., elements that are present in combination in some cases and separately in other cases. Multiple elements listed with "and / or" should be interpreted in the same manner, i.e., "one or more" of the elements so combined. In addition to the elements specifically identified by the "and / or" clause, other elements may optionally be present, whether related or unrelated to those specifically identified elements. Thus, as a non-limiting example, when used in conjunction with open language such as "including", in one embodiment, a reference to "A and / or B" may refer to only A (optionally including elements other than B); in another embodiment, to only B (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); and so on.

[0565] As used herein in the specification and in the claims, "or" should be understood to have the same meaning as "and / or" as defined above. For example, when separating the items in the list, "or" or "and / or" should be interpreted as inclusive, i.e., including at least one of a plurality or a series of elements, but also including more than one, and optionally additional unlisted items. Only terms that clearly indicate the opposite (such as "only one of ..." or "exactly one of ..." or "consisting of ..." when used in the claims) will refer to including exactly one element of a plurality or a series of elements. In general, when there are exclusive terms such as "any", "one of ...", "only one of ..." or "exactly one of ..." in front, the term "or" used in this article should only be interpreted as representing an exclusive alternative (i.e., "one or the other, but not both"). When used in the claims, "essentially consisting of ..." should have the common meaning used in the field of patent law.

[0566] As used herein in the specification and claims, when referring to a list of one or more elements, the phrase "at least one" should be understood to mean at least one element selected from any one or more of the elements in the list of elements, but does not necessarily include at least one of each element specifically listed in the list of elements, and does not exclude any combination of elements in the list of elements. This definition also allows that elements other than the elements specifically identified in the list of elements to which the phrase "at least one" refers may optionally be present, whether related or unrelated to those specifically identified elements. Thus, as a non-limiting example, "at least one of A and B" (or equivalently, "at least one of A or B", or equivalently "at least one of A and / or B") may refer to at least one (optionally including more than one) A, without B (and optionally including elements other than B) in one embodiment; may refer to at least one (optionally including more than one) B, without A (and optionally including elements other than A) in another embodiment; may refer to at least one (optionally including more than one) A and at least one (optionally including more than one) B (and optionally including other elements) in yet another embodiment; and so on.

[0567] It should also be understood that in any method claimed herein that includes more than one step or action, the order of the steps or actions of the method is not necessarily limited to the order in which the steps or actions of the method are described unless explicitly indicated to the contrary.

[0568] In the claims and in the foregoing description, all transitional phrases such as "comprising," "including," "carrying," "having," "containing," "involving," "maintaining," "consisting of," etc. shall be construed as open ended, i.e., meaning including, but not limited to, "consisting of." Only the transitional phrases "consisting of" and "consisting essentially of" shall be closed or semi-closed transitional phrases, respectively, as set forth in Section 2111.03 of the U.S. Patent Office Manual of Patent Examining Procedures.

Claims

1. A method comprising: contacting the probe with a fluid for a first period of time, wherein the fluid is supplied by a bioprocessing system, wherein the fluid is flowing through the probe, wherein an analyte is present in the fluid at a first concentration, and wherein at least a portion of the analyte becomes immobilized on the probe; detecting a change in the signal during a first time period; determining the first concentration based on the change in the signal during the first time period; and Based on the determination of the first concentration, instructions are sent to the biological processing system.

2. A system comprising: a first instrument, the first instrument comprising a probe and a detector, the detector configured to detect a change in a signal over a first time period; and Biological treatment systems, wherein the system is configured to supply fluid from the bioprocessing system to the first instrument, wherein the first instrument is configured to determine a first concentration of an analyte in the fluid based on a change in the signal within a first time period as the fluid contacts and flows through the probe, and wherein the system is configured to send instructions to the bioprocessing system based on the determination of the first concentration.

3. A method comprising: contacting the probe with a fluid for a first period of time, wherein the fluid is flowing through the probe, wherein an analyte is present in the fluid at a first concentration, and wherein at least a portion of the analyte becomes immobilized on the probe; detecting a change in the optical signal during the first time period; and determining the first concentration based on a change in the optical signal during the first time period, The optical signal includes light reflected from an interface inside the probe and light reflected from an end of the probe.

4. A first apparatus, comprising: Probe; and an optical detector configured to detect a change in the optical signal within a first time period, wherein the first instrument is configured to determine a first concentration of an analyte in a fluid contacting and flowing through the probe based on a change in the optical signal during the first time period, and The optical signal includes light reflected from an interface inside the probe and light reflected from an end of the probe.

5. The method according to claim 1, wherein: When in contact with the probe, the fluid is the output of the bioprocessing system.

6. The system according to claim 2, wherein: The fluid is supplied to the first instrument as output from the bioprocessing system.

7. The method according to claim 1 or the system according to claim 2, wherein: The fluid is supplied to the first instrument in an automated manner.

8. The method of claim 1 or the system of claim 2, wherein: The instructions include modifying one or more properties of a fluid in the biological processing system.

9. The system according to claim 2, wherein: The system includes a second biological treatment system.

10. The system according to claim 9, wherein: The second biological processing system is configured to supply a second fluid output from the second biological processing system to the first instrument.

11. The system according to claim 2, wherein: The detector is configured to detect a change in the second signal within a second time period.

12. The system according to claim 10, wherein: The first instrument is configured to determine a second concentration of a second analyte in the second fluid as the second fluid contacts and flows through the probe based on a change in the second signal during the second period of time.

13. The system according to claim 12, wherein: The system is configured to send second instructions to the biological processing system based on the determination of the second concentration.

14. The system according to claim 13, wherein: The second instructions include modifying one or more properties of a fluid in the bioprocessing system, continuing to supply the second fluid to the probe, supplying the second fluid to a different location, and / or taking no action.

15. The method of claim 1 or the system of claim 2, wherein: The bioprocessing system includes a chromatography system.

16. The method or system of claim 15, wherein: The system further comprises a second biological treatment system, and wherein the second biological treatment system comprises a bioreactor.

17. The method of claim 1 or the system of claim 2, wherein: The biological treatment system includes a bioreactor.

18. The method or system of claim 17, wherein: The bioreactor is a fed-batch bioreactor.

19. The method or system of claim 17, wherein: The bioreactor is a fed-batch bioreactor.

20. The method or system of claim 17, wherein: The bioreactor is a perfusion bioreactor.

21. The method of claim 1 or the system of claim 2, wherein: The biological treatment system includes a filtration system.

22. The method or system of claim 21, wherein: The filtration system is a tangential flow filtration system and / or an ultrafiltration / diafiltration system.

23. The method of claim 1 or the system of claim 2, wherein: The bioreactor comprises a centrifugation system and / or a centrifuge.

24. The method of claim 1 or the system of claim 2, wherein: The signal is an optical signal.

25. The method or system of claim 24, wherein: The optical signal includes light reflected from an interface inside the probe and light reflected from an end of the probe.

26. The method or system of claim 24, wherein: The optical signal comprises light reflected from a surface of the probe within a restricted angular range.

27. The method of claim 1 or the system of claim 2, wherein: The signal is a mechanical signal.

28. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus includes a light source.

29. The method, system or first apparatus of claim 28, wherein: The light source supplies light within a restricted wavelength range.

30. The method, system or first apparatus of claim 28, wherein: The light source includes an LED.

31. The method of claim 1 or claim 3, the system of claim 2 or the apparatus of claim 4, wherein: The analyte is unlabeled.

32. The method of claim 1 or the system of claim 2, wherein: The fluid is supplied from a column in the chromatography system.

33. The method or system of claim 237, wherein: The different locations are different columns and / or different chromatographic media in the chromatography system.

34. The method of claim 1 or claim 3, the system of claim 2 or the apparatus of claim 4, wherein: The fluid is supplied from the probe to a waste reservoir.

35. The method of claim 1 or claim 3, further comprising washing the column from which the fluid is supplied.

36. The method of claim 1 or claim 3, further comprising eluting a column from which the fluid is supplied.

37. The method of claim 1 or claim 3, further comprising regenerating a column from which the fluid is supplied.

38. The system of claim 2, wherein: The system includes a processor in electronic communication with the detector, and wherein the processor is programmed to determine the first concentration based on a change in the signal over the first time period.

39. A computer for executing the method according to claim 1, the computer comprising an input interface configured to receive the signal, at least one processor programmed to determine the first concentration based on the change of the signal during the first time period, and an output interface configured to send instructions to the biological processing system.

40. The computer according to claim 39, wherein: The input interface is configured to receive the signal via at least one network.

41. The computer according to claim 39, wherein: The output interface is configured to indicate the first concentration of the analyte in the fluid.

42. The computer according to claim 39, wherein: The output interface comprises a display interface, and wherein indicating the first concentration of the analyte in the fluid comprises providing a numerical indication of the first concentration on the display interface.

43. The method of claim 1 or the system of claim 2, wherein: The signal is received using an input interface, and wherein the first concentration is determined using at least one processor.

44. The method of claim 1 or claim 3, wherein: The computer readable storage medium is encoded with a plurality of instructions which, when executed by a computer, perform the method according to claim 1 or claim 3.

45. The method of claim 1 or claim 3, wherein: The fluid in contact with the probe is a first sample supplied by a source of samples, and the method further comprises: switching a valve positioned upstream of the probe to remove a source of the sample from fluid communication with the probe and to place a source of a regeneration fluid in fluid communication with the probe; and The probe is contacted with the regeneration fluid.

46. ​​The system of claim 2 or the first apparatus of claim 4, further comprising: a valve positioned upstream of the probe; and a source of regeneration fluid, the source of regeneration fluid being positioned upstream of the valve, wherein: The valve is switchable between a plurality of positions. Each position of the plurality of positions places the probe in fluid communication with a source of the plurality of sources, The plurality of sources includes a source of regeneration fluid, and The plurality of sources comprises a source of samples.

47. The method of claim 1 or claim 3, wherein: The fluid in contact with the probe is a first sample supplied by a source of samples, and the method further comprises: closing a first valve to remove a source of the sample from fluid communication with the probe; opening a second valve to place a source of regeneration fluid in fluid communication with the probe; and contacting the probe with the regeneration fluid, The first valve is opened to supply the sample directly to the probe, and / or the second valve is opened to supply the regeneration fluid directly to the probe.

48. The system of claim 2 or the first apparatus of claim 4, further comprising: a plurality of valves positioned upstream of the probe, wherein: The plurality of valves include a first valve positioned between a source of a sample and the probe and a second valve positioned between a source of a regeneration fluid and the probe, and The first valve is opened to supply the sample directly to the probe, and / or the second valve is opened to supply the regeneration fluid directly to the probe.

49. The method of claim 1 or claim 3, wherein: The method is performed in a first instrument, wherein the fluid is a first sample, wherein the probe is a first probe, and the method further comprises: In the first apparatus, the following steps are performed: contacting the first probe with a first sequence of fluids, wherein the first sequence of fluids comprises the first sample and a regeneration fluid, contacting a second probe with a second sequence of fluids, wherein the second sequence of fluids comprises a second sample and the regeneration fluid, and After contacting the first probe with the regeneration fluid, the first probe is contacted with a third sample.

50. The system of claim 2 or the first apparatus of claim 4, further comprising: a plurality of probes, wherein the plurality of probes includes the probe; Multiple entrances; and A source of regeneration fluid, wherein: each inlet is in fluid communication with a probe of the plurality of probes, Each inlet is configured to be in reversible fluid communication with a source of the regeneration fluid and / or a source of the sample, The first instrument is configured to contact each probe alternately with the regeneration fluid and a sample of a plurality of samples supplied from the source of samples.

51. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The signal or the optical signal is associated with a sample.

52. The method of claim 1 or claim 3, further comprising comparing the signal to a model signal profile.

53. The method of claim 52, wherein: The model signal profile is associated with normal operation of the first instrument.

54. The method of claim 52, wherein: The model signal profile is associated with a fault of the first instrument.

55. The method of claim 52, wherein: The model signal profile is associated with the presence of bubbles in the fluid contacting the probe.

56. The method of claim 1 or the system of claim 2, wherein: The change in the signal is the first derivative of the signal.

57. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The fluid is a first sample of a plurality of samples, and wherein the analyte is present in the first sample at a first concentration.

58. The method of claim 1 or the system of claim 2, wherein: The change in the signal is indicative of the association constant between the analyte and the reagent immobilized on the probe.

59. The method of claim 1 or the system of claim 2, wherein: The change in the signal is indicative of the dissociation constant between the analyte and the reagent immobilized on the probe.

60. The method of claim 1 or the system of claim 2, wherein: The change in the signal indicates the affinity between the analyte and the reagent immobilized on the probe.

61. The method of claim 1 or the system of claim 2, wherein: The signal comprises fluorescence.

62. The method of claim 45, wherein: The regeneration fluid is configured to cause detachment of at least a portion of the analyte immobilized on the probe.

63. The method of claim 45, wherein: The regeneration fluid includes a buffer.

64. The method of claim 63, wherein: The regeneration fluid buffer has a pH greater than or equal to 1 and less than or equal to 5.

65. The method of claim 63, wherein: The regeneration fluid buffer comprises glycine.

66. The method of claim 63, wherein: The regeneration fluid buffer comprises sodium acetate.

67. The method of claim 63, wherein: The regeneration fluid buffer comprises citrate.

68. The method of claim 63, wherein: The regeneration fluid buffer comprises phosphate, Tris buffer and / or sodium hydroxide.

69. The method of claim 45, wherein: The regeneration fluid comprises biotin.

70. The method of claim 45, wherein: The regeneration fluid comprises histidine.

71. The method of claim 45, wherein: The regeneration fluid contains nickel ions.

72. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus includes a source of a neutralizing fluid.

73. The method, system or first apparatus of claim 72, wherein: The neutralizing fluid includes a buffer.

74. The method, system or first apparatus of claim 73, wherein: The neutralizing fluid buffer has a pH greater than or equal to 6 and less than or equal to 8.

75. The method, system or first apparatus of claim 72, wherein: The neutralization fluid has a pH greater than or equal to 9.

76. The method, system or first apparatus of claim 73, wherein: The neutralizing fluid buffer is phosphate buffered saline.

77. The method, system or first apparatus of claim 73, wherein: The neutralizing fluid buffer is Tris buffer.

78. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus includes a valve configured to switch between a source of the fluid, the source of a regeneration fluid, and a source of a neutralization fluid.

79. The method, system or first apparatus of claim 78, wherein: The valve is positioned upstream of the inlet.

80. The system or first apparatus of claim 46, wherein: The plurality of sources includes a source of a neutralizing fluid.

81. The system or first apparatus of claim 46, wherein: The plurality of sources includes a source of fluid comprising a first antibody.

82. The system or first apparatus of claim 46, wherein: The plurality of sources includes a source of fluid comprising a second antibody.

83. The system or first apparatus of claim 46, wherein: The plurality of sources includes a source of wash buffer.

84. The system or first apparatus of claim 46, wherein: The plurality of sources includes a source of a fluid comprising a substrate for the second antibody.

85. The method of claim 79, further comprising switching the valve to remove the source of the regeneration fluid from fluid communication with the probe and place the source of the neutralization fluid in fluid communication with the probe.

86. The method of claim 85, further comprising contacting the probe with the neutralizing fluid.

87. The method of claim 86, further comprising switching the valve to remove the source of the neutralizing fluid from fluid communication with the probe and place a source of a sample in fluid communication with the probe.

88. The method of claim 84, further comprising contacting a second sample supplied by the source of the sample with the probe.

89. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus includes a waste receptacle.

90. The method, system or first apparatus of claim 89, wherein: The waste receptacle is positioned downstream of the outlet.

91. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus also includes a purification filter.

92. The method, system or first apparatus of claim 91, wherein: The purification filter is positioned between a source of sample and the probe.

93. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus also includes a degassing filter.

94. The method, system or first apparatus of claim 93, wherein: The degassing filter is positioned between a source of sample and the probe.

95. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus also includes a vacuum degasser.

96. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument also includes an ultrasonic degasser.

97. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument also includes a heater and / or a cooler configured to perform degassing.

98. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument includes a manifold.

99. The method, system or first apparatus of claim 98, wherein: The manifold supplies fluid from a source of the fluid to the probe.

100. The method, system or first apparatus of claim 98, wherein: The probe is in fluid communication with a microfluidic channel positioned in the manifold.

101. The method, system or first apparatus of claim 99, wherein: The microfluidic channel includes a bend.

102. The method, system or first apparatus of claim 100, wherein: The microfluidic channel includes a step.

103. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus also includes a temperature control system.

104. The method, system or first apparatus of claim 103, wherein: The temperature control system is associated with the probe.

105. The method, system or first apparatus of claim 103, wherein: The temperature control system is associated with a conduit fluidly connecting the probe to a valve.

106. The method, system or first apparatus of claim 103, wherein: The temperature control system is associated with the manifold.

107. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus also includes a source of diluent.

108. The method, system or first apparatus of claim 107, wherein: The first instrument is configured to mix the diluent with the plurality of samples upstream of the valve.

109. The method of claim 1 or claim 3, further comprising contacting the probe with multiple fluids in repeated cycles.

110. The method of claim 1 or claim 3, wherein: The second probe is contacted with the second sample while the probe is contacted with the regeneration fluid.

111. The method of claim 1 or claim 3, wherein: The second probe is contacted with the second sample while the probe is contacted with the neutralization fluid.

112. The method of claim 1 or claim 3, further comprising contacting two or more probes with a common sample simultaneously.

113. The method according to claim 112, wherein: The first instrument also includes at least one probe that is not in contact with the sample when the two or more probes are in contact with the common sample.

114. The method of claim 112, further comprising detecting a signal generated from each probe contacting the common sample.

115. The method of claim 112, further comprising comparing the signals generated from probes contacting the common sample.

116. The method of claim 112, further comprising determining, based on the signal comparison, whether an anomaly is present associated with one or more of the probes contacting the common sample.

117. The method of claim 112, wherein: The at least one probe is in contact with a fluid other than the sample.

118. The method of claim 109, wherein: The plurality of fluids includes a fresh sample of the fluid.

119. The method of claim 109, wherein: The plurality of fluids includes a regeneration fluid.

120. The method of claim 109, wherein: The plurality of fluids includes a buffer.

121. The system or first apparatus of claim 50, wherein: The plurality of probes include probes that are different from each other.

122. The system or first apparatus of claim 50, wherein: The plurality of probes includes two or more probes that are not different from each other.

123. The system or first apparatus of claim 50, wherein: The probes in the plurality of probes are not different from each other.

124. The system or first apparatus of claim 50, wherein: The plurality of probes include probes connected in series with each other.

125. The system or first apparatus of claim 50, wherein: The plurality of probes include probes in parallel with each other.

126. The method of claim 1 or claim 3, wherein: Contacting the probe with the fluid includes contacting the probe with the fluid for a period of time greater than or equal to 1 second and less than or equal to 5 hours.

127. The method of claim 1 or claim 3, wherein: Contacting the probe with the fluid includes contacting the probe with the fluid for a period of time greater than or equal to 5 seconds and less than or equal to 1 minute.

128. The method of claim 109, wherein: The repeating cycle occurs within a time period greater than or equal to 30 seconds and less than or equal to 90 seconds.

129. The method of claim 1 or the system of claim 2, wherein: The change in the signal over time indicates the rate of binding of the analyte to the probe.

130. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The fluid is a crude sample.

131. The method, system or first apparatus of claim 130, wherein: The crude sample also includes a buffer.

132. The method, system or first apparatus of claim 130, wherein: The crude sample also comprises one or more components of the cell culture medium.

133. The method, system or first apparatus of claim 130, wherein: The crude sample also contains glucose.

134. The method, system or first apparatus of claim 130, wherein: The crude sample also contained lactate.

135. The method, system or first apparatus of claim 130, wherein: The crude sample also contains one or more types of amino acids.

136. The method, system or first apparatus of claim 130, wherein: The crude sample also includes one or more types of salts.

137. The method, system or first apparatus of claim 130, wherein: The crude sample also comprises one or more types of proteins.

138. The method, system or first apparatus of claim 137, wherein: The one or more types of proteins include protein A.

139. The method, system or first apparatus of claim 137, wherein: The one or more types of proteins include host cell proteins.

140. The method, system or first apparatus of claim 130, wherein: The crude sample also contains peptides.

141. The method, system or first apparatus of claim 130, wherein: The crude sample also contains one or more types of nucleic acids.

142. The method, system or first apparatus of claim 130, wherein: The crude sample also comprises one or more types of cells.

143. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument is in fluid communication with an additional instrument.

144. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument is configured to separate fluid flowing from the second instrument into a plurality of samples.

145. The method of claim 1 or claim 3, further comprising: If the amount of analyte exceeds a predefined amount, a signal is output.

146. The method of claim 145, wherein: The signal is an electrical signal.

147. The method of claim 145, wherein: The signal is transmitted via a standard specified in open platform communications.

148. The method of claim 145, wherein: The signal instructs the attached instrument to perform an action.

149. The method of claim 148, wherein: The action is to stop.

150. The method of claim 148, wherein: The action is to change the flow rate of the fluid flowing out of the attached instrument.

151. The method of claim 148, wherein: The action is to provide fluid from an attached instrument to a different reservoir.

152. The method of claim 148, wherein: The action is to change the flow rate of the fluid flowing within the attached instrument.

153. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: Fluid is received from the additional instrument in a manner that maintains the sterility of the fluid remaining in the additional instrument.

154. The method, system or first apparatus of claim 153, wherein: The additional instrument is a chromatography system.

155. The method, system or first apparatus of claim 153, wherein: The additional instrument is a bioreactor.

156. The method, system or first apparatus of claim 153, wherein: The additional instrument is a filtering device.

157. The method, system or first apparatus of claim 153, wherein: The additional instrument is a centrifuge.

158. The method, system or first apparatus of claim 153, wherein: The additional instrument is a pump.

159. The method, system or first apparatus of claim 153, wherein: The additional instrument is a valve.

160. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The reagent is immobilized on the probe.

161. The method, system or first apparatus of claim 160, wherein: The agent is a protein.

162. The method, system or first apparatus of claim 161, wherein: The protein is protein A.

163. The method, system or first apparatus of claim 161, wherein: The protein is protein G.

164. The method, system or first apparatus of claim 161, wherein: The protein is protein L.

165. The method, system or first apparatus of claim 160, wherein: The agent is a peptide.

166. The method, system or first apparatus of claim 160, wherein: The reagent is an antibody.

167. The method, system or first apparatus of claim 160, wherein: The agent is an antigen.

168. The method, system or first apparatus of claim 160, wherein: The agents are small molecules.

169. The method, system or first apparatus of claim 160, wherein: The agent is a virus.

170. The method, system or first apparatus of claim 160, wherein: The agents are cells.

171. The method, system or first apparatus of claim 160, wherein: The agent is a differentiated cell type.

172. The method, system or first apparatus of claim 160, wherein: The agent is a polysaccharide.

173. The method, system or first apparatus of claim 160, wherein: The agent is a bacterium.

174. The method, system or first apparatus of claim 160, wherein: The agent is a nucleic acid.

175. The method, system or first apparatus of claim 174, wherein: The nucleic acid is DNA.

176. The method, system or first apparatus of claim 160, wherein: The reagent is streptavidin.

177. The method, system or first apparatus of claim 160, wherein: The reagent is aminopropylsilane.

178. The method, system or first apparatus of claim 160, wherein: The reagent is Ni-NTA.

179. The method, system or first apparatus of claim 160, wherein: The agent is a lectin.

180. The method, system or first apparatus of claim 160, wherein: The agent is glutathione.

181. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The first instrument includes a fiber optic cable, and wherein the fiber optic cable transmits light to the optical detector.

182. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument includes a plurality of optical detectors.

183. The method, system or first apparatus of claim 182, wherein: Each optical detector of the plurality of optical detectors is associated with a probe.

184. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The probe is an optical probe.

185. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The probe is a fiber optic probe.

186. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The first apparatus includes a fiber optic cable.

187. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The probe transmits light through one or more apertures.

188. The method, system or first apparatus of claim 187, wherein: One or more apertures are positioned on a side of the probe opposite the fiber optic cable.

189. The method, system or first apparatus of claim 188, wherein: The fiber optic cable is configured to transmit light to the probe.

190. The method, system or first apparatus of claim 188, wherein: The fiber optic cable transmits light from a light source to the probe.

191. The method, system or first apparatus of claim 190, wherein: The light source supplies light of multiple wavelengths.

192. The method, system or first apparatus of claim 190, wherein: The light source is a halogen lamp.

193. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus includes a plurality of light sources, each light source being associated with a different probe.

194. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: Two or more probes are associated with a single light source.

195. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument includes an optical switch configured to switch a probe associated with a light source.

196. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: A fiber optic cable is configured to transmit light from the probe.

197. The method, system or first apparatus of claim 196, wherein: The fiber optic cable transmits light from the probe to an optical detector.

198. The method, system or first apparatus of claim 197, wherein: The optical detector is a spectrometer.

199. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The analyte is a protein.

200. The method, system or first apparatus of claim 199, wherein: The protein is protein A.

201. The method, system or first apparatus of claim 199, wherein: The protein is a host cell protein.

202. The method, system or first apparatus of claim 199, wherein: The protein is an Fc receptor.

203. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a peptide.

204. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is an antibody.

205. The method, system or first apparatus of claim 204, wherein: The antibody is IgG.

206. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is an antigen.

207. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The analyte is a small molecule.

208. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The analyte is a virus.

209. The method of claim 1 or claim 3, the system of claim 2, or the first apparatus of claim 4, wherein: The analyte is a capsid.

210. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analytes are cells.

211. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a differentiated cell type.

212. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a polysaccharide.

213. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is bacteria.

214. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a nucleic acid.

215. The method, system or first apparatus of claim 214, wherein: The nucleic acid is DNA.

216. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is RNA.

217. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is mRNA.

218. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is an exosome.

219. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is an extracellular vesicle.

220. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a plasmid.

221. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is an antibody fragment.

222. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a nutrient.

223. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a metabolite.

224. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analytes are metabolic byproducts.

225. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The analyte is a hormone.

226. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first apparatus also includes a controller.

227. The method, system or first apparatus of claim 226, wherein: The controller periodically provides instructions.

228. The method, system or first apparatus of claim 226, wherein: The controller provides instructions as needed.

229. The method, system or first apparatus of claim 226, wherein: The controller provides instructions, and wherein the instructions are related to fluid flow.

230. The method, system or first apparatus of claim 226, wherein: The controller provides instructions, and wherein the instructions are related to optical signal detection.

231. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: The first instrument interfaces with an additional instrument that performs a biological process.

232. The method, system or first apparatus of claim 231, wherein: The first instrument monitors the biological process.

233. The method, system or first apparatus of claim 231, wherein: The first instrument reports results of measurements performed on a fluid undergoing the biological process.

234. The method, system or first apparatus of claim 233, wherein: The measurements are performed on a sample of a fluid undergoing the biological process.

235. The method, system or first apparatus of claim 233, wherein: The measurement results are reported with a sufficiently low time lag to enable bioprocess control.

236. The method of claim 1 or claim 3, the system of claim 2 or the first apparatus of claim 4, wherein: When the fluid flows through the probe, the analyte becomes immobilized on the probe.

237. The method of claim 1 or the system of claim 2, wherein: The instructions include instructions to modify one or more properties of a fluid in the bioprocessing system, supply the fluid to a different location, pause, and / or take no action.

238. The method or system of claim 237, wherein: The fluid in the biological treatment system differs from the fluid in one or more aspects.

239. The system of claim 2, wherein: The system includes a processor in electronic communication with the detector, and wherein the processor is programmed to determine whether a threshold has been reached based on a change in the signal during the first time period.

240. The computer according to claim 39, wherein: The output interface comprises a display interface, and wherein the display interface is configured to provide a digital indication of the signal and / or a first derivative of the signal.

241. The method of claim 1 or claim 3, further comprising: If the derivative of the optical signal changes by more than a predefined amount, a signal is output.

Citation Information

Cited By

  • Molecular detection method and device based on optical fiber probe and multi-channel optical fiber sensing system

    CN119470356A

  • Intelligent control and adjustment method for high-precision fermentation and purification of stachyose

    CN120400433A